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Abstract
This study involves the development and validation o f methods for the analysis o f 
antibiotic drug molecules. Techniques for the extraction o f residues o f these drugs from 
biological matrices were investigated and subsequently validated. Extraction o f 
sulphonamide residues from porcine muscle was investigated using on-line dialysis, 
followed by trace enrichment. Direct UV detection and post-column derivatisation was 
investigated and methods validated. Matrix solid phase dispersion was investigated for 
the extraction o f penicillin residues form porcine muscle. HPLC separation coupled 
with UV detection o f derivatives o f the extracted residues was performed. The 
determination o f aminoglycoside residues from m ilk and porcine liver was investigated. 
The chromatographic behaviour o f these analytes was studied, followed by analysis o f 
aminoglycoside residues using ion-exchange and immunoaffmity column
chromatography. Finally, a HPLC method for the separation o f aminoglycosides and 
related compounds was developed, using MS detection.
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CHAPTER 1
IN TR O D U C TIO N  TO A N T IB IO T IC  
DRUG RESIDUE ANALYSIS
l
1.1 ANTIBIOTIC RESIDUES IN FOOD
Food safety, which assures that food is “ safe”  for human consumption, involves the 
determination o f various substances present that are likely to cause a toxic effect. 
Chemical residues may be naturally occurring or be present as a result o f human 
intervention. In agriculture, selected antibiotics are available and licensed (under EU and 
national regulations) for use in animal husbandry. The main groups utilised are (3-lactams, 
tetracyclines, sulphonamides, aminoglycosides, and macrolides1. Originally, naturally 
occurring antibacterials were classed as antibiotics, whereas synthetically produced 
antibacterials were classified as chemotherapeutics. More recently, the term antibiotic 
includes naturally occurring and synthetic molecules, which are used for the treatment o f 
bacterial infections. In the 1920’s, the discovery o f penicillin transformed the world o f 
medicine and veterinary science, and was the first o f a wide range o f antibiotics that could 
be used for treating previously fatal bacterial infections.
1.1.1 Reasons for antibiotic use and consequences of residues in food
While antibiotics are required to treat infections in individual animals (therapeutic use), 
they are also used prophylactically, to prevent the occurrence and spread o f infections in 
intensive production systems such as pig and poultry. Prophylactic antibiotic 
administration, through the use o f medicated feedstuffs, has resulted in increased 
resistance to bacterial diseases and improved performance in animals. The use o f 
antibiotics as growth promoting agents also results in improved performance as a result o f 
suppression o f mild, non-diagnosed infections, increased absorption efficiency o f nutrients 
and elimination o f toxins produced by microbes. The presence o f antibiotic drug residues 
in animal products such as milk, meat and eggs can present hazards for public health,
2
industry and the environment. The undesirable effects can be classified as toxicological, 
development o f resistant strains o f bacteria and allergic responses.
A  major public health concern is the increasing occurrence o f strains o f bacteria resistant 
to antibiotics. Some antibiotics are beginning to loose their effectiveness, thereby making 
it difficult to treat some common illnesses. This is due to over-exposure o f humans to 
antibiotics. This phenomenon has resulted in the removal, or restriction on the use o f 
certain antibiotics. The use, and misuse, o f antibiotics in treating diseases in humans is the 
prime cause for development o f resistant bacteria. Continuous use o f antibiotics can result 
in the emergence o f a new generation o f organisms, which possess genes w ith resistance 
to certain antibiotics. Therefore, the use o f antibiotics in animal production can result in 
animals becoming carriers o f resistant bacteria that cause diseases which are difficu lt to 
treat; for example, resistance is common in Salmonella strains originating from veal2. 
Prolonged exposure to antibiotics as a result o f consuming residues contained in food is 
also suspected to contribute to antibiotic resistance. The question as to whether ingestion 
o f antibiotic contaminated food is capable o f suppressing the natural microflora in the 
digestive tract is still controversial. The micro flora protect the body from colonisation by 
pathogenic organisms within the stomach and intestines, and are necessary for the body's 
natural defence mechanisms.
The presence o f antibiotic residues in food is o f major industrial importance. A 
fermentation step is frequently employed for the manufacture o f food products, such as 
cheese and yoghurt, from milk. M ilk contaminated with antibiotic residues, and
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subsequently employed in the manufacture o f cheese or yoghurt, can result in the 
inhibition o f culture development, due to elimination or reduction o f the micro-organism 
necessary to allow fermentation.
While most antibiotics are not toxic at residue levels, some do elicit toxic responses. 
Chloramphenicol3 and penicillin4 antibiotics may exhibit toxicological effects. These 
antibiotics have been responsible for triggering intense immune reactions in susceptible 
individuals. Nitrofuran antibiotics can also elicit toxicological effects, when they persist 
as bound residues that are released as toxic substances5. For most other classes of 
antibiotics, residue levels likely to occur in foods are insufficient to cause acute toxic 
effects.
1.1.2 Factors responsible for antibiotic drug residues occurring in foods
A number o f factors may be responsible for the persistence o f antibiotic drug residues in 
foods. The main reason reported is failure to observe withdrawal times. Following 
antibiotic administration, withdrawal times are specified, after which time the animal or 
animal products are fit for human consumption (residue levels should be below the 
maximum residue lim it (MRL) set by regulation). Early slaughter can result in  the 
occurrence o f residues in animal tissue. Biological factors pertaining to each animal's 
metabolism can also cause residues in foods. Impaired liver or renal function can result in 
incomplete elimination o f the parent compound or its active metabolites from the animal's 
system. Administration o f a number o f drugs in a short time period can affect drug 
elimination from the body, due to inhibition o f hepatic enzymes essential for drug
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metabolism. Improper injection can result in deposition o f the antibiotic, and the rate o f 
elimination from the body is reduced. Also, in intensive farming systems where 
antibiotics are administered in drinking water or medicated feed, carry-over can result in 
the presence o f residues in the finishing feed6.
1.1.3 Control of antibiotic residues
EU member countries are required to test for the presence o f antibiotics and other 
veterinary drug residues in foods o f animal origin7. Maximum Residue Limits (MRLs) 
are the levels o f drug legally permitted and recognised as acccptable in a food. The MRL 
is the maximum concentration o f residue, resulting from the correct use o f a veterinary 
drug, which should occur in food. MRLs are based on the type and amount o f residue 
considered to be without any toxicological hazard for human health as expressed by the 
acceptable daily intake and an additional safety factor. MRLs give an indication o f food 
safety and provide trading standards. Minimum withdrawal periods, post administration, 
are established, which ensure elimination o f the drug and/or metabolites from edible 
tissues to levels at or below the MRL, at m ilking or slaughter.
1.1.4 Matrices examined for antibiotic drug residues
The first step in residue analysis is to decide on a suitable sample. For the analysis o f 
residues o f permitted antibiotics, edible tissues are analysed to check whether any residues 
present are at or below the MRL. Antibiotic levels are frequently determined in milk, 
eggs, meat (muscle, liver, kidney), blood, urine and animal feedstuffs. Body fluids such as
5
urine, m ilk or plasma are easily available and can be used for analysis when animals are 
not intended for slaughter. Determination o f residues in urine can be used as an indication 
o f the levels likely to exist in tissue. Antibiotic monitoring in m ilk is common, as 
antibiotics are frequently employed in the therapeutic treatment o f diseases affecting the 
lactating animal, such as mastitis. For residues o f prohibited antibiotics, a target matrix 
may be used. This is the matrix where the drug residues are most likely to persist. Urine, 
liver and kidney are target matrices due to their role in metabolism and excretion. The 
influence o f tissue matrix on antibiotic detection lim its was investigated by Okennan et 
a l s. The Four-plate test was employed for the analysis o f pork, beef and chicken muscle 
samples. Tetracyclines, sulphonamides, aminoglycosides, (3-lactams, quinolones, and 
macrolides were tested. Tetracyclines were the only antibiotics detected with similar 
efficiency both in the presence and absence o f matrix. Some beta-lactams and 
aminoglycosides were not detected in spiked muscle tissue at concentrations five-fold 
higher than the detection limits without tissue.
Animal feedstuffs are also analysed for antibiotic residues. Animal finishing feed, that 
which is fed to animals in the period before slaughter, should be certified free o f veterinary 
drugs and a specific withdrawal period is set for each antibiotic. The antibiotics 
commonly administered through animal feeds are the macrolides and polypeptides which 
are used in growth promotion and the ionophoric polyether antibiotics, used to improve 
feed efficiency and for the treatment o f coccidiosis. In a recent study by Lynas et al. on 
the analysis o f feedstuffs in Northern Ireland, the authors concluded that o f the 
contaminated feedstuffs detected, chlortetracycline was detected in 50 % o f the samples.
6
Sulphonamides were the next most frequently detected category9. Cross-contamination 
during m illing is the prime cause o f unintended antibiotic residues in feedstuffs.
1.1.5 Method development for analysis of antibiotic residues
In the following section, areas o f particular importance in the chemical analysis o f 
veterinary drug residues are discussed. In addition, terminology frequently employed in 
drag residue method development, and employed in the chapters to follow is addressed.
Quantification Quantification is the determination o f the amount o f antibiotic residue 
present. The amount o f analyte present in the sample is determined by comparison w ith a 
range o f standards, in the form o f a standard curve.
Validation: Once a method has been developed for the determination o f a residue(s), it 
must then be validated. This is the process used to confirm that the analytical procedure 
employed is capable o f determining residues between specific concentration lim its with 
specified accuracy and precision. In the validation o f methods for veterinary drug 
residues, the percentage recovery is determined at various concentrations o f analyte and 
the variation in the recovery assessed over different assays. In the validation o f a 
quantitative analytical method for the determination o f antibiotic residues in biological 
matrices, a number o f important parameters must be clarified, such as sensitivity, 
specificity, accuracy, precision, linearity, and the detection and quantification limits.
Limit o f  detection/quantification'. To be o f use, the method chosen must be capable o f 
determining the analyte at levels below the MRL. The lim it o f detection is defined as the 
smallest concentration o f analyte that produces a signal that exceeds the signal to noise
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ratio by three times. It is also necessary to establish the smallest concentration o f analyte 
that can be determined in a sample, with a specified degree o f accuracy and within 
laboratory reproducibility. This level is defined as the lim it o f quantification o f the 
method. These limits can be expressed in terms o f concentration or absolute mass; 
however, for veterinary drug residues concentration is employed, and expressed in terms 
o f the amount o f sample used for analysis (e.g. ng g'1 or ppb).
Interferences'. An interference is any constituent o f a sample that acts in such a way as to 
hinder the process o f assaying the analyte10. Interferences may be multiplicative or 
additive. Multiplicative interferences do not themselves produce signals o f their own, but 
alter the signal produced by the analyte. They can act in a number o f ways. One example 
is by decreasing the availability o f the specific form o f the analyte responsible for 
producing the measured signal, such as inhibiting derivatisation. Multiplicative 
interferences may also affect the physical process by which the signal is generated (for 
example, during fluorescence detection, quenching o f the signal can occur), or may alter 
the efficiency with which the signal produced by the analyte is transmitted to the detector 
(e.g. emitted luminescence may be absorbed by other sample constituents, preventing it 
from being detected). Additive interferences are species that produce signals o f their own, 
which add to that o f the analyte. These interferences are also apparent in the control 
sample. The presence o f interferences can increase the lim it o f quantification o f the 
method. When the residue concentration is well in excess o f the interferences, their 
presence may go undetected, however; as the residue concentration approaches the lim it o f 
detection o f the method, the analyte signal detected is much lower and so other 
background signals play a much greater role. Therefore, the method may not be 
considered quantitative/qualitative at analyte concentrations affected by interferences.
Precision and accuracy. The accuracy o f a measurement is "the closeness o f agreement 
between the true or assigned value and the mean result obtained by applying the 
experimental procedure a very large number o f times", as defined by ISO. The accuracy 
o f a procedure may be evaluated by applying it to the measurement o f a certified reference 
material or by determining the concentration o f the analyte by an alternative independent 
technique. In addition, a measure o f accuracy may be made by the analysis o f fortified 
samples. The precision is "the closeness o f agreement between the results obtained by 
applying the experimental procedure several times to the same sample under prescribed 
conditions". The precision is the repeatability within one assay (intra-assay) and may be 
extended to several assays (inter-assay).
1.1.6 Overview of the protocol employed for antibiotic residue testing
Sample
Extraction Clean-up
V
positive negative
result result
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The flow chart shows the steps typically involved in antibiotic residue analysis. Similar to 
most residue procedures there are two main areas; sample preparation followed by 
determination. The sample preparation step may be divided into extraction o f the drug 
from the biomatrix, followed by clean-up o f the extract although, in some cases, there is 
overlap between the two categories. The most difficult challenge to the residue analyst is 
that o f extracting the analyte from a complex matrix, w ith a minimum o f matrix co­
extractives. The extent to which the extract requires clean-up varies, depending on the 
method o f determination and the matrix under analysis. Sample pre-treatment is usually 
more extensive for tissue samples than body fluids and the presence o f co-extractives can 
result in higher limits o f determination. Screening methods ideally require minimal 
sample preparation, therefore, the clean-up step is frequently omitted, whereas 
quantitative/confirmatory methods generally require more extensive sample extraction and 
clean-up.
Methods for determining the presence o f antibiotic residues in foods usually fa ll into one 
o f two categories, screening or quantitative/confirmatory methods. When large numbers 
o f samples are presented for analysis, they are often put through an initial screening 
process and those samples found to give a positive result are subjected to further, more 
specific and accurate quantitative analysis. While chemical assays are more specific and 
quantitative than microbial inhibition assays, they usually require considerably more 
sample preparation. Changes in EU legislation and advances in consumer awareness have 
increased the need to develop more specific and sensitive methods for antibiotic analysis. 
With trends towards multiresidue analysis on the increase, a reliable separation technique 
is essential. In addition, the sample extract presented for final determination contains
matrix co-extractives, therefore the quantitative technique must be capable o f 
separating/distinguishing the analyte from any matrix present. A  wide range o f 
determination techniques are available for antibiotics and advances are being made in 
areas such as chromatography and spectroscopy.
1.2 SCREENING ASSAYS 
Screening tests are usually less expensive and less time consuming than the more specific 
quantitative or confirmatory methods. In general, they do not require very laborious 
sample pretreatment steps. They may detect the presence o f an antibiotic residue or a 
class o f antibiotics and usually allow high sample throughput. Biologically based assays, 
frequently employed for screening purposes, include microbial inhibition assays, 
immunoassays, enzyme and receptor assays. Microbial inhibition assays tend to be non­
specific in nature, therefore they are used as screening methods to identify samples which 
may contain antibiotic residues and these query positive samples are then subjected to 
further analysis. They are commonly employed for routine, qualitative analysis, due to 
their speed and ease o f use. Receptor-based assays also allow high sample throughput. 
Immunochemical assays may offer increased specificity and high sample throughput but 
are generally inferior to chemical methods for quantitative analysis.
1.2.1 Microbial inhibition assays
The agar diffusion assay can be carried out as a tube or plate assay11. An agar gel capable 
o f supporting the growth and multiplication o f micro-organisms is inoculated uniformly
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with a suspension o f a test organism that is sensitive to the antibiotic(s) under test. When 
an aqueous solution is placed in contact with the gel, any antibiotics present may diffuse 
from the solution into the gel. Therefore, a tissue extract or m ilk solution containing 
antibiotics w ill behave similarly and diffuse into the gel. The antibiotic w ill inhibit the 
growth and multiplication o f the micro-organism and so a clear zone w ill appear in the 
agar around where the sample was applied. This is termed the zone o f inhibition11. The 
size o f the zone is proportional to the concentration o f the antibiotic present. The disc- 
assay is a form o f agar diffusion test, where a filter paper disk is soaked in an antibiotic 
solution or sample extract containing antibiotic, and the disc is placed on the agar that is 
inoculated with antibiotic sensitive micro-organisms. Penicillins, tetracyclines, 
aminoglycosides and cephalosporins have all been detected using this method12.
The Four-Plate Test, alternatively known as the Frontier Post Test, is a popular choice for 
antibiotic screening13. As the name infers, four agar plates are required, three using 
Bacillus subtilis at pH 6.0, 8.0, and 7.2 and the fourth using Micrococcus luteus at pH 8.0. 
The sample (in the form o f a disk o f tissue) is incubated on the plates at 37°C for 24 hours. 
The B. subtilis, pH 6.0 plate is sensitive to penicillins and tetracyclines, while the pH 8.0 
plate responds to aminoglycosides and the pH 7.2 plate is for the detection o f 
sulphonamides. The M. luteus plate responds to macrolide antibiotics. The Four-Plate 
Test is not sufficiently sensitive to all antibiotics (for example sulphonamides, 
chloramphenicol) to ensure that they are below the MRL values. The test is also incapable 
o f determining which antibiotic o f a certain class is present and false positive and false 
negative results have been reported. Okerman et a/.14 used the Four-Plate Test to screen 
meat samples from retail outlets within the European Union. Positive samples were
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confirmed by enzyme immunoassay, thin layer chromatography and receptor assays. The 
authors concluded that the method was not capable o f detecting samples containing 
sulphonamides and quinolones at EU MRLs o f 100 ppb and 50 ppb, respectively, and 
reported a likelihood o f false positives using plates seeded with M. luteus. A  derivation o f 
the Four-Plate Test, the one plate test, has been described by Koenen-Dierick et ctl.v\ 
Various antibiotic classes including p-lactams, tetracyclines, aminoglycosides, 
sulphonamides, macrolides and quinolones were included in the study. The method was 
based on the detection o f antibiotic residues by growth inhibition o f Bacillus subtilis in 
agar medium at pH 7. The medium contained trimethoprim to aid detection o f 
sulphonamides and (3-glucuronidase to aid detection o f chloramphenicol residues. The 
authors compared the performance o f this One-plate test w ith the Four-Plate Test and 
tested its ability to detect residues at the MRLs established in the EU. They concluded 
that the One-plate assay was relatively similar in sensitivity for detection o f P-lactams, 
sulphonamides and aminoglycosides. The One-plate was less sensitive to 
chloramphenicol and macrolides than the Four-plate test. In general the One-plate test 
was less sensitive for the detection o f the tetracyclines and less sensitive to flumequin yet 
more sensitive to enrofloxacin.
1.2.2 Charm test
The Charm II tests are microbial receptor or antibody assays for the detection o f 
antimicrobial drugs. Separate tests for the antibiotic drug families P-lactams, macrolides, 
sulphonamides, tetracyclines and chloramphenicol are available. The tetracyclines and 
chloramphenicol assays are antibody assays and the remaining are microbial receptor
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assays. A binding reagent (a microbial cell with specific receptors for the antibiotic in 
question or, for tetracyclines and chloramphenicol, an antibody specific to the antibiotic) 
is added to the sample. I f  an antibiotic is present it w ill bind to the receptors on the 
microbial cell (or antibody) and prevent the binding o f radiolabelled antibiotic, which is 
added subsequently. Therefore, the more radiolabelled antibiotic detected the lower the 
concentration o f antibiotic in the sample. Korsrud et a V 6 described the detection o f 
antimicrobial residues in suspect meat samples using the Charm II receptor assay. 
Sulphonamides, streptomycin and erythromycin were the antibiotics o f interest. They 
compared the results with those obtained using thin layer chromatography or liquid 
chromatography, and confirmed the Charm II test to be an acceptable alternative, with a 
lower lim it o f detection. The results showed the incidence o f false positives to be higher, 
using the Charm II test, however, this may be due to the lower sensitivity o f the Charm II 
assay. The detection sensitivities o f the Charm II test assay, estimated by Korsrud et al. 
were 10 ppb for penicillin G (which has an MRL of 4 ppb in m ilk), 200 ppb for 
gentamicin (which has an MRL o f 100 ppb in milk), and 300 ppb for tetracycline (which 
has an MRL o f 100 ppb in milk).
Other bioassay kits available include the Cite Probe ([3-lactam) k it12, which is based on the 
binding o f P-lactam antibiotics by a penicillin binding protein on a membrane. An 
absorbance reader is used to assess the colour change which indicates i f  the sample is 
positive or negative. The Lactek (P-lactam) k it17 is based on the principle o f enzyme 
linked immunosorbent assay (ELISA), where antibodies are coated inside a tube and 
response measured as optical density. Rapid tests which have been developed include the 
“Delvotest” , based on microbial inhibition, enzyme inhibition assays, such as “Penzyme” ,
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and bacterial metabolism inhibition assays18 . Korsrud el a V 9 recently evaluated a large 
number o f microbial inhibition k it assays. They concluded that while the ideal test k it 
does not exist, due to limitations in sensitivity, specificity and ruggedness, they ranked the 
New Dutch Kidney Test (One-plate test) and the "Swab Test On Premises" (STOP)19 
highest with respect to cost, labour, and specificity.
1.2.3 Biosensors
Biosensors have been used extensively in clinical and environmental monitoring. 
However their application in antibiotic drug residue analysis has been limited. They 
utilise biological molecules, such as enzymes, or antibodies, capable o f recognising 
specific target analytes. The molecules are coupled to a transducer that responds to the 
reaction between the analyte and the bound biological molecule. An automated flow 
injection immunoanalysis system was described for the determination o f cephalexin in 
milk. Protein G was immobilised on the surface o f an immuno-reactor serving as a matrix 
for the polyclonal anti-cephalexin antibody20. A  conjugate was added to the sample, 
which bound in a competitive manner to the antibodies in the immuno-reactor. 
Aminophenol was enzymatically generated and was detected at a carbon electrode. The 
assay required 16 min per sample and had a lim it o f determination o f 1 ng ml"1 in milk. A  
recombinant Escherichia coli sensor for the detection o f tetracycline antibiotics has been 
described by Korpela et al.2\  The sensor is based on genetically engineered bacteria, 
which emit visible blue light in the presence o f tetracyclines. This is due to the presence 
o f luciferase genes, which were activated in the presence o f tetracyclines. The sensor was 
specific only to tetracycline antibiotics. Optimal induction o f luminescence occurred
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within 90 min in the presence o f tetracycline antibiotics and detection sensitivities were 
approximately 10 ng m l'1. P-lactam antibiotics were detected using a biosensor containing 
immobilised penicillinase and amidohydrolase. The enzymes were covalently bound to 
pH membrane electrode material, resulting in a biosensor with a shelf life  o f 2 months. 
Response time was 2.5 min and 30 ppb (3-lactam could be detected22.
Application o f molecular imprinted polymers to sensor technology has been reported; 
chloramphenicol antibiotic residues in serum have been determined using a biosensor 
containing a molecular imprinted polymer23. Various polymers were investigated in the 
development o f the sensor. The main interactions between the polymer cavity and the 
analyte were identified as the two hydroxyl groups o f chloramphenicol. An optical 
detection system was developed based on displacement o f chloramphenicol-methyl red by 
chloramphenicol from the sensor and linearity was observed over the range 1 to 1000 ug
1.2.4 Chemical screening methods
Absorption spectrophotometry involves the detection o f an absorption signal at a specific 
wavelength, characteristic for the analyte under study. UV absorption detection can also 
be employed, where the analyte is not directly measured, but a product o f analyte activity 
is detected. This may serve to increase the non-specificity o f UV detection for antibiotic 
residues. An example o f this is the spectrophotometric assay described by Everest et al. 2 ] 
for the determination o f (3-lactams in kidney tissue. The assay utilises the inhibition o f the 
enzyme carboxypeptidase by (3-lactam antibiotics, h i the absence o f P-lactam residues,
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the action o f this enzyme results in the release o f alanine and H20 2. The H20 2 oxidises a 
chromogen, also present, to a coloured compound that absorbs at 512 nm. When (j- lactam 
residues are present in the sample extract, the enzyme action is inhibited resulting in 
decreased absorption intensity. Derivative spectrophotometry has been applied to the 
screening o f P-lactam antibiotics. In this method, the spectrum o f the sample, acquired 
under a specific set o f conditions (such as in acidic solvent) is subtracted from the 
spectrum o f the sample acquired under a different set o f conditions (such as alkaline 
solvent). Absorption bands can be considerably sharpened and the method can be used to 
discriminate between the analyte and matrix. Third derivative spectrophotometry has been 
used to determine mixtures o f penicillins in commercial injectables2S, but no methods have 
been reported for the analysis o f residues in animal tissues.
Thin layer chromatography (TLC) methods are also employed for antibiotic screening, as 
they can provide high sample throughput and relatively high detection sensitivities. Silica 
and cellulose acetate plates are commonly employed and a variety o f solvents and 
mixtures o f solvents used for analyte separation. Various detection techniques have been 
employed. Detection may require the addition o f a visualisation agent, such as Fast Violet 
B salt to the plate, with heating, to create a coloured product. Direct UV scanning o f the 
plate is frequently employed. Derivatisation o f the analytes on the plate by fluorescent 
dyes provides a rapid, inexpensive method for detection. Thin layer chromatography- 
bioautography is a popular method for the analysis of antibiotic residues. Following 
separation by thin layer chromatography, the analytes are detected by a microbial 
inhibition assay. The chromatography plate may be incubated against an agar plate seeded 
with sensitive micro-organisms. This method o f screening was one o f a few screening
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techniques employed by MacNeil et al.26 for the determination o f penicillin residues in 
veal tissue. The authors reported better sensitivity when penicillin residues were detected 
in liver and kidney than similar concentrations in muscle tissue. TLC has been applied to 
a large range o f antibiotic residues including sulphonamides27, aminoglycosides28, 
macrolides29, and [3-lactams30. TLC-mass spectrometry has recently been reported as an 
antibiotic residue screening method. The method can be performed manually or with on­
line detection. Manual detection requires removal o f the spot from the TLC plate 
followed by solvent extraction o f the analyte, and this solution is subject to MS 
determination. Alternatively the TLC plate, once developed, can be placed on a stage 
inside the mass spectrometer. The plate can be scanned or the spots imaged. Extensive 
sample preparation is generally not required, relative to that required for HPLC 
determination. The method is applicable to an extensive range o f compounds, yet the 
unavailability o f commercial interfaces allowing direct detection o f analytes on the TLC 
plate currently presents a problem. TLC-MS determination o f tetracycline residues has 
been reported31. The TLC plate was developed using non-volatile solvents (oxalic acid, 
NajEDTA). Employment o f similar solvents for the LC-MS o f tetracycline residues 
resulted in clogging o f the interface and deposits in the ion source. Using TLC-MS, the 
solvents remain on the plate and are not introduced into the mass spectrometer. The TLC 
plate was developed and the tetracycline spots were condensed. The FAB matrix was 
applied to the condensed tetracylines on the TLC plate. The stationary phase containing 
the condensed zone was mulled with FAB matrix and subject to MS detection. Sensitivity 
o f 0.1 jig  per spot was reported, when a condensation technique was employed to 
concentrate the spot on the TLC plate.
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1.3 EXTRACTION METHODS
Fedeniuk and Shand recently described the energy theory for transfer o f an analyte from 
matrix to the extraction solvent1. The first step involves removal or desorption o f the 
solute molecule from its matrix. The second step involves dissolution o f the solute in the 
extraction solvent. The energy required for the extraction process to occur can be 
described by the following equation:
where E Desorb is the energy required for the analyte to desorb from the matrix, E Cavjty is 
the energy required to create a cavity in the extraction solvent and E soiute.soiVent the 
energy released when the analyte interacts with the extracting solvent. Desorption o f the 
analyte depends on the strength o f the molecular interactions between the analyte and the 
matrix (ionic, covalent, hydrogen bonding or dipole-dipole interactions). The ease with 
which these analyte-matrix interactions can be broken can be calculated using the 
following equation:
where Cb is the concentration o f bound drug, k is the dissociation constant, Cf is the 
concentration o f drug in the extracting solvent, and m is a measure o f the availability o f 
the drug for desorption. The value o f m depends on the functional groups o f the drug, the 
extracting solvent used and composition o f the matrix (fat, water content). This equation 
is known as the Freundlich sorption isotherm. This approach has been applied to calculate 
the optimal number o f extractions necessary for determination o f oxytetracycline in  bone, 
or sulphonamides in fish32. The authors describe the application the sorption isotherm to 
estimate the degree o f analyte binding to matrix. They concluded that repeated extraction
^  Total ^  Desorb r ^  Cavity ®  solute-solvent (1.1)
log Cb = log k  + mCf (1.2)
can increase the liberation o f tetracycline residues from calcium rich tissues, and that 
sulphonamide tissue-binding is reduced as the pH o f the extraction medium approaches 
the pKa o f the sulphonamide.
1.3.1 Homogenisation
I f  the sample for analysis is a solid, an homogenisation step is employed. This serves to 
create a uniform sample and also disrupts the sample structure, thereby assisting in the 
release o f any residues contained. Homogenisation techniques using a blade blender or 
mechanical probe are the most common methods. The first step in the extraction 
procedure is sometimes included with homogenisation. The sample may be homogenised 
in the presence o f a solvent (deproteinising agent), or alternatively, the sample may be 
homogenised first to provide an increased surface area for contact w ith the solvent.
1.3.2 Solvent extraction
Following homogenisation ( if  necessary), the sample is mixed with the extraction solvent. 
This serves to dissolve the antibiotic residues and other matrix co-extractives and 
frequently the solvent facilitates deproteinisation o f the sample. Organic solvents are 
particularly advantageous in antibiotic residue analysis as they enable extraction o f protein 
associated drugs, with simultaneous deproteinisation o f the sample. Some examples o f 
extraction solvents are summarised in Table 1.1, The most important factor in selecting an 
extraction solvent are its thermodynamic properties, such as polarity and ability to interact 
with the analyte through proton donation or acceptance. The solubility o f an analyte in a
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solvent can be calculated (see section 1.4.1), but the solubility o f an analyte in the 
presence o f matrix cannot be calculated, due to the complexity o f biological matrices. 
Salvatore and Katz33 studied the solubilities o f several antibiotics in various organic 
solvents. They reported methanol and dimethylsulfoxide to be the most widely applicable. 
The authors reported employing organic solvents to partially separate antibiotics in animal 
feeds, based on the solubilities o f the different antibiotics in different solvents. Different 
combinations o f antibiotics resulted in the extracts when different solvents were 
employed, therefore qualitative identification o f the antibiotics contained was made. The 
extracts were then subject to paper electrophoresis and bioautography determination34.
Water miscible organic solvents such methanol, ethanol or acetonitrile are often used in 
antibiotic residue extraction, due to the polar nature o f most antibiotics. Water immiscible 
organic solvents, used in extracting chloramphenicol and tetracyclines, may require a 
slightly more labour intensive extraction method to ensure the matrix (with the analyte o f 
interest) is exposed to the solvent. Proteins are generally insoluble in organic solvents, so 
they precipitate out, and in doing so, residues can be released from protein binding sites. 
Therefore, the precipitating agent should be one in which the analyte is soluble, to prevent 
co-precipitation o f the analyte with the protein. Due to the toxic properties o f many 
organic solvents and the problems o f disposal o f solvents, trends towards low solvent or 
solvent free methods are encouraged.
Since the majority o f residue determination methods use reversed phase chromatography, 
organic solvents often have to be removed, otherwise the analytes may not be retained on
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the column due to the high elution strength o f the sample solvent. Evaporation o f the 
solvent allows the analyte to be reconstituted in mobile phase allowing optimum 
interaction between the analyte and the stationary phase and providing a rapid pre­
concentration step. Mechanical methods such as vortexing, centrifugation and sonication 
are also employed at the initial extraction step to disrupt tissues, assisting solvent exposure 
to the matrix. For aqueous extraction, varying the pH o f an extraction solvent can render 
the extraction solvent more polar so that it may have greater capacity for solubilising a 
polar antibiotic.
Strong mineral acids have been used for the extraction o f tetracyclines as these 
compounds are not acid labile35. Trichloroacetic acid has also been used as a protein 
precipitant for the extraction o f kanamycin from tissue36, oxytetracycline from fish tissue40 
and tobramycin from kidney37. Due to the zwitterionic nature o f proteins, they are usually 
positively charged (cations) in strongly acidic environments and negatively charged 
(anions) in strongly basic environments. Acids form insoluble protein salts w ith the 
cationic proteins, and so they are commonly employed as extractants and protein 
précipitants. Shaikh et a/.38 used acidic buffer and heat to extract neomycin from tissues. 
Acid extraction is unsuitable for analysis o f analytes prone to hydrolysis, such as 
penicillins.
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Table 1.1 Extraction solvents used for antibiotic residue analysis.
APPROACH MATRIX ANTIBIOTIC
Mineral Acids (e.g. HC1, HCIO4) Meat, Fish, Blood Tetracyclines35
Tungstic acid Tissue Penicillin39
Trichloracetic acid Tissue Kanamycin36
- with HC1 Fish Tetracycline40
- with NaOH Kidney Tobramycin37
Buffer Liver, Fish Tetracycline41
Neomycin38
Water-immiscible organic Tissues Tetracyclines42
solvents (for example, hexane, M ilk Chloramphenicol43
ethylacetate)
Sulphonamides44
Water-miscible organic solvents Milk Penicillins45
(for example, methanol, acetone)
A relatively new form o f solvent extraction is that o f microwave-assisted solvent 
extraction46. The extraction solvent can be microwave-absorbing (possess a high dielectric 
constant) or non-microwave-absorbing (possess a low dielectric constant). Using a 
microwave-absorbing solvent such as water, radiation heats the solvent to a temperature 
higher than its boiling point and the hot solvent provides a rapid extraction o f analyte 
under moderate pressure (a few hundred pounds per square inch). In the case o f non­
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microwave-absorbing solvent, such as chloroform, the solvent does not become hot, while 
the sample (which usually contains water or compounds with a high dielectric constant) 
absorbs the microwave energy and releases the heated analytes into the cool surrounding 
solvent, in which the analyte is soluble. Microwave-assisted solvent extraction has been 
applied to the analysis o f salinomycin antibiotic residues with recoveries in the range o f 
78-100 %47. The authors claim the method to be rapid, accurate, environmentally friendly 
and cost-effective. Tissue samples were irradiated in ethanol for 9 sec, centrifuged, and 
the pellet irradiated in an ethanol/propanol solution. The combined supernatant was 
evaporated, the residue was reconstituted and subject to HPLC determination.
1.3.3 Supercritical fluid extraction
Supercritical fluid extraction (SFE), is becoming an increasingly popular technique in the 
field o f residue analysis. Supercritical fluids are advantageous for the extraction o f drugs 
at residue levels by virtue o f their enhanced solvating power. In addition, concentration o f 
the extracted analyte can be readily achieved by removal or evaporation o f the extracting 
solvent, which is more readily accomplished with supercritical fluids than with an 
ordinary solvent. However, for analysis o f antibiotic residues in animal tissue, the 
solvating properties o f supercritical fluids result in the extraction o f tissue fats and other 
non-polar matrix components. The polarity o f the supercritical fluid can be varied by 
changing its density through altering pressure. The procedure can be carried out with on­
line or off-line analyte collection (trapping). Supercritical carbon dioxide is the most 
popular fluid used, though others such as pentane, diethyl ether, methanol and 
tetrahydrofuran have been used. However, carbon dioxide is sometimes too non-polar to
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extract many antibiotic residues efficiently, so modifiers are employed, which increase the 
polarity o f the extracting fluid and its solvating power. Typical modifiers are organic 
solvents such as methanol, acetonitrile, acetone or toluene. Sulphonamides were extracted 
from incurred pork tissue using carbon dioxide modified with 10-20 % methanol48. 
Recoveries in the range 52-97 % were reported for various sulphonamide residues. 
Maxwell et al.49 applied supercritical fluid extraction to the analysis o f sulphamethazine, 
sulphadimethoxine and sulfaquinoxaline in chicken, beef and pork tissues. On applying 
the method to beef and pork liver, the authors reported reduced recoveries due to matrix 
binding o f the sulphonamide residues. A variety o f pre-SFE treatments were investigated. 
The pH o f the liver was adjusted with sodium hydroxide and phenylbutazone was added to 
compete with the sulphonamide residues and displace them from the matrix binding sites. 
Recoveries o f 80-107 % were obtained for samples fortified at 100 ng g'] w ith the three 
sulphonamides.
1.3.4 Matrix solid phase dispersion
Matrix solid phase dispersion (MSPD) involves the dispersion o f the sample (usually 
tissue) onto a solid sorbent or dispersant. The technique involves blending the tissue 
sample with a tissue dispersant and the resulting mixture is then packed into a column, 
allowing the mix to be washed with various solvents, similar to conventional solid phase 
extraction. Octadecylsilane (Cl 8) is the most popular tissue dispersant used but 
diatomaceous earth50 and silica51 have also been used. Blending o f sample and C l 8 
material is performed using a pestle and mortar. The C l8 material acts to disrupt the 
tissue cells, thereby exposing the cell contents and rendering any residues extractable.
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C l 8 material consists o f a silica base onto which long carbon chains, which are non-polar 
and hydrophobic in nature, are bonded. The cell membrane is constructed o f a lipid 
bilayer. The hydrophobic C l8 w ill therefore solubilise these lipid regions exposing their 
hydrophilic, polar regions where most drug residues are located. The method uses small 
sample size, thereby lim iting sensitivity but has many advantages relative to the more 
classical methodology. It provides a rapid, simple method o f extraction that involves low 
solvent usage and does not require sophisticated equipment. MSPD is discussed more 
fully in Chapter 3 where its application to the extraction o f penicillin residues from muscle 
tissue is described. Other antibiotics extracted using this technique include 
chloramphenicol52, tetracyclines53, sulphonamides5'1 and cephalosporins55. Long et al.56 
described the determination o f oxytetracycline in fish tissues using MSPD extraction 
followed by HPLC determination. A  hexane wash removed non-polar substances, such as 
lipids. Antibiotic elution was effected using an acetonitrile/methanol solution containing 
butylated bydroxyanisole, which prevented oxidative loss o f oxytetracycline during extract 
preparation. Recoveries o f 67 to 86 % were reported with standard deviation o f 5 to 13 % 
for samples fortified in the range 50-3200 ng g"1. Van Poucke et al.51 used MSPD for the 
analysis o f sulphonamide residues in m ilk samples. The method described involves 
mixing o f the C l8 material with the m ilk sample within the syringe barrel, followed by 
washing and elution. Using HPTLC with fluorescence detection, recoveries o f 83-91 %, 
with standard deviations between 2 and 4 %, were obtained for m ilk samples (2, 5 or 10 
ml), when 2 g C l 8 was employed.
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Table 1.2 outlines the membrane techniques available for drug residue analysis and the 
principles by which separation/extraction occur. These techniques are relatively new to 
sample preparation, particularly in the area o f antibiotic residue analysis. There are a 
range o f formats for membrane techniques, many o f which are easily incorporated in an 
on-line system. In addition, they are low on organic solvent consumption and some 
techniques do not require very sophisticated equipment.
Table 1.2 Membrane based extraction techniques
1.3.5 Membrane-based extraction methods
Technique Principle Driving force
Filtration Size Exclusion Pressure difference
Dialysis Size Exclusion Concentration difference
Electrodialysis Size Exclusion & Selective 
Ion transport
Potential difference
Membrane Extraction Partitioning Concentration difference
1.3.5.1 Filtration
Filtration o f samples and sample extracts is used routinely in sample preparation. 
Disposable membranes are employed, in the form of filte r paper, syringe filters or 
ultrafiltration devices. Recently 96 well filter plates have become available58. Separation 
takes place under gravity (through filter paper), or by the application o f external pressure
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in the form of a vacuum, centrifugal force or positive pressure (in hand held devices). 
Large molecular size matrix co-extractives remain on the upper-side o f the membrane 
while the analytes and small molecules pass through to the under-side. Prior to 
chromatographic determination, samples are frequently filtered to remove any non­
solubilised material. Ultrafiltration was applied to (5-lactam determination in serum59. 
Ultrafiltration differs from ordinary filtration in terms o f the size o f the particles that are 
separated and in the application o f centrifugal force as a driving force for the separation 
process. Am picillin was separated from serum prior to LC determination using 
ultrafiltration60. A two-chambered centrifugation tube was used. The diluted serum was 
placed in the upper chamber, which was separated from the lower chamber by the filter 
membrane. Centrifugation forced the low molecular weight components through the 
micro-porous membrane filter and into the lower chamber, while high molecular weight 
proteins were retained on the filter membrane. Thomas61 achieved recoveries o f near 100 
% for the determination o f tetracycline residues in whole m ilk, with direct injection o f the 
filtrate. This method is useful for the analysis o f analytes sensitive to classical 
deproteinisation agents (acids or organic solvents).
1.3.5.2 Dialysis
Dialysis has traditionally been overlooked in residue analysis as it was regarded as a 
lengthy technique, resulting in a dilute sample requiring concentration and with poor 
recovery. However, the advent o f automated dialysis has rendered this technique much 
more convenient. Dialysis has been widely used to separate proteins from small 
molecules, often for purification o f the protein. In trace analysis, the reverse approach is
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adopted where the protein is eliminated and the dialysate recovered. The majority o f trace 
analysis applications using dialysis are performed using commercial dialysis block, 
(depicted in Figure 1.1). This approach has been employed for the analysis o f nitrofurans 
in m ilk, eggs and meat62. In order to achieve good recoveries in a short time, two long 
channels o f minimum depth are employed, separated by a membrane. The sample is 
pumped into the channel on the upper-side (donor) o f the membrane. The molecules o f 
large molecular weight (proteins) remain on the upper-side while the residues o f interest 
migrate to the under-side (acceptor). Most membranes employed for this technique have a 
molecular weight cut-off in the region o f 15,000 daltons, while most drug residues are in 
the region o f 200-500 daltons. Membranes o f smaller pore size would increase dialysis 
times and are likely to become blocked.
Figure 1.1 Dialysis block, showing donor moiety, membrane and acceptor moiety.
As dialysis is a diffusion process, to increase the efficiency o f the process the solvent on 
the under-side o f the membrane must be renewed continuously to avoid equilibrium being
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established, where both sides o f the membrane hold a similar concentration o f residue. 
This results in a dilute solution, consequently membrane dialysis is followed by a 
concentration step. On-line trace enrichment has been employed to facilitate this 
requirement. The dialysate is directed onto a small cartridge, which concentrates the 
analyte(s), prior to HPLC. In most analytical applications, the acceptor channel is 
continuously being renewed, and this form o f the technique is termed continuous dialysis. 
There is a trade-off between dialysis time and recovery, as the longer the period o f time 
the sample is allowed to dialyse, the greater the recovery. The size o f the dialysis channel 
on the upper-side o f the membrane limits the size o f the sample, thereby determining the 
sensitivity o f the method. The sample can be introduced into the channel in one injection 
(stagnant), in more than one aliquot (pulsed) or by continuous injection (continuous flow). 
The membrane is regenerated in preparation for the next sample by solvent washing. This 
step should also be sufficient to prevent sample carryover. Dialysis involves aqueous 
extraction, thereby eliminating the co-extraction o f fats, which contribute to fouling o f the 
analytical column.
The analysis o f sulphonamides by this technique is discussed in Chapter 2. Agas0ster63 
described an automated dialysis method for the analysis o f oxytetracycline antibiotic 
residues in muscle, liver, milk, and egg. Dialysis was followed, after concentration on an 
enrichment cartridge, by direct automatic injection onto a HPLC column, followed by 
post-column derivatisation. Two fifteen kD molecular weight cut-off cellulose acetate 
membranes were employed in series, the first capable o f dialysing 370 p i and the second 
capable o f dialysing 100 pi. A  polystyrene packed enrichment column was employed to 
concentrate the extract before HPLC analysis. Recoveries were generally high (66-100
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%), relative to dialysed standards, from all matrices with lim its o f determination o f 1 ng g"
1. Another antibiotic residue, mitomycin C64, has been extracted from human blood and 
urine with a lim it o f determination o f 1 ng g“1. Dialysis was also followed by 
concentration on a C8 pre-column before direct HPLC separation. Dialysis is commonly 
employed on-line with liquid chromatographic, gas chromatographic65, and 
electrophoretic66 techniques.
1.3.5.3 Electrodialysis and membrane extraction
Electrodialysis is an extension o f dialysis, where the membrane is coupled to an 
electrophoretic separation mechanism. Typically a dialysis block is used with electrodes 
inserted in the donor and acceptor channels. The concentration gradient together w ith the 
electric potential difference cause the transport o f charged compounds through the 
membrane. Positively charged compounds migrate towards the negative electrode, while 
negatively charged compounds migrate towards the positive electrode and neutral 
compounds only undergo passive diffusion through the membrane. Therefore, analytes 
are separated on the basis o f molecular size and their charge. On-line electrodialysis has 
been employed for the determination o f acids, bases and quaternary amines in water 
samples67. However, the application o f electrodialysis to the analysis o f veterinary drug 
residues has not been reported. Most studies are explorative and no routine methods have 
been reported.
As with dialysis, membrane extraction typically involves a planar membrane, between a 
donor and an acceptor phase. Membrane extraction may be considered under three types:
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1) supported liquid membranes, 2) silicone rubber membranes and 3) micro-porous 
membrane liquid-liquid extraction (MMLLE). In the supported liquid membrane, the 
membrane is impregnated with a water-immiscible organic solvent. In the donor phase, 
the pH is such that the analytes are uncharged and readily extract into the membrane 
liquid, or silicone polymer (in the case o f the silicone rubber membranes). The acceptor 
phase pH is such that the analytes are charged upon entering, to prevent back extraction 
into the organic/silicon membrane. In the MMLLE membrane, organic solvent is present 
in both the acceptor phase and membrane pores. This technique involves a single liquid 
extraction, as opposed to an extraction followed by a back-extraction, for the other 
membranes. To obtain high recoveries, the analyte must exhibit high solubility in the 
membrane material. Hydrogen bonding reagents are frequently added to the membrane to 
facilitate the extraction o f polar analytes into the membrane. Ion-pair reagents may be 
added which can selectively bind to specific functional groups, thereby aiding extraction 
o f the analyte. Transport across the membrane can also be “ facilitated” , where a carrier in 
the membrane, which is insoluble in the donor and acceptor phases, interacts with the 
analyte at the interface between the donor phase and the membrane and transports it into 
the acceptor phase. The technique has been applied to the analysis o f penicillin G in 
fermentation media68, carboxylic acid69, amines70, and organic acids (citric acid, lactic 
acid). Penicillin G was determined in a continuous flow system using a biosensor 
consisting o f a bilayer lipid membrane71. In this membrane, enzymes were immobilised 
into a lipid matrix, so no organic solvent was used. On reaction o f the enzyme with the 
analyte, hydronium ions were produced which caused a fluctuation in current, relative to 
the concentration o f analyte detected.
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As with electrodialysis, application to veterinary drug residue analysis has not yet been 
reported. Supported liquid membranes have been applied to the analysis o f herbicides and 
pesticides in drinking and ground water72,73. Analysis o f the anabolic steroid, bambuterol, 
has also been performed in plasma, using a liquid membrane74 and a silicon membrane 
was applied to the analysis o f triazines in vegetable o il75.
1.4 CLEAN-UP M ETHO DS
The requirement for sample clean-up in residue analysis depends on the detection system 
used and the matrix under analysis. HPLC with UV detection is a very popular 
determination method for analysis o f drug molecules. However, most sample matrices 
contain endogenous compounds that have UV-absorbing properties, so a clean-up step to 
remove these interferences is necessary. The types o f interferences and their effects are 
discussed in section 1.1.5. Prior to detection, a separation step is usually employed and 
extracts may need to be cleaned-up to avoid fouling o f the components used for this 
separation, such as the chromatographic column. Another important feature o f sample 
clean-up techniques is their ability to pre-concentrate extracts which is often very 
necessary in residue analysis to improve the lim it o f determination.
1.4.1 Liquid-liquid partitioning
Convenience, ease o f use and the availability o f highly purified organic solvents have 
contributed to the widespread use o f this clean-up technique in residue analysis. The 
antibiotic is partitioned between two immiscible phases so as to bring about favourable
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extraction o f the drug into one phase, while the unwanted matrix co-extractives partition 
into the other phase. Multiple extractions are frequently employed to ensure maximum 
recovery o f the analyte. The analyte may be selectively extracted from a large solvent 
volume into a much smaller volume o f solvent, or for volatile solvents, evaporation o f the 
solvent serves to concentrate the analyte. The degree o f extraction is dependent on the 
distribution co-efficient KD where
K d = [A ]0/[A L  (1.3)
when [A ]0 is the molar concentration o f the analyte [A ] in the organic phase and [A ]a is the 
concentration o f the analyte in the aqueous phase76. K D is dependent on the type o f 
organic solvent used, the pH and the ionic strength o f the aqueous phase, so the procedure 
must be optimised for each analyte. The organic solvent selected is that which affords 
maximum analyte extraction efficiency, with the minimum extraction o f interferences. 
The solvent chosen is usually o f the minimum polarity necessary to extract the residue so 
that the more polar interferences are not extracted. Liquid-liquid partitioning using hexane 
is common in antibiotic residue analysis in tissues. This non-polar solvent dissolves 
lipophilic molecules (fats) and so acts as a clean-up solvent. The pH o f the aqueous phase 
can also be adjusted to allow extraction o f endogenous compounds with a view to their 
elimination. This was employed by Moats et al.11 in the analysis o f tylosin in muscle. 
Acidic buffer was added to the muscle extract to remove interferences, and methylene 
chloride was then added to extract the tylosin.
Liquid-liquid extraction can be difficult for residues that are soluble in water at all pH 
values. In this case, “ salting out”  has been employed, where the addition o f a salt to an
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aqueous solution increases its ionic strength and its polarity, thereby increasing the affinity 
o f the more polar residues for the aqueous phase and the non-polar residues for the organic 
phase. Malisch and Huber78 found that many compounds partitioned into the organic layer 
on the addition o f a salt (or methylene chloride) to acetonitrile filtrates. However, this 
method does not work for very polar analytes. In the analysis o f tetracyclines, Moats79 
described the recovery o f tetracyclines from the water layer formed when a methylene 
chloride solution was added to a filtrate containing hexane. The water was immiscible 
with the methylene chloride and hexane, resulting in the formation o f a water layer. The 
analytes partitioned from the least polar hexane into the more polar methylene chloride 
and into the most polar water. Another method for the liquid-liquid extraction o f highly 
polar ionic residues is to convert the analyte into a neutral ion-pair complex, by the 
addition o f an excess o f suitable ions o f opposite charge and to extract this complex into 
an organic solvent. This was demonstrated by Modin and Schroder-Nielsen80 for the 
extraction o f penicillins from fermentation media. The ion-pairing agent, a 
tetrabutylammonium ?, was added as a cation, and complexed with the penicillins present 
as anions, allowing their extraction into organic solvent. In residue analysis from complex 
matrices, liquid-liquid back-extraction is often employed. After the initial extraction into 
an organic solvent, the analyte can be back-extracted into an aqueous phase with pH 
adjusted so the analyte ionises and remains in the aqueous phase.
However, liquid-liquid partitioning is a relatively time-consuming technique. Losses may 
occur due to degradation o f analytes on evaporation, emulsion formation or adsorption o f 
the analytes to glassware. Also, the trend towards reducing organic solvent usage is
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forcing analysts to look to more environmentally-friendly methods o f extraction. In 
addition, the technique does not lend itself well to automated methods.
1.4.2 Gel permeation chromatography
Gel permeation chromatography, also known as molecular exclusion chromatography, 
size exclusion chromatography or gel filtration, separates molecules on the basis o f size. 
The stationary phase packings are generally gels or resins consisting o f beads w ith small 
pores that can be penetrated by small molecules but not by large molecules. The columns 
have a high loading capacity, however selectivity is generally reduced in comparison to 
conventional chromatographic packings. The liquid phase carries the sample onto the 
column and through the gel phase. The small molecules are delayed on the column as 
they pass in and out o f the gel particles, while the larger molecules stream past and are 
excluded from entering the gel particles. No chemical interactions occur between the 
analyte and the stationary phase, unlike other forms o f chromatography. Biancotto et al.sl 
have assessed the suitability o f gel permeation chromatography for the determination o f 
sulphonamides, nitrofurans and growth promoters in animal feedstuffs. The method 
described allows simultaneous analysis o f a wide range o f analytes, exhibits high 
recoveries (98-100 %) and performs effectively in removing matrix co-extractives. 
However, the method was only tested on samples containing relatively high levels o f 
analyte (1000 ppb). Gel permeation was employed on-line, for the analysis o f gentamicin, 
amikacin and tobramycin in serum82. A  Sephadex column was employed for extraction 
followed by reversed-phase, ion-pair chromatography with post-column derivatisation. 
Recoveries were in the range 89 to 100 % with between day coefficients o f variation in the 
range 3 to 4 %. Pctz and Meetschen83 conducted a study using gel permeation as a clean­
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up procedure for the analysis o f 40 veterinary drugs including sulphonamides, nitrofurans, 
tetracyclines, oxytetracycline, penicillin G and tylosin. Residues were determined in liver, 
kidney, muscle, egg and milk, and UV detection was employed. The authors concluded 
that similar results could be achieved when silica SPE columns were used for clean-up, 
with final determination being by HPLC with UV detection.
1.4.3 Solid Phase Extraction
Solid Phase Extraction (SPE) is a technique used in residue analysis to clean-up samples 
prior to determination and/or to concentrate samples to improve determination limits. It is 
a fast, easy to use method offering efficiency and reproducibility.
The first step in an SPE procedure is the selection o f an appropriate sorbent; for example 
octadecylsilane is commonly used for non-pol ar residues, and ion-exchange materials are 
used for strongly acidic or strongly basic drugs. The typical steps involved in the use o f 
SPE are shown in Figure 1.2. A  large number o f SPE stationary phases exist, as shown in 
Table 1.3, many o f which are bonded silica-based materials. Traditionally, reversed- 
phase, normal phase and ion-exchange columns have found wide application for the 
analysis o f antibiotic residues. A number o f new stationary phases have been developed, 
such as mixed-mode sorbents, porous graphite carbon, polymeric columns, restricted 
access columns and metal-loaded columns. For multi-residue analysis, mixed-mode 
cartridges are available. A  large number o f drugs contain nitrogen atoms in a form that 
may be readily protonated. Therefore, mixed-mode sorbents have been developed that 
contain reversed-phase alkyl chains in the same column as ion-exchangers, resulting in a
37
mixed mode column. An SPE column containing C l8 and cation-exchange groups was 
employed for the analysis o f gentamicin in tissue and whole m ilk84. Very clean 
chromatograms resulted, free o f matrix interference. The column was prepared in neutral 
buffer, so that the amino groups on the analytes were uncharged. The analytes were 
retained on the column due to ionic interactions and other matrix co-extractives were 
retained through hydrophobic interactions. Therefore the matrix components could be 
removed using a methanol wash, which was followed by analyte elution using a basic 
solution.
1. Cleaning and activation o f the sorbent.
2. Conditioning o f the sorbent with a solvent o f similar nature to the sample 
extract.
3. Loading o f the sample, containing the analyte (+) and matrix co-extractives 
(o) at approximately 1 ml m in1.
4. Washing o f the cartridge to remove the unwanted matrix components.
5. Elution o f the analytes by disruption o f the analyte-sorbent interactions.
Figure 1.2 Protocol involved in the SPE procedure
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Graphite carbon columns exhibit higher efficiency for trapping polar analytes than the 
classical C l8 column. Retention mechanisms include hydrophobic, ionic and other non- 
classified electrostatic interactions; therefore, both polar and non-polar analytes are 
retained with high affinity. The packing consists o f homogeneous particles o f relatively 
small diameter (5 |.im), which provide a large surface area for high binding capacity. 
Elution problems have been reported when using porous graphite carbon columns. 
Elution with methanol or acetonitrile has resulted in low recoveries and methylene 
chloride or tetrahydrofuran are employed85. Rose et a/.86 employed porous graphite carbon 
SPE for the determination o f penicillins in liver and muscle. The authors claim that the 
flat crystalline surface o f the SPE packing, in combination with the reversed phase 
mechanism, was ideally suited to the clean-up o f the highly conjugated organic analytes 
and allowed elution o f the penicillins in acetone, which could be easily concentrated. 
Polymeric resins in the form o f SPE columns have been reported for the analysis o f 
tetracyclines35. These columns are frequently employed for trapping polar analytes, 
particularly those with strong electron withdrawing moieties. The retention mechanism 
was reported to be a combination o f adsorption and partitioning87.
Recently, a 'hydrophilic-liphophilic balanced' (HLB) sorbent has been introduced 
commercially. This polymeric column is capable o f trapping basic, acidic and neutral 
analytes. The resin contains two monomers, allowing for both hydrophilic and lipophilic 
retention. Unlike traditional C18 sorbents, the need for column activation in methanol is 
omitted, the column can run dry without adverse effects on performance and the non-polar 
analytes can also be retained. Oasis® HLB columns (from Waters, M ilford, MA, USA) 
were employed for the analysis o f tetracycline in plasma and high recoveries resulted,
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even when the packing was allowed to run dry during the SPE procedure88. High specific 
surface area, together with the presence o f polar hydrogen groups, is responsible for the 
universal retention possible.
Restricted access SPE sorbents have become popular for on-line SPE methods. These 
sorbents combine size exclusion o f matrix co-extractives o f high molecular mass with 
enrichment o f low molecular mass analytes at the inner pore surface. Therefore, direct 
injection o f biological samples without the traditional deproteinisation step is possible. In 
addition to their size exclusion properties, the sorbent particles are coated w ith a 
hydrophilic protein or polymer to avoid adsorption o f proteins and clogging o f the SPE 
column. Internal surface revcrsed-phase sorbents (ISRP) are the most popular form o f 
restricted access SPE. ISRP packing was employed by Ibach et al. for the analysis o f 
oxacillin residues in m ilk89. After protein precipitation using acetonitrile and fat removal, 
samples were subjected to on-line SPE-HPLC. The method was compared with that 
described by Petz and Meetschen90, where samples were deproteinated using acid and 
acetonitrile and extracted using complicated liquid-liquid extraction procedures. Results 
o f both methods agreed well, demonstrating the validity o f the rapid ISRP method.
Antibiotic residues have also been derivatised to promote retention on SPE. Agarwal91 
employed this approach for the analysis o f gentamicin residues in beef. The tissue 
samples were deproteinated by immersion in boiling water followed by centrifugation, and 
the extracted residues were cleaned-up using silica SPE. The analytes were loaded on the 
column in the presence o f ortho-phthalaldehyde, which derivatised the gentamicin
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residues. The derivatives were eluted in ethanol, which could be easily evaporated to 
concentrate the extract. Alternatively, ion-pairs have been employed to promote retention. 
Lou et al.92 employed sodium pentanesulphonate to assist retention o f ampicillin and 
amoxicillin residues on a C l8 SPE column. Solid phase extraction is based on 
chromatographic principles, the only difference being the much increased capacity factor 
when the analyte is retained on the column and interferences washed off, or the much 
decreased capacity factor when the analyte is eluted in the void volume leaving the 
interferences behind on the cartridge. I f  necessary, vacuum or positive pressure can be 
used to increase the rate o f passage o f the sample through the sorbent but in general the 
longer the residence time o f the sample on the cartridge, the better the retention o f the 
analyte and the higher the recovery.
Conditions on the SPE column are optimised to maximise the retention o f the compounds 
o f interest while minimising retention o f interfering substances, often by introducing 
controlled pH conditions. As with liquid-liquid extraction, the strongest wash solvent, 
which does not elute the drug residue, is used to remove matrix interferences and the 
weakest solvent to give complete recovery o f the residue is used in the elution stage, to 
avoid eluting more strongly retained interferences.
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Table 1.3 Table showing the various SPE packings available and their 
application in antibiotic residue analysis.
Sorbent Analyte
Butyl (C4) 93Qumolones
R eversed
Octyl (C„) Aminoglycosides'*4,
P hase Octyadecyl (Clg) Quinolones')i, Tetracyclines96
Cyclohexyl (C6 H„) Chlortetracylcine97
Phenyl (C6H6) Tetracyclines 8, Quinolones"
Cyano (CN) Macrolides100
N orm al Silica (SiOH) Sulphonamides116
Florisil (Mg2Si03) Tetracyclines101
Adsorbents Alumina (AljOj) Suiphonamides1 ( Ionophores1 03
Bonded phases Diol (COHCOH) Macrolides104,
Aminopropyl (Nil,) Suiphonamides1 Di
Ion Amino (NIIj) Nitrofurans106
E xch an ge
Anion sorbents
Quaternary amine (N+) 
SAX
Suiphonamides 1 )7,Cephalosporins11 ,s
Carboxylic Acid (COOH) Aminoglycosides1 u9,
Cation sorbents Stilphonic Acid (HS03) Suiphonamides110, Aminoglycosides'11
Propyl Sulphonic Acid 
((CH2)3S03H)
1 t iChloramphenicol
Size exclusion Sephadex Aminoglycosides82, Cephalosporins'15
P olym eric XAD Tetracyclities35
M ixed -m od e SPE C l8 & Cation-exchange AminoglycosidesS4
R estricted  A ccess Reversed-phase Penicillins89, Suiphonamides114
C arbon  B ase  S orbents Porous graphite carbon Penicillins“’
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SPE is well suited to automation due to the repetitive nature o f the operations involved. 
The technology requires dedicated instruments and relies on computer support to provide 
systems capable o f prolonged unattended operation. On-line SPE is used in conjunction 
with chromatographic determination procedures. The technique is automatically 
controlled by means o f valve switching, and the analyte(s), when eluted, is directed to the 
final detection system. On-line methods are becoming increasingly popular, allowing 
reproducible analysis, largely unattended. On-line SPE has been described for the analysis 
o f sulphamethazine in plasma115. SPE, in the form o f C l8 disposable extraction 
cartridges, was employed allowing automatic sample preparation followed by on-line 
injection o f the sample extract into the HPLC system. Analyte recoveries o f 90 % and 
greater were obtained and typical RSD values were 0.7 % (within day) and 2.0 % 
(between day).
Two SPE cartridges can be used in tandem for the analysis o f residues from complex 
matrices, one reversed-phase and the other normal phase. This can serve to remove both 
polar and non-polar interferences. This was demonstrated by Cooper et a l U6 in the 
determination o f sulphonamide residues in porcine kidney. Following deproteinisation 
using acetonitrile, clean-up was effected by a two stage SPE method using reversed phase 
(C l8) and normal phase (silica) cartridges. The first clean-up, on C l8, removed very 
hydrophobic matrix components that might be irreversibly retained on the HPLC column, 
and removed very polar matrix co-extractives that might interfere with the second SPE 
step. SPE on silica allowed further removal o f matrix components and the analytes eluted 
in a relatively small volume (2.5 ml) methanol-dichloromethane solution.
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Solid phase extraction disk technology has been growing in popularity over recent years46. 
SPE disks resemble membrane filters, usually 1 mm or less in thickness, w ith diameters 
ranging from 4 to 96 mm. The disks are usually polytriflouroethylene (PTFE) material, 
embedded with the stationary phase sorbent. The relatively large cross-sectional area and 
thinness enable higher flow rates and eliminate channelling, which can result in losses in 
packed bed columns. The number o f stationary phases currently available for SPE disk 
technology is more limited than for SPE cartridge technology. One o f the newest formats 
o f SPE disk technology is the 96 well plate format117. This is used mainly for high sample 
throughput in the pharmaceutical industry, usually in an automated system. A  major 
advantage o f SPE disk technology is the low volume elution required, but low sample 
capacity has hindered its application in veterinary drug residue analysis.
1.4.4 Immunoaffinity column chromatography
Immunochemical methods for the isolation o f veterinary drug residues are becoming 
increasingly popular. The methods display specificity, sensitivity, and high sample 
throughput. These benefits, combined with the versatility o f the column format, have 
resulted in the development o f immunoaffinity column chromatography. In 
immunoaffinity column chromatography, antibodies raised against the analyte(s) o f 
interest, are immobilised onto a sorbent support, which is packed into a syringe barrel. 
The poor availability o f antibodies is the major reason for the limited use o f 
immunoaffinity chromatography. In developing an immunoaffinity method, a number o f 
parameters can be varied to achieve ideal conditions. The nature o f the support, the 
coupling mechanism for immobilisation o f the antibody on to the solid support and the
44
nature o f the antibody (monoclonal or polyclonal), all play a role in determining the 
characteristics o f the method. Following preparation o f the immunoaffinity column, 
optimum sample loading, washing and elution procedures must be determined. Since the 
success o f the method depends on the ability o f the antibody to bind the analyte, it is 
necessary to work under conditions optimal for antibody/antigen interaction, which are as 
close as possible to physiological conditions. This feature lim its the application o f 
immunoaffinity to water-soluble drugs, which includes most antibiotics. Extremes o f pH, 
heat, salt concentration and organic solvent content can result in denaturation o f the 
antibody. During sample loading, conditions must be conducive to the formation o f the 
antigen-antibody complex. The complex must be unaffected by washing solvents and 
elution conditions require dissociation o f the antigen-antibody complex. In addition, 
dissociation o f the complex should ideally be reversible so that the antigen-antibody 
complex can easily be reformed, allowing re-use o f the immunoaffinity column. Washing 
procedures should be optimised so that sample carryover is prevented. Dietrich et a/.118 
described the production and characterisation o f monoclonal antibodies against ampicillin 
and their applicability for the preparation o f a multiresidue immunoaffinity column for p- 
lactams. They reported on the isolation o f one group o f antibodies that showed no major 
cross reactivities with other penicillins, except for amoxicillin, and one group that had 
marked cross reactivities with many other P-lactams. They coupled the latter antibody and 
an antibody against cloxacillin to CNBr activated Sepharose. The capacity o f the resulting 
column was 6.6 and 5.4 m l'1 for ampicillin and cloxacillin, respectively, and recoveries 
for six different penicillins were in the range 67-100 %.
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Molecular imprinting involves the preparation o f polymers with specific recognition sites 
for certain analytes. Briefly, a number o f monomers are assembled around a template 
molecule (the analyte) and the template is removed, leaving an 'imprint' or cavity into 
which the analyte fits. The polymer can be packaged into a syringe barrel, and imprinted 
polymers have also been used as a stationary phase for liquid chromatographic 
separation1 '9. Preparation o f solid phases for thin-layer chromatography120 have employed 
MIPs and they have been employed in receptor assays, as an alternative to the more 
traditional antibodies, as the specific binding reagent'22. Desoiption o f the analyte is the 
main problem encountered, due to the high affinity o f the polymer for the analyte. 
Conditions required to elute the analyte can result in leakage o f the molecules responsible 
for the imprint or deformation o f the site, preventing more than once o ff use. To ensure 
capture o f the analyte by the imprint, samples must be applied in organic solvent. 
Therefore, the analyte must be extracted from biological samples into organic solvent 
prior to application onto the polymer. However, research into the development o f non- 
covalent molecular imprints is ongoing, allowing polar solutions (aqueous samples) to be 
applied to the column121. There are no reports published for the application o f MIPs in 
antibiotic residue analysis. An MIP was used in a solid phase extraction format for 
isolation o f the herbicide, atrazine, from beef liver122. The authors reported high non­
specific binding with aqueous solvents, caused by the partitioning o f the lipophilic 
atrazine into the organic polymer. Complete retention on the column occurred with 
chloroform and elution was achieved with acetonitrilc. Sample preparation prior to MIP 
SPE, was limited to shaking and centrifugation in chloroform. Molecularly imprinted
1.4.5 Molecular imprinted polymers
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polymers have also been employed for the determination o f theophylline in serum and 
plasma119.
1.4.6 Liquid chromatography fractionation
Liquid chromatography (LC) has been applied as a clean-up step in addition to its use for 
residue determination. The technique is used to separate analytes from each other or from 
interferences in the sample matrix. Using LC, a fraction o f the mobile phase eluate, 
containing the analyte is collected, based on the retention time o f the peak o f interest. 
This technique is employed as a clean-up step in residue analysis when followed by 
another quantitative techniques (such as immunoassay or HPLC). A drawback o f the 
technique is the dilution factor, which results, for example, 100 |il sample injected and a 1 
ml fraction collected due to the width o f the peak as the analyte elutes o ff the column. 
However, there are many advantages to employing LC fractionation as a clean-up step. 
Operating costs for LC fractionation are low, once the necessary equipment is present and 
most residue laboratories are well equipped with LC instrumentation. The clean-up is 
highly reproducible and can be fu lly automated and carried out unattended. Tarbin et al.123 
described the analysis o f penicillin G in m ilk using LC fractionation followed by LC 
determination. For fractionation clean-up, 1.5 ml sample extract was loaded into an 
injection loop installed before the column. The sample was focussed by bracketing the 
injection on either side with phosphoric acid. The extracts were chromatographed and a 2 
ml fraction collected. 1 ml o f this fraction was re-chromatographed, for quantification, 
again using focussing at the top o f the column to achieve the desired sensitivities. The 
same column could be used for both LC steps, or use o f two similar columns allowed
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automatic injection of the cleaned-up extract into the analytical column. Zomer et al.m  
used LC fractionation followed by microbial receptor detection for the analysis of P- 
lactams in milk. The method combined the advantages of liquid chromatography with the 
selectivity and sensitivity of a microbial receptor assay. After SPE, the extracted residues 
were separated by isocratic HPLC and the fractions analysed using the Charm II test. The 
resulting LC-receptogram gave added confidence to immunoassay results because of the 
assurance of a specific retention time coupled with a specific microbial receptor reaction.
1.5 RESIDUE SEPARATION TECHNIQUES
Following extraction and clean-up, analytes arc subjected to separation from each other or 
any matrix co-extractives and finally detected. Therefore, quantification involves 
separation of the extracted residues, followed by detection. These latter steps are usually 
described as one system e.g. HPLC separation followed by UV or fluorescence detection. 
Chromatographic methods are the most widely used methods for quantitative residue 
analysis offering sensitivity and versatility. Chromatographic analysis combines 
separation capabilities with a variety of sensitive detection techniques. Final detection 
may be by a confirmatory technique e.g. mass spectrometry (MS).
1.5.1 Liquid chromatography
Liquid chromatography has emerged as the method of choice for antibiotic determination 
due to the polar, non-volatile nature of most antibiotic molecules and the adequate 
sensitivity of the detection techno logics available. Advances in instrumentation allow
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liquid chromatography separation with detection at very long and short wavelengths, 
including visible, ultra-violet and fluorescence. Another advantage is that procedures can 
be easily linked to form partially or completely automated systems. Pre- and post-column 
derivatisation techniques enhance sensitivity and allow detection at wavelengths that are 
less affected by matrix interferences.
The term "high performance liquid chromatography" evolved with the availability of 
column packings with small particle diameters and is used to distinguish HPLC from the 
original, more classical glass column liquid chromatography methods. For antibiotic drug 
residue analysis, non-polar, reversed-phases are most popular. Some of the SPE packing 
materials already discussed are also employed for HPLC stationary phases in liquid-solid 
chromatography. The advent of column end-capping has made reversed-phase 
chromatography more efficient for the analysis of polar antibiotic residues. The presence 
of silanol groups on reversed-phase columns traditionally resulted in broad, tailing peaks 
for polar analytes. The advent of base-deactivated columns, and polymeric columns 
assisted in overcoming this drawback. Internal surface reversed-phase chromatography 
(ISRP)125, where the column packing allows direct injection of samples rich in protein, is 
available, but the highly complex nature of many sample matrices, has hindered the 
application of this column type. Ion-exchange packings have also been employed for 
antibiotic separation. Ion-exchange columns possess stationary phase resins with 
functional groups attached. Analyte ions, possessing affinity for these functional groups, 
are retained on the stationary phase. Walker and Coates126 employed a cation-exchange 
column for the determination of gentamicin in plasma and urine. Pre-column 
derivatisation was employed, where fluorescamine reacted with the amine group of
gentamicin to produce a carboxyl group. This allowed the use of a cation-exchange 
column with a low mobile phase pH to suppress ionisation of the carboxyl group and to 
effect separation on the basis of protonated amino groups.
1.5.2 Gas chromatography
Gas chromatography (GC) is also used in the determination of antibiotic residues, but to a 
much lesser extent than HPLC methods. Most antibiotics are polar, non-volatile 
compounds, therefore derivatisation is necessary in order to use GC analysis. The high 
temperatures necessary for GC analysis often exceed the temperatures at which many 
antibiotic molecules are stable. Separation using GC offers some desirable properties for 
antibiotic residue analysis. The high sensitivity of detection techniques, such as electron 
capture, may justify the time and inconvenience of derivatisation to enhance the volatility 
of antibiotic residues. Allen127 has reviewed the GC detection of chloramphenicol with 
detection limits in the range 1-10 ng g'1. GC analysis has been applied to penicillin 
residues by Petz and Meetschen128. After isolation of several penicillins from animal 
tissue, the residues were methylated, cleaned-up further on diol cartridges, evaporated and 
dissolved in cyclohexane. A derivatisation step was required to form volatile methyl 
esters, which improved thermal stability and polarity, allowing separation on a fused-silica 
capillary column. Detection limits of 2 ng g 1 were reported.
1.5.3 Immunoassays
Immunoassays may be applied as rapid screening methods, or as semi-quantitative 
determination techniques. Immunochemical detection is based on the ability of antibodies
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to bind specifically with antibiotic residues. Various forms of this technique are in use, 
such as radioimmunoassay (RLA) and enzyme immunoassay (EIA), the main difference 
being in the method of labelling. Competitive assays are frequently used for the analysis 
of antibiotics. These methods are based on the competition of free antigen and labelled 
antigen for a limited amount of antibody. The assay response represents the amount of 
bound labelled antigen, which is inversely proportional to the concentration of the analyte. 
Immunochemical tests may be of microtitre plate format, for routine applications, or 
membrane based dip-stick tests for rapid screening129. The use of RIA for analysis 
presents problems such as the requirement for expensive scintillation counters, the 
disposal of radiolabelled waste and the commercial availability of labelled antigens. 
However, the technology provides good sensitivity, suitable for residue level detection, 
and can be applied to routine analysis of large numbers of samples. Enzyme linked 
immunosorbent assay (ELISA) is a popular immunological assay used in screening and 
determination of antibiotics in muscle and Iddney. ELISA assay kits are commercially 
available for a wide range of antibiotics. Small amounts of sample are required relative to 
that required for some other analytical or microbiological techniques. ELISAs using a 
microtitre plate format have been described for streptomycin130 and sulphonamides131. 
Detection limits in the range of 1-10 pg ml"1 can be achieved. Chloramphenicol has been 
detected by a microtitre plate assay hyphenated to HPLC. The sample extract was 
chromatographed and the fraction of interest subjected to immunoassay. This LC- 
immunogram technique resulted in a highly selective, reliable method with good detection 
limits132. This antibiotic was also detected by enzyme-linked immunofiltration assay 
(ELIFA). A nylon membrane was coated with polyclonal antibodies against 
chloramphenicol to which the sample was exposed. A developer was then added and
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colour intensity was inversely proportional to the amount of antibiotic present. The results 
were read visually133.
1.5.4 Capillary electrophoresis
Capillary electrophoresis (CE) is a rapidly growing separation technique that involves the 
migration of solutes in an electric field. The technique allows separation of analytes on 
the basis of charge. The analytes, present as charged ionic species, move at different 
velocities, depending upon their charge, through an activated capillary column. Optical 
detection can be made at the column outlet end. The technique is low on organic solvent 
consumption, can be easily automated, has efficiencies similar to capillary gas 
chromatography and requires small amounts of sample. The small sample permitted, lack 
of simultaneous multi-sample analysis capabilities, in addition to the requirement for 
highly charged ions have hindered the application of capillary electrophoresis in antibiotic 
residue analysis. Flurer134 has described the analysis of twelve aminoglycoside antibiotics 
by CE. A (used silica capillary was operated at 34°C with borate buffers and UV detection 
at 195 nm. The analysis of amikacin in human plasma, by CE, has been described by 
Oguri and Miki, with sample preparation limited to ultrafiltration135.
1.5.5 Supercritical fluid chromatography
Supercritical fluid chromatography (SFC), often described as a hybrid of gas and liquid 
chromatography, has been used in antibiotic residue analysis. It offers some of the best 
features of gas and liquid chromatography and avoids the use of organic solvents. The
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mobile phase is a supercritical fluid, which possesses physical properties intermediate to 
those of gases and liquids. The universal detectors suitable for gas-liquid chromatography 
are applicable to this technique. Open tubular columns are the most popular choice. 
Because of the low viscosity of supercritical fluids, columns can be much longer than 
those used in liquid chromatography, thereby leading to greater efficiency. SFC is still a 
relatively new technique and its impact on the field of residue analysis has not yet been 
fully realised. However, the low solvent consumption and applicability to non-volatile, 
thermally unstable compounds that do not possess easily detectable chromophoric groups, 
will result in developments of the technique in the area of residues. Packcd column SFC 
with UV detection has been evaluated for the determination of sulphonamides in kidney 
extracts136. Both silica and amino bonded stationary phases were examined and each 
provided different selectivities for the sulphonamides under study. The amino packing 
was more sensitive to modifier (methanol) concentration and the authors claim that other 
modifiers are of limited value for sulphonamide analysis by SFC.
1.6 DETECTION TECHNIQUES
The final step of antibiotic residue analysis, the detection method, has a large impact on 
the amount of sample preparation required. In addition, the nature of the separation step 
employed can often limit the detection steps applicable. The conjugated ring structure of 
most antibiotic molecules allows detection by UV spectrophotometry. However, for 
antibiotic residue analysis, UV detection may be undesirable, as many materials absorb 
appreciably in this spectral region, presenting matrix interference problems. 
Derivatisation techniques are frequently employed to enhance detection sensitivity and to
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overcome the problem of matrix co-extractives, which can mask the presence of the 
residue. Derivatisation can allow detection at wavelengths beyond that at which most 
substances absorb or can result in the formation of a molecule with strong absorption 
properties, producing a high intensity signal. Alternatively, it can allow a completely new 
detection technique to be employed. The addition of a fluorophore, allowing fluorescence 
detection is frequently employed for antibiotic residue analysis, both in pre-column and 
post-column mode. Fluorescence detection is more specific and generally offers enhanced 
detection sensitivity. Pre-column derivatisation can affect the separation, either positively 
or negatively, if the moiety added dominates the chromatographic properties. Derivative 
stability is another feature to be considered when employing derivatisation in the pre­
column mode. The number of samples in a run may be limited to the stability time of the 
derivative. For post-column derivatisation, additional equipment is required and 
additional optimisation is necessary with respect to mobile phase and reagent flow rates, 
mixing coil length and diameter. Post-column derivatisation can also result in increased 
base-line noise due to the pumping action of the reagent pump.
Electrochemical detection can be employed for antibiotic residues containing amines 
(penicillins), thiols and hydroxyl groups (aminoglycosides). This non-confirmatory 
technique does not require derivatisation but detects analytes directly. Its high sensitivity 
requires relatively long equilibration times and requires the presence of salts in the mobile 
phase, to assist ionisation of the residue molecules. Oxidation of the analyte, at the 
surface of an electrode causes a change in current flow and chromatograms are obtained 
by plotting current against time. Carbon paste and gold electrodes have been employed 
for aminoglycoside residue detection137. Polarimetric detection has been used for the
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detection of antibiotic residues that exist as isomers. Specific rotation detection has been 
applied to the study of erythromycin in milk138, allowing identification of various forms of 
the same drug, which possess minor structural differences. Refractive index detection has 
also been employed for aminoglycoside residue detection139 with a detection limit of 1 mg 
ml'1. This method of detection is often less sensitive than the more classical detection 
techniques but is more specific. Currently, since not all veterinary preparations are 
required to be chirally pure, the requirement for methods capable of detecting optically 
active substances is limited.
Mass spectrometric detection of antibiotic residues is becoming increasingly popular, as 
analysts require confirmatory techniques for determining the presence of antibiotic 
residues. Briefly, mass spectrometric detection involves the ionisation of molecules, 
resulting in a pattern of molecular ions and fragments that are specific to that antibiotic. 
Mass spectrometric detection can theoretically provide unequivocal identification for all 
antibiotics. The high cost and requirement for skilled operators initially hampered the 
application of this technique to veterinary drug residue applications. However, LC-MS is 
now routinely employed for the determination of antibiotic residues with most MS 
systems now being commercially available as bench-top LC detectors. The difficulty in 
obtaining diagnostic molecular ions has led to the existence of a wide range of ionisation 
techniques. Ease of operation and cost have resulted in quadrupole instruments becoming 
most popular. Many LC-MS methods reported in the literature employ thermospray 
interfaces; however, the mass spectrometric analysis of antibiotics has significantly 
benefited from the development of electrospray ionisation (ESI) and atmospheric pressure 
chemical ionisation (APCI). The ionisation method employed is influenced by a variety
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of parameters such as mobile phase flow rate and composition, analyte thermal stability, 
volatility, and ionisation state. Criteria that define the performance of confirmatory 
methods for residues have been established. For application of mass spectrometry in 
regulatory residue analysis, monitoring of four ions is required and ion ratios in samples 
must be within 20 % of the ion ratios determined in standards.
1.7 CONCLUSION
In the past ten years, the science of veterinary drug residue analysis has moved towards 
less labour intensive, more automated assays. For antibiotic residue analysis, rapid 
screening methods are frequently employed, most of which employ the principle of 
microbial inhibition. Immunodiagnostic techniques, such as EIA have also featured, 
offering increased specificity and sensitivity, relative to microbial inhibition methods. In 
chemical analysis, HPLC remains the method of choice for antibiotic residues. A wide 
range of detection techniques are used, including UV, fluorescence and electrochemical 
detection. The employment of confirmatory detection for routine analysis has increased 
significantly. The on-line combination of LC-MS has bccome a popular technique. The 
ease of operation and robustness of newly-developed interfaces has resulted in the routine 
employment of MS for detection and simultaneous confirmation.
In sample preparation, trends have been towards more automated, environmentally 
friendly methods, exhibiting high sample throughput. Currently, SPE is the sample
preparation technique most widely employed in antibiotic residue analysis. Liquid-liquid
5 6
partitioning has been largely superseded by this rapid, efficient technique. Reasons for 
this include the ease with which SPE procedures can be fully automated and automated 
systems are now readily available commercially. SPE is relatively low on solvent 
consumption and does not make huge demands on operator time, when compared with 
liquid-liquid partitioning. Supercritical fluid extraction has also featured in sample 
preparation, however, its requirement for specialised equipment has hindered its 
employment.
Sample preparation is the rate-limiting step in many veterinary drug residue methods. 
Despite trends towards rapid methods with high sample throughput, many of the methods 
reported in the scientific literature still employ techniques that have been in use for many 
years. In recent years, much research has been directed at developing the ideal 
confirmatory detection technique, and attention has been focussed on making MS 
detection more widely applicable and more sensitive. However, there have been some 
moves towards the development of automated sample preparation systems, such as 
automated dialysis, or on-line SPE. Nevertheless, even these methods require 
considerable sample preparation, prior to employing an automated procedure. Therefore, 
sample preparation techniques in general remain labour intensive and demand a 
considerable proportion of the analyst’s time.
Trends in sample preparation are to develop methods that are less labour intensive and that 
are amenable to automation. The objectives should be to increase the reliability of 
existing methods and eliminate clean-up steps, by employing more selective extraction
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procedures. Ideally, a universally applicable extraction method is desirable, possessing 
reliability, specificity, rapidity and simplicity. The development of multiresidue methods 
is increasing with on-line enrichment to improve sensitivity. The ideal method would 
incorporate sample preparation on-line with the entire analytical procedure and produce a 
confirmative result. Future trends for antibiotic residue analysis are likely to involve 
methods that may be used 011-site, without the need for extensive instrumentation and 
skilled operation, and yet produce a reliable result.
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CHAPTER 2
THE ANALYSIS OF 
SULPHONAMIDE DRUG RESIDUES 
IN PORK MUSCLE USING 
AUTOMATED DIALYSIS
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Sulphonamides are a class of veterinary drug that find use in the treatment and prevention 
of various bacterial infections in farm animals. They are commonly administered for the 
treatment of respiratory diseases in animals, such as pneumonia, for intramammary 
infections, such as mastitis, and for urinary and intestinal tract infections. 
Sulphamethazine is the most commonly used member of the class. As discussed in 
Chapter 1, the use of these antimicrobial agents may leave residues in tissues or milk, 
which can pose a risk to consumer health. A high level of exposure of some micro­
organisms to these drugs may manifest itself in the development of drug resistant strains1. 
The use of sulphonamides has been approved by regulatory agencies, provided sufficient 
withdrawal periods are adhered to, allowing elimination of the residues from edible 
tissues. Maximum Residue Limits (MRLs) of 100 ng g'1 (ppb) have been set by the EC 
for sulphonamides in tissue2.
2.1.1 Mechanism of action
Sulphonamides, first discovered in 1935, are bacteriostatic chemotherapeutics, which act 
by inhibiting the growth of new bacteria. They act by preventing the production of folic 
acid (needed for DNA production) through competition with the folic acid precursor, p- 
aminobenzoic acid. Diaminopyrimidines, such as trimethoprim, are frequently 
administered alongside sulphonamides, as they possess a synergistic relationship with 
sulphonamide antibiotics, resulting in a bactericidal effect.
2.1 INTRODUCTION
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Chemically, sulphonamides are substituted aromatic amines, substituted at the N-l 
position as shown in Figure 2.2. Sulphanilamide, shown in Figure 2.1, depicts the basic 
chemical structure for the sulphonamide class. Sulphonamide antibiotics are amphoteric, 
possessing an NH2 group and an S 02 moiety. The various members of the class have a 
wide range of pKa values, which can make analysis difficult. In general, they are 
insoluble in water, diethyl ether and chloroform, but readily soluble in polar organic 
solvents such as acetone. All members of the class possess UV absorption properties at 
254 nrn or 270 nm.
2.1.2 Physical/chemical properties
Figure 2.1 Basic chemical structure for sulphonamide antibiotics.
Generally sulphonamides are stable compounds, but a few members of the class are 
sensitive to UV degradation. In vivo, the aromatic amine becomes acetylated resulting in 
the production of N-acetyl-sulphonamide. Stability of sulphonamide residues in the 
presence of matrix components has been studied. Thomas et al? studied the effects of 
frozen storage on the stability of sulphonamide antibiotic residues in fortified porcine 
liver. They examined the effects of storage at -20°C on sulphamethazine, sulphathiazole, 
sulphadimethoxine, sulphachloropyridazine and sulphaquinoxaline. They concluded that
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all the analytes degraded during storage. Sulphaquinoxaline degraded most rapidly (half- 
life 271 days) and sulphadimethoxine was the most stable (half-life 567 days). This study 
demonstrates the need for analysis of samples close to time of slaughter as the residue 
content in samples which have been held in frozen storage for extended periods will not be 
indicative of the residue content when the animal was slaughtered. Hasset et al.4 
concluded that temperatures reached during frying, roasting, grilling and boiling of meat 
were insufficient to degrade sulphonamide residues.
Various studies have been reported on identification of the target organ for sulphonamide 
residue analysis. Randeclcer et al.5 reported higher levels of sulphamethazine in liver than 
kidney after administration of medicated feedstuffs. They also suggested that 
sulphamethazine serum and urine levels could be indicative of tissue levels. The Sulpha- 
On-Site (SOS) test, used by the USDA, for regulatory control of sulphamethazine, 
determines the level of analytes in the urine, as an indication of the concentration in 
tissues. DePaolis et a lb administered radio labelled sulphamethazine to pigs and found 
levels of radioactivity to be greater in liver than in kidney. However, it is possible that the 
activity measured is not just indicative of levels of the parent compound but also that of 
metabolites present. Shearer et al.7 reported highest levels of sulphamethazine in plasma, 
followed by kidney, liver and muscle. Two trials were included in the study; in the first 
trial, pigs were fed sulphamethazine treated feed up to the day of slaughter. In the second 
trial, pigs were fed sulphamethazine treated feed and then fed unmedicated feed prior to 
slaughter. Samples were collected at slaughter and analysed. The distribution of 
sulphamethazine was in the ratio 1:2:3:6 for muscle:liver:kidney:plasma.
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2.2 METHODS FOR THE ANALYSIS OF SULPHONAMIDE 
RESIDUES IN TISSUES
2.2.1 Sample preparation
As discussed in Chapter 1, a critical step in residue analysis is sample preparation, 
designed to extract the residues while eliminating the problem of matrix interferences. 
Traditionally, organic solvent extraction methods, using several extraction solvents, were 
employed followed by centrifugation, pH adjustment and back extraction. These steps 
may result in a laborious, time-consuming method, allowing a limited number of samples 
to be analysed per day. Due to the number of sulphonamide drugs employed in veterinary 
medicine, multi-residue methods are desirable, which are capable of determining a number 
of residues simultaneously. However, this task can be difficult, due to the varying pKa 
values within the group (5.1-11.5). Most methods reported follow the general protocol of 
homogenisation in an extraction solvent, mixing to achieve extraction, centrifugation, 
clean-up using solid phase extraction, or liquid-liquid partitioning with various washes 
and pH adjustments, and finally chromatographic determination.
2.2.1.1 Solvent extraction and liquid-liquid partitioning
Chloroform, ethyl ether, acetone and methylene chloride are commonly used for 
extraction of sulphonamides. Acetonitrile has been used for deproteinisation. Smedley 
and Weber8 described a method for the analysis of ten sulphonamide residues in milk at 10 
ppb, based on chloroform-acetone extraction followed by dissolution of the residues in 
potassium phosphate buffer and removal of fat with hexane. Tsai et al.9 used acetonitrile
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for extraction and deproteinisation of milk samples for the analysis for six sulphonamides. 
The sulphonamides were derivatised prior to HPLC separation and fluorescence detection. 
For the determination of sulphamethazine in porcine tissue, Thomas et al.'" extracted 
tissue with ethyl acetate and back extracted into methylene chloride. Emulsions were 
minimised by inclusion of a centrifugation step. Sulphamethazine analysis in muscle by 
Boisson and Keng" involved initial extraction with chloroform followed by back 
extraction into alkaline sodium chloride solution in a separatory funnel. Haagsma et aV 2 
extracted sulphamethazine from porcine tissue by ultrasonication in the presence of 
dichloromethane. Petz13 used a liquid-liquid partitioning method for the determination of 
sulphanilamide and sulphaguanidine in muscle and liver. The residues were extracted 
with acetonitrile at pH 8.5, and the aqueous portion of the extract was separated by adding 
sodium chloride. The extracted residues were subsequently partitioned between aqueous 
methanol and hexane. The residues partitioned into the aqueous methanol layer and this 
was used for chromatographic determination.
Ion-pair extraction has been described for the extraction of sulphadimethoxine from fish 
tissue14 and sulphapyridazine from serum15. Tetrabutylammonium hydroxide was 
employed in both studies. The addition of the ion-pair rendered the sulphonamides more 
extractable by chloroform or dichloromethane, as it complexed with the negatively 
charged sulphonamide, resulting in a neutral molecule, which partitioned into the 
relatively non-polar organic solvent.
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Sulphamethazine, sulphadimethoxine and sulphamonomethoxine were determined in 
animal tissue and egg by Hori et al.u\  The method of analysis for these drugs involved an 
initial acetonitrile deproteinisation followed by a hexane wash to remove lipids. An SPE 
clean-up step was employed with Bond-Elut™ C l8 from which the sulphonamides were 
eluted using acetonitrile, containing triethylamine (TEA). The TEA acted as an amine 
modifier competing with unbonded silanols on the silica back bone. Recoveries in the 
range of 81-98 % were obtained for residues at 0.1-0.2 jo.g g"1 tissue. Haagsma and De 
Water17 described a method for the rapid detennination of sulphanilamide, 
sulphamethazine, sulphaquinoxaline, sulphadoxine and sulphadiazine in porcine kidney 
and muscle, with a detection limit of 50 ng g"1. Following an initial chloroform-acetone 
extraction, an ion-exchange clean-up step was used. An aromatic sulphonic acid cation- 
exchange column was employed. This allowed the retention of the sulphonamide drugs 
(of various solubilities and pKa’s) from an acidified extract. Elution could be achieved 
with alkaline buffer, but this was not suitable for subsequent HPLC analysis, so ammonia 
vapour was passed through the column, followed by methanol elution. The authors 
postulated that ammonia deprotonates the sulphonamides thereby breaking the bond with 
the sulphonic acid column and permitting elution in a small volume of solvent.
A method for the detennination of sulphamethazine in milk using SPE was earned out by 
Unruh et al.18 with recoveries of 96 tolOO % over the range 0.5 to 15 ng ml"1. Two clean­
up columns were arranged in tandem. An initial C l8 SPE column retained the 
sulphamethazine and sulphabromomethazine (internal standard), when applied in 
phosphate buffer, pH 5.7. The sulphonamides were found to elute off the Cl 8 sorbent in
2 . 2 . 1 . 2  S o l i d  p h a s e  e x t r a c t i o n
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methanol, but this eluate contained riboflavin, lipids and other compounds, which 
interfered with the subsequent chromatographic analysis. Therefore, aluminium oxide and 
cation-exchange resin (AG MP-1) were arranged in a tandem column arrangement to 
clean-up and isolate sulphamethazine and sulphabromomethazine. The aluminium oxide 
removed the interfering fluorescent riboflavin and free fatty acids from the extract. 
Sulphamethazine and sulphabromomethazine were eluted off the AG MP-1 resin with an 
acidic acetone solvent, which could be easily applied to determination by TLC.
Silica SPE has been employed for the clean-up of four sulphonamide drugs and their N4 
metabolites in porcine muscle19. Cooper et al.20 also employed silica SPE for the 
determination of sulphadimethoxine, sulphaquinoxaline and sulphamethazine in porcine 
lddney. Suhren and Heeschen21 employed aromatic sulphonic acid cation-exchange SPE 
for the determination of eight sulphonamide residues in milk. This allowed the milk to be 
deproteinated using acid and the acidic extract could be applied directly onto the SPE 
column.
Cox et al.22 have used SPE columns packed with XAD-2 polymer for clean-up of samples 
containing sulphamethazine. A phosphate buffer extract (pH 6.8), resulting from liquid- 
liquid extraction, was applied to the column and sulphamethazine eluted using methanol. 
Aerts et al,23 also used XAD-2 and XAD-4 microcolumns for sulphonamide multi-residue 
analysis. They described an automated dialysis system for the extraction of sulphonamides 
from milk, meat and eggs, followed by clean-up and concentration on C l8, Corasil or 
XAD material.
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Matrix solid phase dispersion (MSPD) has been employed for single and multi- 
sulphonamide residue analysis in biological fluids and tissues. The basic principles 
behind the method are discussed in Chapter 1. Chapter 3 describes the isolation of 
penicillin residues using this method. It has been employed in combination with thin layer 
chromatography, to provide a simple, rapid method for the determination of six 
sulphonamide residues in tissue and milk24. Matrix interferences were removed using a 
hexane wash and the sulphonamide residues were eluted using dichloromethane. Long et 
al.2S extracted eight sulphonamide drug residues from pork tissue using this technique. 
Sulphonamides were eluted from the Cl 8-tissue blend using dichloromethane, yielding 
extracts clean enough for HPLC separation with UV detection at 270 nm. Recoveries 
were in the range 70-95 % with a limit of determination of 62.5 ng g'1. A hexane wash 
removed lipid material and neutral chromophores that interfered with UV detection. 
Dichloromethane elution allowed elimination of highly polar compounds, which were 
retained on the column.
Shearan et al.2b have compared MSPD with a standard solvent extraction method for 
sulphamethazine in pork tissue. The MSPD protocol was similar to that described by 
Long25 and residue content of extracts were determined by HPLC and TLC. The authors 
concluded that MSPD, linked with the TLC system described required improvement, as 
the detection system was not sensitive enough to measure levels of sulphamethazine at or 
below the MRL. Increasing the quantities of tissue and packing material, in an effort to 
improve sensitivity, would prove expensive, so the authors recommended the use of more 
concentrated extracts. They also described an alternative approach to evaporation of
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methylene chloride resulting from MSPD, which was back extraction of sulphamethazme 
into 500 pi 0.01 N sodium hydroxide. Solvent extraction in an ultrasonic bath was 
employed, followed by SPE clean-up, providing extracts suitable for TLC and HPLC 
detection systems at levels as low as 50 ng g However, this method was inferior in 
terms of time and ease of use and recoveries were no better than with MSPD.
The same authors have published an on-site method for sulphamethazine determination in 
pork carcasses27. It links MSPD with a micro-column concentration step, prior to 
determination by a modification of the TLC based “Sulpha-On-Site” test. The method 
overcomes the requirement for sophisticated instrumentation. MSPD elution was effected 
using methylene chloride. Petroleum spirit was added to the methylene chloride extract to 
aid sulphamethazine retention during clean-up on a silica micro-column, similar to that 
used by Unruh et al.]S. Sulphamethazme was eluted with 150 pi methanol, which was 
applied to TLC and residues were detected using fluorescence. Multi-residue MSPD 
extraction has been applied to the determination of five sulphonamide residues in salmon 
muscle28. C l8 sorbent was employed, fat was removed using a hexane wash, and analytes 
were eluted in dichloromethane, which could be easily concentrated.
2.2.1.4 Immunoaffinity column chromatography
Immunoaffinity column chromatography provides a simple, quick method for sample 
clean-up. The production and characterisation of polyclonal antibodies to 
sulphamethazine and their potential for use in immuno affinity column chromatography 
has been reported by Crabbe et al.29 After characterisation of the antibodies in an ELISA, 
the IgG fractions were coupled to CNBr activated Sepharose and employed for the
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immunoaffimty column clean-up of urine samples. The column had a high capacity for 
sulphamethazine (1900 ng ml'1 gel), and showed high cross reactivities for the major 
metabolites of sulphamethazine present in urine. Mean recovery from urine samples 
fortified at 100 ng ml"1 was 96 % (CV = 5 %).
Immunoaffimty column chromatography was employed by Martlbauer et a/.30 for 
sulpbonamide analysis. Monoclonal antibodies developed for sulphamerazine and 
sulphadiazine capture, were mixed with activated Sepharose and loaded onto a syringe 
barrel. Milk was defatted, by centrifugation, and diluted with saline prior to loading onto 
the immunoaffmity column. The eluted analytes were determined by LC with UV 
detection. The sulphadiazine antibodies showed cross reactivity with sulphamerazine, 
with 84-96 % of the two drugs being bound to the column.
2.2.1.5 Supercritical fluid extraction
As previously mentioned, many sulphonamide residue analysis methods employ solvent 
extraction steps, which are time-consuming and use relatively high volumes of organic 
solvents. Therefore, the application of supercritical fluid extraction for the analysis of 
sulphonamide residues is appropriate. Supercritical trifluoromethane and methanol 
modified trifluoromethane were compared with supercritical carbon dioxide and methanol 
modified carbon dioxide for the extraction of sulphonamides from fortified chicken liver31. 
Supercritical trifluoromethane and methanol modified trifluoromethane had higher 
solvating powers and extraction selectivity for the extraction of sulphamethazine, 
sulphadimethoxine and sulphaquinoxaline. This was likely due to the strong hydrogen
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bonds formed between the basic analytes and trifluoromethane. For both fluids, methanol 
modification was necessary to achieve recoveries of greater than 67 %. Mean recoveries 
of 100 %, 86 % and 31 % with RSD values of 4 %, 12 % and 14 % were obtained for 
sulphamethazine, sulphadimethoxine and sulphaquinoxaline, respectively, for chicken 
liver samples fortified at 5 ppm. Maxwell and Lightfield32 have described a multiresidue 
method for the determination of sulphamethazine, sulphadimethoxine and 
sulphaquinoxaline in chicken liver. Unmodified carbon dioxide was employed, with in­
line trapping on neutral alumina. Determination was by HPLC. Recoveries of 72-98 % 
were achieved with standard deviations in the range 1.2 to 10.2, for samples fortified 
between 50 and 1000 ppb.
2.2.2 Screening methods
Screening techniques commonly used in antibiotic drag residue analysis are discussed in 
Chapter 1 and many of these have found application for sulphonamide residue screening. 
Microbiological inhibition methods including the Four Plate Test, the new Dutch kidney 
test, swab test on premises (STOP), Calf Antibiotic and Sulfa Test (CAST) and Fast 
Antibiotic Screen Test (FAST) have been used.
2.2.2.1 Microbial inhibition assays
The STOP test has been used for the analysis of sulphonamide residues in kidney. A 
cotton swab was inserted into the tissue sample and then incubated overnight, on agar 
medium containing Bacillus subtilis. Johnston et al,33 compared STOP results with 
standard microbiological inhibition plate assays and reported 94 % agreement. The CAST 
assay is very similar in method protocol and sensitivity to the STOP assay, with overnight
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incubation at 44°C. The FAST procedure is also similar in protocol but the growth 
medium contains a purple dye that becomes yellow in the presence of bacteria (due to acid 
production during bacterial metabolism); the change in colour from purple to yellow 
indicating the absence of antimicrobial residues. Results are available more rapidly using 
FAST screening, as only a six hour incubation is required. The Delvotest works on the 
same principle as the FAST assay, and requires shorter incubation (around 2 h). Bugyei et 
al.34 have used the Delvotest for the analysis of sulphamethazine in chicken liver and 
kidney. They compared the results obtained with those obtained for samples analysed by 
a standard plate assay. Limits of determination were lower using the Delvotest, however, 
a greater incidence of false negatives occurred. The Brilliant Black Reduction Test uses 
B. Stearothermophilus as the test organism and also works on the basis of a change in 
colour of the medium. The limit of determination for most sulphonamides is 1 ppm using 
this test, however, sensitivities for the various members of the class vary; for example, 100 
ppb sulphadimethoxine may be detected35.
2.2.2.2 Bacterial receptor assays
Receptor based assays, such as the Charm™ test, have been reported for sulphonamide 
residue screening36. The method has been applied to the analysis of residues in liver, 
kidney and muscle. Limits of detection are in the low ppb range. In this assay, microbial 
cells possessing specific receptor sites for the sulphonamide residues are added to the 
sample. Radiolabelled drug standard is also added, and the labelled drug competes with 
any residues from the sample for the receptor sites. Further sample treatment involves 
centrifugation and the precipitate (containing the receptor-bound radiolabelled drug 
standard) is measured for radioactivity. The activity measured is inversely proportional to
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the amount of residue in the sample. The test is only specific for a particular family of 
antibiotics, such as sulphonamides. A relatively high rate of false positives have been 
attributed to screening using Charm kits, and the test has different sensitivities for 
different members of the same family. Zomer et al.31 described a method for the 
determination of ten sulphonamide residues in milk. Liquid chromatography was 
employed to isolate the analytes and detection was by the Charm II test. The limit of 
determination of the assay was between 1 and 5 ppb for the various sulphonamides under 
study. Samples fortified at the minimum determination level for each sulphonamide were 
analysed and variation in recovery of 7.6 to 24 % resulted.
2.2.23 Immunoassays
Immunoassays have been employed as screening methods for sulphonamides in milk and 
tissues. It has been reported that immunoassay methods require greater sample 
preparation than many other screening methods employed, such as microbial inhibition 
and receptor assays38. Garden and Spoms39 described a method for the analysis of 
sulphamerazine in milk using an EIA. Sample dilution with water was the only sample 
preparation step required and the method had a limit of determination of 0.15 ppb. 
Jackman et al.40 reported the analysis of raw milk using an EIA. The assay proved linear 
between 0.02 and 40 ppb, for twelve sulphonamide residues. Cross reactivities of other 
sulphonamides with each antisera were less than 1 %, with four exceptions at 55, 33, 13 
and 3 %. Dixon-Holland and Katz41 described an EIA for the detection of 
sulphamethazine in porcine urine and muscle. Urine samples without any clean-up, or 
muscle extracts, were analysed and detection was by absorbance measurement using 2,2'- 
azino (3-ethyl-benzothiazole) sulphonic acid as a chromogen. Sulphamethazine was
detected at concentrations of 20 ng g ' in muscle and 10 ng ml 'in urine. A similar 
competitive EIA for the specific determination of sulphamethazine in plasma was 
developed by Singh et al.42 for the concentration range 10-1000 p.g kg '; thirty-six 
sulphonamides were assayed for cross reactivity and only one, sulphamerazine, showed 
cross reactivity of 12 %. Ram et a/.43 developed an EIA for sulphamethazine 
determination at 1-5 ng ml"1 porcine plasma and serum using an automated technique.
Crooks et cd,44 have developed an immunobiosensor for the detection of sulphamethazine 
and sulphadiazine residues in porcine bile. The method described employed an optical 
biosensor (BIAcore™) for routine screening. For this instrument, antibodies were 
immobilised onto sensor chips and the sample pumped over the surface of the chip for 5 
min. The false positive results were 0.14 % for sulphamethazine and 0.34 % for 
sulphadiazine, which were lower than those achieved using the classical enzyme 
immunoassay. Biosensor analysis showed no false negatives and provided a rapid, simple 
screening technique.
2.2.2.4 Thin layer chromatography
Thin layer chromatography has been widely used for the determination of sulphonamide 
residues in foods. The use of selective detection reagents such as the Bratton-Marshall 
reagent, p-dimetliylaminoben/,aldehyde or floureseamine have provided sensitive 
methods. Bieganowska et al.45 compared the chromatographic behaviour of some 
sulphonamides on normal phase and reversed-phase HPTLC plates. They investigated the 
influence of ion-pair reagents on the retention of sulphonamides on reversed-phase TLC
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plates and also the influence of different modifiers on normal phase plates. They reported 
that Florisil and polyamide were more selective adsorbents than silica and concluded that 
sulphonamides were more strongly retained on reversed-phase adsorbent as the 
concentration of organic modifier in the mobile phase was increased. Reimer et al.46 have 
reported a TLC based screening method for five sulphonamides in salmon muscle with a 
limit of determination of 40 ppb for sulphamethazine, sulphadimethoxine, sulphadiazine, 
and sulphapyridine and 100 ppb for sulphamerazine. The sulphonamides were detected on 
silica gel HPTLC plates after derivatisation with fluorescamine.
Van Poucke et al.24 detected sulphonamide residues in milk at a concentration of 4 jig kg'1 
using TLC with fluorescence derivatisation and a three-phase multiple development 
chromatographic system. Shearan and co-workers26 described the determination of 
sulphamethazine at 0.4 fig ml'1 from direct application of urine on a TLC plate. Unruh et 
al.41 described the quantification of sulphamethazine in pork tissue by TLC where silica 
gel plates were run, dried, dipped in fluorescamine solution, dried and sprayed with borate 
buffer. The plates were then stored at approximately -20°C for five minutes before 
scanning at 366 run (excitation) and 400 nm (emission). This cooling step overcomes the 
problems of heat lability of fluorescent derivatives.
The “Sulfa-On-Site” (SOS) test is a commercially available TLC based kit for the analysis 
of sulphamethazine residues in porcine urine. It was designed for residue control at meat 
slaughter plants, so skilled technicians are not required. Using this method, residues may 
be visually detected under UV light. The migration distance (Rf value) is used for 
presumptive identification and the intensity of the fluorescence allows approximate
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quantitation. The intensity of the sample spot is compared with the intensity of the spots 
for two standard solutions of 0.4 and 1.3 pg ml"1. Where the intensity of the sample spot 
exceeds that of the 0.4 pg m l1 standard, it is considered that the liver contains 
sulphamethazine residues in excess of the MRL (0.1 pg ml'1), and where the sample spot 
intensity exceeds that of the 1.3 pg ml'1 standard, the carcass (muscle) is considered to 
contain sulphamethazine in excess of the MRL (0.1 pg g'1).
2.2.2.5 Spectrophotometric assays
The highly sensitive Bratton-Marshall colour test forms the basis of the 
spectrophotometric method used by Schwartz48, hi this method, the free aryl primary 
amine (N4, see Figure 2.1) is converted to a diazoniimi salt, using nitrous acid, and after 
removal of the excess acid, the diazonium salt is coupled to a chromogen to form an azo 
dye with a detection wavelength of 545 nm. The method is not highly specific, so other 
primary amines interfere. The non-specificity of the reaction in feeds has been overcome 
by anion-exchange extraction, in the method described by Schwartz49. Sulphamethazine, 
on reaction with Bratton-Marshall reagents, yielded a pink coloured compound. Schwartz 
used this method to detect sulphamethazine in milk at low ppb levels. The quantification 
was carried out spectrophotometrically at 540 nm. He also used this detection system for 
sulphathiazole in honey.
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Quantitative residue methods for sulphonamides are based on chromatographic methods, 
particularly HPLC, and less frequently GC. Aside from UV detection, most other 
methods require derivatisation.
2.2.2.1 High performance liquid chromatography (HPLC)
Reversed-phase liquid chromatography has proven to be the most popular method for 
sulphonamide drug residue analysis. A review of various HPLC methods was prepared by 
Agarwal50. Numerous studies have been developed for single and multiresidue methods. 
Most sulphonamide methods use C l8 or C8 columns. Horii et al,16 used a Nucleosil C l8 
column for sulphamethazine, sulphadimethoxine and sulphamonomethoxine separation. 
A C2 column was employed by Alwai and Russel51 for the separation of sulphamethazine 
and sulphadiazine in milk extracts. Weiss et al.'4 used a |Li-Porasil column for the analysis 
of sulphadimethoxine. Capacity factors could be easily influenced by varying the 
concentration of ammonium acetate in the mobile phase buffer. Normal phase 
chromatography with a silica stationary phase was employed for the analysis of 
sulphadiazine and ormethoprim in fish tissue52. A cation-exchange column was employed 
by Rychener et al.53 for the chromatographic separation of thirteen sulphonamide residues 
in muscle, liver and kidney extracts. However, two separate HPLC mobile phases were 
necessary, as it was not possible to separate all residues in one chromatographic run. 
Brewster et al.54 evaluated restricted access media for the HPLC analysis of sulphonamide 
residues. Three commercially available columns were tested for their suitability for 
multiresidue sulphonamide analysis. The authors reported matrix problems when bovine 
serum samples were directly injected and only one column allowed a multiresidue
2.2.3 Quantitative methods
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method. Mieellar liquid chromatographic separation of twelve sulphonamides was 
described by Yang and Khaledi55. Sodium dodecyl sulphate micelles were employed with 
an endcapped C l8 column. The retention behaviour and selectivity pattern of the 
sulphonamides were examined under various concentrations of sodium dodecyl sulphate 
and organic modifier. Direct on-column injection was used to separate twelve 
sulphonamide residues extracted from human urine and cow’s milk. The method showed 
repeatable retention times with standard deviation values in the range 0.005 to 0.035. 
Mieellar liquid chromatography has also been described by Symanski and Szczepaniak for 
the analysis of six sulphonamides56. The method is based on the reversed-phase separation 
of the analytes with the anionic surfactant sodium dodecyl sulphate as the mieellar mobile 
phase. The pH and micelle concentration were the two most important parameters 
affecting retention of the analytes. Good peak symmetry and resolution were obtained. 
Reproducible retention times were noted (RSD values of 0.26 to 0.86 min). UV detection 
was employed, allowing limits of detection between 0.02 and 0.2 jig ml"1. Mieellar liquid 
chromatography has been applied to the analysis of five sulphonamide residues in serum. 
Azo dye pre-column derivatisation was employed and the derivatives were separated on a 
C l8 column with SDS-pentanol mobile phase57. The method proved linear between 1 and 
20 f ig  ml'1. Baseline resolution was not achieved for all five analytes in one run.
The retention behaviour of sulphonamides on reversed-phase columns is dependent not 
only on the polarity of the molecules, but also on the extent of ionisation of the functional 
groups. Therefore, the pH of the mobile phase is important. Mobile phases generally 
contain a high percentage of aqueous buffer (phosphate or acetate buffered between pH 2 
and 5 and acetonitrile or methanol modifier. Sulphonamides possess a UV absorbance
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band at approximately 270 nm, which allows HPLC with direct UV detection. Typical 
sensitivities achieved for UV detection of sulphonamides are in the region of 2 to 10 ng. 
Photodiode array detection has been commonly applied to sulphonamide analysis. Cooper 
el al.20 employed diode array detection for the analysis of sulphonamides in porcine 
kidney. This allowed the detection of sulphamethazine at 299 nm, sulphadiazine at 251 
nm and sulphaquinoxaline at 256 mn. Alternatives to direct UV detection are precolumn 
derivatisation and post-column derivatisation. These techniques are employed to improve 
the specificity of sulphonamide detection. For sulphonamide residue analysis, several 
derivatisation techniques employing a fluorescent tag have been described. Fluorescamine 
and /j-dimcthylammobenzaldehyde (DMAB) are widely used as derivatisation reagents for 
sulphonamide analysis with HPLC. Pre-column derivatisation with fluorescamine was 
used by Takeda and Akiyama58 for the detection of sulphonamides in meat. A limit of 
detection of 10 ng g"1 was reported. Sulphonamides in the presence of fluorescamine, at 
pH 3, yielded highly fluorescent compounds measurable with excitation at 405 nm and 
emission at 495 nm. Gehring el al.59 have used fluorescamine for post column 
derivatisation of fourteen sulphonamide residues in salmon tissue. Fluorescamine is an 
expensive reagent, which only remains stable for 48 hours in a cooled solution. It reacts 
with the free N4-amino group of sulphonamide molecules.
DMAB fluorescence derivatisation is the method employed in this study and is dealt with 
in greater detail in the discussion section. It was developed initially as a spray reagent for 
TLC60 and later adapted as a HPLC post-column derivatisation technique by Stringham el 
al.bi. They compared it to the Bratton-Marshall colorimetric method and found 
derivatisation with DMAB to be safer, quicker, less demanding in terms of glassware and
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requiring fewer clean-up steps due to the longer wavelength used for detection of DMAB 
derivatives. Tsai et al.bl used fluorescamine derivatisation followed by post-column 
reaction with TDPO (bis[2-(3,6,9-trioxadecanyloxycarbonyl)-4-nitrophenyl] oxalate) and 
hydrogen peroxide, resulting in limits of detection around 1 ppb. Derivatisation of 
sulphonamide residues using o-phthaldialdehyde in the presence of mercaptoethanol was 
described by Vinas et al.63. The method was applied, post-column, to the determination of 
residues in meat, fish and eggs. The limits of determination were in the range 11 to 19 
ppb with a maximum RSD of 0.7 %, using a level of fortification of 0.4 ppm.
Electrochemical detection has also been applied in sulphonamide residue analysis. Alwai 
and Russel51 also used electrochemical detection in the determination of sulphamethazine 
and sulphadiazine in milk. Sample preparation was limited to chloroform extraction of 
milk samples and the authors reported electrochemical detection to be more sensitive than 
UV detection at 263 nm. The lhnit of detection was 10 ppb. Parks64 described the 
analysis of sulphanitran, amongst other mtro-containing drugs in chicken muscle using 
HPLC with amperometric detection. A glassy carbon electrode was used with an applied 
potential of -0.8 V. Adsorptive stripping voltammetry has been described for the 
determination of sulphamethazine in milk samples65. Milk was extracted using solvent 
extraction procedures. The residue was diazotized and coupled with 1-naphthol, to form a 
stable compound. The diazotized sulphonamide accumulated on the mercury electrode by 
electrochemical adsorption and was stripped cathodically. The method had a limit of 
determination of 3.8 ppb.
2.2.3.2 Gas chromatography
Gas chromatographic methods for sulphonamide analysis have the advantage of being 
more sensitive than HPLC. The low volatility and high polarity of these drugs necessitate 
derivatisation. Manuel and S teller66 reported a method for determining six sulphonamides 
in bovine and porcine tissues. The residues were methylated at the N4 position by 
diazomethane, separated on a packed column and detected by electron capture detection. 
The methylation of sulphamethazine by diazomethane was found to be approximately 90 
%. However, methylation with diazomethane was reported to produce N-methyl and ring- 
methyl derivatives and the latter failed to elute off the GC column38. Matusik et al.67 
modified the method of Manual and S teller for the determination of sulphamethazine and 
two of its metabolites in incurred animal tissues. Later, they extended the method to 
include sulphachloropyridazine, sulpadimethoxine, and sulphathiazole68. Holtmannspotter 
and Their69 described a capillary GC method with flame ionisation detection for 
sulphonamide residue analysis. The method could be applied to the analysis of six 
sulphonamides in eggs, milk and tissue. However, the limit of detection was 10 ppm and 
MRLs for the sulphonamide residues in tissues are 0.1 ppm.
2.2.3.3 Supercritical fluid chromatography
Supercritical fluid chromatography (SFC) with UV and mass spectrometric detection was 
employed by Perkins et al,70 for nine sulphonamides. Packed-column SFC separation on 
silica or amino-bonded silica was reported, using C 02 with methanol modifier, as the 
mobile phase. Tissue fortified at approximately 3 mg leg"1 was used to test the method. 
The authors investigated the effects of various modifiers on the separation of
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sulphonamides, using both columns, and reported the amino bonded column to be much 
more sensitive to modifier variations. Separation of the nine drugs on silica was possible, 
but it was not satisfactory due the requirement for low pressures, resulting in long run 
times with broad peaks. The application of an amino-bonded phase allowed higher 
pressures and higher modifier concentration resulting in sharper peaks in a much shorter 
time.
2.2.3.4 Capillary electrophoresis
Sulphonamide residues extracted from serum and urine were analysed by capillary 
electrophoresis71. Residues were analysed using on-line SPE employing columns packed 
with styrene/divinylbenzene. Samples were loaded onto the columns without any pre­
treatment. Elution was effected using acetonitrile and the analytes were separated using a 
fused silica capillary column with phosphate buffer of pH 7. RSDs values were between 6 
and 9 % and between 7 and 10 % for the analysis of serum and urine, respectively. The 
same authors analysed serum and urine for sulphonamide residues using on-line dialysis 
coupled to capillary electrophoresis72. Following removal of particulates and proteins by 
automated dialysis, the extracted residues were concentrated on a C l8 SPE column. The 
analytes were desorbed and subsequently injected into the capillary electrophoresis 
system. Using UV detection, the method had a limit of determination of 0.05 to 0.3 pg 
ml'1 for the range of sulphonamides. RSD values were between 3 and 8 % for serum and 
between 2 and 6 % for urine samples fortified at five times the limit of detection (between 
50 and 100 ng ml"1 for urine, and 100 and 300 ng ml"1 for serum). Sixteen sulphonamide 
residues were determined in porcine muscle using capillary electrophoresis, by Ackermans 
et al.73. Sulphonamide residues were extracted by stomaching in acetonitrile, followed by
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centrifugation and filtering, and 39 nl were pressure injected into the capillary. UV 
detection at 254 nin was employed and the limit of detection was between 2 and 9 ppm for
the various sulphonamides.
2.2.3.5 Mass spectrometry
Mass spectrometric (MS) detection of sulphonamides has been employed using direct MS, 
HPLC-MS and GC-MS. Most methods employ positive ion monitoring and the 
protonated molecular ion [M+H]+ as the base peak, with the exception of sulphanilamide, 
for which the base peak is [M+NH4]+. Pleasance et al.14 reported the separation and 
identification of twenty-one sulphonamides by reversed-phase HPLC with ion-spray MS. 
Tandem mass spectrometry provided structural infonnation. Henion et al.15 described the 
detection of three sulphonamide residues in urine by means of LC-atmospheric pressure 
chemical ionisation MS. The protonated molecular ion was primarily detected using 
single ion detection. HPLC-atmospheric pressure chemical ionisation MS of eight 
sulphonamides was described by Combs et al.76. In full scan mode, 0.8 ng analyte could 
be detected and selected ion monitoring allowed detection of 50 pg for most of the 
analytes. The method was applied to the determination of residues extracted from chicken 
liver, by supercritical fluid extraction.
Mass spectrometry with GC separation has been reported. Detection limits of 1 jig kg'1 
sulphonamides from pork tissue were achieved by Carignan and Carrier77 using LC clean­
up. Subsequent N4-methylation followed by GC-MS with electron ionisation in the 
multiple-ion detection mode was employed. GC-MS determination of sulphamethazine in 
porcine tissues has been described by Cannavan et al.1*. Samples were extracted with
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chloroform-acetone, followed by two SPE clean-up steps, prior to organic solvent 
partitioning. The extracted residue was methylated and silylated to allow GC analysis 
with selected ion-monitoring MS detection. Recovery values from muscle, liver and 
kidney ranged from 86 to 114 % with RSD values between 2.8 and 9.0 %. The assay had 
a limit of detection of 10-20 ppb in the various matrices. The authors reported that the 
methyl/trimethylsilyl derivatives exhibited better chromatography than the commonly 
used TVmiethyl-denvatives.
Mass spectrometric detection of residues, without the application of a chromatographic 
separation technique has proved popular for sulphonamide analysis. Brumely el al,79 
applied collision-induced dissociation-mass analysed ion kinetic energy spectrometry 
(CID-MIKES) to the identification of sulphonamide residues in tissues. Extracts were 
introduced directly with a solid probe and spectra obtained by chemical ionisation with 
helium being used as the collision gas.
2.2.4 Summary
This review of the literature highlights the large number of methods available for the 
determination of sulphonamide residues. However, most methods employ a number of 
sample preparation steps that are lengthy, labour intensive and consume relatively large 
volumes of organic solvents. Few methods employ automated techniques and most 
methods are applicable to only one to three sulphonamide residues. Despite the strong UV 
absorbance properties of the sulphonamides, most HPLC methods require derivatisation to 
achieve the desired specificity, as the commonly used sample preparation techniques result 
in co-extraction of excessive matrix interferences. Methods that do not employ HPLC
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with derivatisation are frequently outside the detection range of interest for veterinary drug 
residue analysis. Therefore, there is a need for a rapid, automated, multiresidue sample 
preparation method.
This study investigates the application of dialysis, followed by trace enrichment, for 
extraction of sulphonamide drug residues from porcine tissue. The Gilson ASTED system 
(Automated Sequential Trace Enrichment of Dialysates) was employed in the 
development and validation of the method. The procedure described investiagted nine 
sulphonamide drug residues using reversed-phase HPLC as the method of determination. 
Muscle samples were blended in saline, centrifuged, and the harvested supernatant was 
filtered before being subjected to dialysis for an optimised time of 11 min. The resulting 
dialysate was concentrated on a reversed-phase trace enrichment cartridge (TEC) prior to 
HPLC analysis. This sample preparation method is highly automated, is confined to three 
sample preparation steps (homogenisation, dialysis and trace enrichment) and has low 
consumption of chemicals.
The developed method was evaluated by carrying out intra- and inter-assays on fortified 
porcine muscle. Both UV detection at 280 nm and post column derivatisation were 
investigated. The derivatisation reaction involved reaction of the sulphonamides with 
DMAB to yield a coloured derivative with air absorption maximum at 450 nm. Mean 
recoveries were high (56 - >100 %) using both methods of detennination. Using UV 
detection at 280 mn, the detection limit was found to be 30 ng g1, while post column 
derivatisation gave detection limits of 20 ng g'1.
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2.3 EXPERIMENTAL
2.3.1 Introduction
In this study, on-line dialysis was performed in the pulsed mode where the sample was 
held static in the donor stream (on the upper side of the membrane) and the recipient 
stream flowed continuously, at a fixed rate, along the under-side of the membrane. Small 
molecules, such as sulphonamides, passed through the membrane pores into the recipient 
stream while larger molecules such as lipids and proteins failed to dialyse across the 
membrane and were flushed to waste. The resulting dialysate was then concentrated on a 
reversed-phase sorbent, and, when the maximum amount of dialysate was loaded on the 
enrichment cartridge, the concentrated extract was backflushed onto the analytical column 
for residue determination.
Sulphonamide antibiotics were determined in pork muscle samples at concentration levels 
of 40 to 200 ng g"1. Both UV detection at 280 nm and post column derivatisation using 
DMAB with detection at 450 nm were investigated. Figure 2.2 shows the chemical 
structure of the drugs studied, with the drugs being listed in order of elution from the Cl 8 
analytical column.
2.3.2 Chemicals and reagents
All solvents were of analytical HPLC grade and purchased from Merck Ltd., Dorset, UK. 
Sulphanilamide (SA), Sulphaguanidinc (SG), Sulphadiazine (SD), Sulphathiazole (STh), 
Sulphapyridazine (SPR), Sulphamerazine (SME), Sulphamethizole (SMT), 
Sulphamethazine (SMZ) Sulphamethoxypyridazine (SMP), Sulphachlorpyridazine
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(SCPR) and Sulphafisoxazole (SFX) were purchased from Sigma-Aldrich Company Ltd., 
Dorset, UK. Stock solutions of 1 mg ml'1 were prepared in 100 % methanol and dilutions 
were prepared in water:acetonitrile (80:20). The HPLC mobile phases used were sodium 
acetate buffer (0.05 M, pH 4.6):acetonitrile (30:70), for UV detection at 280 nm, and 
sodium acetate buffer (0.05 M, pH 4.6):acetonitrile:methanol (80:10:10), for post-column 
derivatisation. The pH was adjusted using glacial acetic acid, added drop-wise while 
stirring. Both mobile phases were vacuum filtered through a 0.45 pm filter and degassed 
in a ultrasonic water bath for 20 min. The mobile phase flow rate was set to 1 ml min"1. 
Aqueous sodium azide solution (0.5 %) and acetonitrile (75 %) were prepared monthly 
and used as system maintenance solvents. 500 ml of post-column derivatising reagent was 
prepared by dissolving 7.5 g DMAB (Sigma-Aldrich Company Ltd., Dorset, UK) in 400 
ml HPLC grade water and slowly adding 100 ml phosphoric acid (85 %). This was stirred 
continuously for 30 min prior to degassing in an ultrasonic water bath for 30 min. The 
reagent solution remained stable for 48 hours when protected from light.
2.3.3 Equipment
A Gilson ASTED™ XL system was employed, which was equipped with two Gilson 
401C dilutors. A Waters 510 HPLC pump was used to deliver the mobile phase. A 
Waters 501 HPLC pump was used to deliver the post column derivatising reagent, at a 
flow rate of 0.5 ml min"1. The derivatisation reagent was combined with the column eluate 
in a stainless steel mixing tee and reacted in a 5 foot stainless steel coil of 0.5 mm internal 
diameter, prior to detection at 450 nm. A Jones Chromatography column heater was used 
to maintain the column temperature at 25°C (for UV detection at 280 nm) and 30°C (for 
post-column derivatisation). The analytical column was a Waters Symmetry Cl 8 column,
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5jxm, 100 A, 4.6 x 250 mm. A Waters 486 tunable absorbance detector set at 280 nm (for 
UV detection at 280 nm) or 450 nm (for post-column derivatisation) was used. 
Chromatograms were acquired and processed using Millennium software, version 2.15. 
Two dialysis blocks were used: Gilson ASTED™ 100 |_l1 dialysis block for UV detection 
at 280 nm and Gilson ASTED™ 370 |il dialysis for post-column derivatisation. The 
cellulose acetate membranes used in the blocks (100 (il, 15 ldD membrane for UV 
detection at 280 nm and 370 jj.1, 15 kD membrane for post-column derivatisation) were 
mounted on inert polytriflouroethylene frames. Membranes were changed after 
approximately 50 samples. Trace enrichment cartridges (TEC) were Gilson ODS packed, 
Prelute 3 (70 mg, 10 mm) from Anachem Ltd., Luton, UK.
2.3.3.1 ASTED maintenance
When not in use, the membrane (over and under) and the sample lines were flushed with 
the sodium azide solution to prevent microbial growth. The sample lines were flushed 
with the acetonitrile solution to remove protein deposits, prior to storage. The trace 
enrichment cartridge was flushed with acetonitrile (100 %) which was used as a storage 
solvent.
2.3.4 Sample preparation
A 10 g quantity of homogenised porcine muscle was weighed out, which was fortified by 
spiking the tissue with 50 fil of a known concentration of drug solution (containing the 
nine sulphonamides of interest), hi all assays, samples fortified at a high level of 
fortification and at a low level of fortification, and a drug free sample were included. 20 
rain after fortification, the samples were blended with saline solution (0.9 %, 20 ml) in a
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stomacher for 30 min. An aliquot (10 ml) of the resulting mix was centrifuged for 30 min 
at 3500 rpm. 1 ml of the supernatant was filtered through a 0.45 pm syringe filter into a 
vial for ASTED™ extraction (dialysis and trace enrichment) and HPLC determination.
2.3.5 Dialysis and trace enrichment conditions
Sodium acetate buffer (50 mM, pH 4.6), was used as donor and recipient solutions. A 
sample extract (100 pi for UV detection at 280 nm, 370 pi for post-column derivatisation) 
was dialysed for 11 min into a 2 ml volume of recipient solution. The donor was held in 
static mode while the recipient was in pulsed mode (i.e. the recipient was drawn 
continuously at a fixed rate along the under-side of the membrane until 2 pulses of 1 ml 
volumes had travelled the under-side of the membrane and had passed onto the TEC). 
The trace enrichment cartridge was prepared by flushing with acetonitrile (500 pi) 
followed by water (500 pi) and finally sodium acetate buffer (50 mM, 500 pi). Following 
TEC loading, the analytes were removed and earned onto the analytical column by 
backflusliing the column with HPLC mobile phase.
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2.4 RESULTS AND DISCUSSION
2.4.1 Principle of automated dialysis
Dialysis is a technique capable of separating macromolecules from small molecular 
compounds. The technique has been applied to a variety of biological matrices including 
serum, plasma, whole blood, milk, egg and tissue homogenate80,81,82 83. Dialysis is 
becoming increasingly popular in residue analysis as the technique can be easily 
automated and is less demanding than the more traditional methods84-85.
Figure 2.3 depicts how the ASTED™ system operates. The sample was removed from the 
ASTED sample rack (by means of an injection needle, powered by dilutor 1) and 
delivered onto the donor side of the dialysis block, via the injection port and the right hand 
side six port valve (A). The recipient stream was continuously renewed at a fixed rate for
11.1 min, during which time analytes and other small molecules diffused across the 
cellulose acetate membrane and were loaded onto the trace enrichment cartridge. The 
analytes were trapped on the reversed-phase material of the TEC, while other dialysates 
were flushed to the waste reservoir. Following concentration on the enrichment cartridge, 
the left hand side valve (B) switched, allowing the mobile phase to backflush the 
enrichment cartridge and sweep analytes onto the analytical column. The dialysis 
membrane was then regenerated by flushing, over and under, with water, followed by 
dialysis solvents. 1 ml of each was found to be sufficient to avoid sample carry-over. 
Sample carry-over was also avoided by bracketing the sample in the needle with air 
segments. This reduced dispersion of the sample along the needle. The TEC was
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reconditioned by rinsing with water (500 fil), followed by acetonitrile (500 fil), water (500 
(0.1) and finally dialysis recipient solvent (sodium acetate buffer, 500 ul).
Figure 2.3 Schematic o f the AST ED™ system.
2.4.2 Optimisation of dialysis and enrichment
Optimisation of dialysis involved investigating the nature and volume of dialysis 
solutions. The buffer component of the mobile phase proved to be the best donor and 
recipient solutions, possibly due to more selective removal of the analytes from the trace 
enrichment cartridge using buffered mobile phase. Mobile phase buffer (sodium acetate) 
was prepared at various pH values and employed as dialysis solutions. Figure 2.4 shows 
the detector response for sulphamethazine recovery to be greatest when the mobile phase 
buffer (pH 4.6) was employed as dialysis solutions. Sulphamethazine was frequently 
chosen as the test analyte, as this is considered the most important sulphonamide from a
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residue viewpoint. In addition, it was considered to be representative of medium polarity 
for the analytes under study.
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Figure 2.4 Optimisation o f dialysis solution pH, fo r  sulphamethazine.
Optimisation of the time allowed for dialysis involved optimising the aspiration rate of the 
recipient solution. The recipient solution was continuously renewed, since, as new 
recipient solution was aspirated in, the current solution was pushed out of the membrane 
onto the trace enrichment cartridge. The trace enrichment cartridge contained C l8 as the 
packing material and therefore, it acts in a similar fashion to the analytical column, where 
the less polar analytes are retained and the more polar analytes elute more rapidly. As the 
recipient dialysis solution continuously sweeps the TEC, the analytes make their way from 
the head of the cartridge to the end. At a certain point, the volume of recipient solution 
that has swept the cartridge becomes large enough to elute the more polar analytes off the 
cartridge. This is termed the breakthrough volume and this volume limits the dialysis time 
permissible. The longer the dialysis time, the greater the volume of recipient solution.
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The breakthrough volume of the TEC for the nine sulphonamides was found to be 2 ml, 
therefore the recipient solution was set to two pulses of 1 ml volume. The graph in Figure
2.5 shows the effect of dialysing into various volumes of dialysis recipient solution. 2 ml 
was chosen as the optimum volume to allow sufficient enrichment of the more non-polar 
analytes, without complete loss of the polar analytes. The graph shows sulphaguanidine 
and sulphanilamide to be non-retained, even when 1 ml of dialysis recipient solution was 
employed. This is due to the polar nature of these analytes. They possessed low capacity 
factors on the analytical column, so they were lost in the matrix front, under all recipient 
volume conditions, in the presence of matrix.
Figure 2.5 Optimisation o f TEC breakthrough volume.
To achieve maximum dialysis time, the aspiration rate of the recipient solution was set to 
the minimum value possible (0.18 ml min'1). Therefore, optimum dialysis time, consisting 
of the time to dialyse a total volume of 2 ml was 11.1 min. Figure 2.6 demonstrates that 
recovery was greatest, at this time, for most analytes. Longer dialysis times resulted in 
larger volumes of dialysate, which exceeded the breakthrough volume of the TEC.
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Figure 2.6 Optimisation o f dialysis time.
It was suspected that creation of a temperature gradient might exhibit an effect on the 
concentration gradient that exists during dialysis. The effect of varying the recipient 
solution temperature (6°C, 20°C, and 41°C), while maintaining the donor solution constant 
at 20°C, and, conversely maintaining constant recipient solution temperature with varying 
donor solution temperature was evaluated, but found not to have any marked effect on 
recovery. A larger dialysis block, capable of dialysing 370 pi was employed for post­
column derivatisation. This allowed greater sensitivity and brought the limit of 
determination down from 30 ng g'1 to 20 ng g"'.
During the investigation, good trace enrichment was obtained using C l8 TECs without 
extensive interference effects. However, Aerts et al f  stated that trace enrichment on C18 
material was inadequate and resulted in too many interferences. Their chromatograms 
displayed matrix interferences up to 60 min and they concluded that an additional clean-up 
step or more specific detection was necessary. Various TEC washing procedures were
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investigated, with UV detection at 280 nm being employed, as a means for removing 
matrix co-extractives. Flushing the cartridge with water, or with sodium acetate or sodium 
phosphate buffers did not remove matrix co-extractives without removing some of the 
retained analytes also.
2.4.3 Chromatographic separation
The electron withdrawing sulphoxide group (S02) on the sulphonamide molecules results 
in the presence of acidic NH linkages (Figure 2.2), with pKa values in the range 4.79-8.56, 
for the analytes under study. The pH of the mobile phase is therefore important and the 
mildly acidic mobile phase (pH 4.6) gave good separation for most of the sulphonamides 
investigated. Buffers of various pH values between 4 and 7 were investigated, to achieve 
optimum resolution of thirteen sulphonamides (sulphaguanidine, sulphanilamide, 
sulphadiazine, sulphathiazole, sulphapyridine, sulphamerazine, sulphamethizole, 
sulphamethazine, sulphamethoxypyridazine, sulphachloropyridazine, sulphafisoxazole, 
sulphadimethoxine, and sulphaquinoxaline). At a pH of greater than 5.0, retention time 
for some analytes increased and baseline resolution was not achieved for many analytes. 
Various columns were also investigated with respect to peak resolution and peak shape, 
and the Waters Symmetry™ column proved best. With the chromatographic conditions 
described, certain sulphonamides such as sulphaguanidine and sulphanilamide eluted very 
close to the solvent front, most likely due to the presence of free amine groups on these 
molecules, while other sulphonamides such as sulphaquinoxaline and sulphadimethoxine 
were seen to elute at 45-50 min, likely due to the presence of two aromatic rings. Mobile 
phase composition was varied in an effort to increase the retention of the more polar 
analytes and to decrease the retention of the less polar drugs. An isocratic method could
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not be achieved which eluted all analytes, within 30 min, without a loss of resolution 
between many analytes, or poor retention of the polar sulphaguanidine and 
sulphanilamide. Gradient elution was not desirable, when post-column derivatisation was 
investigated, as fluctuations in mobile phase composition would result in baseline drift. 
When the anlaytes were analysed in the presence of matrix, sulphaguanidine and 
sulphanilamide, the early eluting drugs, were severely affected by matrix interference, 
therefore they were removed from validation studies. The late eluting sulphadimethoxine 
and sulphaquinoxalone exhibited broad peak shape, resulting in poor sensitivity. When 
these two analytes were removed, it was possible to shorten the run time to 30 min. 
Further studies, therefore, were limited to the nine sulphonainides shown in Figure 2.2.
2.4.4 Sample pre-treatment
Saline of pH 7 was used to blend samples. Various solutions differing in pH (4 to 8) were 
investigated. It was suspected that the pH of the extraction solution may affect the 
polarity of the sulphonamide residues, thereby influencing their partitioning into the 
extraction solution, or their ability to associate with tissue proteins. pH was not seen to 
have any significant effect on the extraction of the nine sulphonamides. Various 
deproteinisation reagents were investigated, such as trichloroacetic acid (TCA) and 
ammonium sulphate. Ammonium sulphate failed to give a clear supernatant following 
centrifugation, while TCA treatment gave a clear supernatant and firm pellet following 
centrifugation. Addition of 2 ml of a 50 % TCA solution to 20 ml saline, prior to 
stomaching with tissue, produced a clear extract and did not affect the recovery of the 
analytes after dialysis. However, it failed to remove chromatographic interferences and 
increased the size of the early eluting matrix front. Therefore, saline at pH 7 (unadjusted)
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was employed as the extraction solution. Various volumes were investigated. Using 10 g 
of porcine muscle, a volume of less than 20 ml resulted in a non-homogenous mix, 
requiring longer stomaching times.
A stomaching time of 30 min was found necessary to extract the antibiotic residues. 
Figure 2.7 shows that longer times resulted in no significant increase in recovery and 
shorter times resulted in lower recoveries of analytes. A centrifuge time of 30 min 
resulted in a supernatant clear enough for direct injection into the ASTED system, 
following filtering through a 0.45 ^m filter. Shorter time resulted in a more cloudy 
supernatant, which clogged the dialysis membrane over time.
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Figure 2 .7 Optimisation o f stomaching time required for sulphonamide extraction.
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Recovery of the method can be addressed in two ways, absolute or relative. Absolute 
recovery refers to the quantity of sulphonamides that are recovered after dialysis and 
enrichment. This can be assessed by comparing the response (peak areas) of standards 
chromatographed directly by HPLC, to that of standards prepared by ASTED-HPLC (i.e. 
dialysis, trace enrichment and HPLC). Table 2.1 shows the absolute recoveries for the 
nine sulphonamide residues using a 0.05 fig ml'1 standard drug solution. Relative recovery 
is the recovery of sulphonamides from the fortified sample, relative to that of the standard, 
both of which are prepared by ASTED-HPLC. Therefore, relative recovery reflects the 
capacity of the entire extraction and clean-up method to recover the sulphonamide 
residues from porcine tissue. As standards are processed through dialysis and trace 
enrichment similarly to samples, the relative recovery was used for quantitation.
Table 2.1 Absolute recoveries for nine sulphonamide drugs at 0.05 f i g  ml'1 (n=3).
2.4.5 Quantification
Drug Mean Recovery
(%)
Drug Mean Recovery
(%)
SD 36.1 SMZ 54.8
STh 63.7 SMP 52.1
SPR 61.5 SCPR 49.0
SME 57.3 SFX 41.8
SMT 48.7
Sulphonamides:Sulphadiazme (SD), Sulpkathiazole (STh), Sulphapyridine (SPR), Sulphamerazine (SME),
Sulphamethiazole (SMT), Sulphamethazine (SMZ), Sulphamethoxypyridazine (SMP),
Sulphachloropryidazine (SCPR), Sulphafisoxazole (SFX)
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Linearity of dialysed standards was compared with that of standards chromatographed 
directly by HPLC. Standards in the range 0.005 jag ml'1 to 0.5 \ig ml'1 were prepared and 
linearity was comparable for both methods. R2 values of 0.9995 were obtained for the 
direct HPLC measurement of the standards. ASTED-HPLC analysis gave R2 values of 
0.9992.
2.4.6 Determination with UV detection at 280 nm
The limit of determination for the nine sulphonamides was 30 ng g'1 (equivalent to a tissue 
extract concentration of 0.01 fig ml"1) using UV detection at 280 nm. The method was 
evaluated by carrying out intra- (within day) and inter- (between day) assays on muscle 
samples fortified at 40, 120, and 200 ng g'1. A five point calibration curve in the range
0.005 (ig ml'1 to 0.32 |ig ml'1 was employed. The curve proved linear between these points 
with an R2 value of 0.99. Intra-assay variation was based on the results for five different 
fortified samples, all chromatographed in the same assay. The results are presented in 
Table 2.2. All recoveries were high (71-117 %). The standard deviation is relatively 
higher for those drags affected by interferences (sulphadiazine, sulpamerazine). This was 
particularly evident at the lower levels of fortification (40 and 120 ng g"1). Figure 2.8 
shows chromatograms resulting for a fortified tissue sample and a residue free tissue 
sample (control), where matrix interference is clearly evident, affecting the sulphadiazine 
response. Inter-assay variation was based on the results for five different fortified tissue 
samples, chromatographed in five separate assays. The results are presented in Figure 2.9. 
Mean recoveries were in the range 80 to 131 %. Standard deviations (depicted by the 
eiTor bars) were somewhat higher than those of the intra-assay and were relatively higher 
for sulphonamides affected by matrix interferences. For example, samples fortified at 40
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ppb, resulted in mean recovery, for sulphadiazine, of 116 % with SD of 45 %, at 120 ppb, 
recovery was 117 % with SD of 29 %, and at 200 ppb, recovery was 130 % with SD of 33 
%. Sulphonamides not affected by matrix showed high recovery and relatively low 
variation; for example recovery for sulphamethazine at 40 ppb was 90 % with SD of 12 %, 
at 120 ppb, recovery was 80 % with SD of 2 % and at 200 ppb, recovery was 91 % with 
SD of 9%.
Table 2.2 Intra-assay variation for the determination of sulphonamides in 
muscle using automated dialysis-HPLC with UV detection at 280 nm 
(n = 5).
Recovery of sulphonamides (Mean ± SD, %)
Fortification level: 40 ng g 1 120 ng g ’ 200 ng g 1
SD 110 ±26.5 117 ± 19.0 101 .±3.7
STh 81 ±10.1 84 ±8.0 78 ±3.9
SPR 81 ±3.7 97 ± 9.4 87 ± 1.2
SME 86 ±3.0 94 ±13.5 88 ± 0.6
SMT 83 ±6.1 93 ±18.5 81 ±1.8
SMZ 83 ± 17.5 93 ± 15.4 92 ±2.1
SMP 80 ±20.0 82 ±5.8 80 ±3.2
SCPR 57 ± 11.5 90 ±6.6 71 ±3.7
SFX 102 ±8.9 94 ± 9.6 90 ± 4.2
Sulphonamides: Sulphadiazine (SD), Sulphathiazole (STh), Sulphapyridine (SPR), Sulphamerazine (SME),
Sulphamethiazole (SMT), Sulphamethazine (SMZ), Sulphamethoxypyridazine (SMP),
Sulphachloropryidazine (SCPR), Sulphafisoxazole (SFX)
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Figure 2.8 Chromatogram showing control muscle and muscle samples fortified at 40
and 120ppb, using direct UV detection at 280 nnu
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Figure 2.9 Inter-assay variation for the determination o f sulphonamides in muscle, 
with detection by UV at 280 nm. Bar charts show the mean recoveiy and 
standard deviation (error bars), for the nine drugs in tissue samples 
fortified at a) 40 ppb b) 120 ppb and c) 200 ppb in five separate assays.
Sulphonamides: Sulphadiazine (SD), Sulphathiazole (STh), Sulphapyridine (SPR), Sulpharaerazine (SME),
Sulphamethiazole (SMT), Sulphamethazine (SMZ), Sulphamethoxypyridazme (SMP),
Sulphachloropryidazine (SCPR), Sulphafisoxazole (SFX)
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Initial attempts to overcome matrix effects were directed to the sample preparation prior to 
ASTED extraction. Various extraction methods were investigated including enzymatic 
degradation of tissue, blending using an homogenising probe and protein precipitation. 
The enzyme-catalysed degradation, using Subtilisin A, resulted in a solution of small 
proteins/peptides capable of dialysing across the 15 kD dialysis membrane. Blending in a 
stomacher was compared to blending using an homogenising probe and, since no 
differences were found, stomaching was chosen because of its ease of use.
Post-column derivatisation resulted in a more specific detection system. The post-column 
derivatisation reaction used was that recommended by Aerts et al.23 and is a modification 
of the reaction performed according to Stringham el al.b>. It was necessary to establish the 
optimum length and diameter of the reaction coil, so that the derivatisation reaction had 
adequate time to occur and non-ideal mixing of the derivatisation agent with the column 
eluent was prevented. In this reaction, the nucleophilic amine group common to all 
sulphonamides (Figure 2.1) attacks the carbonyl group on the DMAB, resulting in a 
nucleophilic substitution reaction. Under the acidic conditions provided by the mobile 
phase and the phosphoric acid in the derivatising agent, a conjugated product is formed, 
having absorbance at 450 mn. A coil of similar bore to that used by Aerts et al.23 (0.5 mm
i.d.) proved to give the best peak resolution, allowing adequate mixing of the column 
eluent with the derivatising reagent. Non-ideal mixing resulted in a noisy baseline, which 
was probably due to the high viscosity of the phosphoric acid in the derivatising agent. 
Aerts et al.23 used a coil length of 25 ft.; in this study, the coil length was limited to 5 ft. as 
a longer coil resulted in poor resolution between sulphadiazine and sulphathiazole. Using
2.4.7 Post-column derivatisation
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this derivatisation configuration and employing a modified mobile phase it was possible to 
operate at a column temperature of 30°C which was found to be more controllable than the 
lower temperature of 25°C used for UV detection at 280 nm.
The limit of determination for the nine drugs, using post-column derivatisation was 20 ng 
g"'. Standards in the range 0.007 ng ml"1 to 0.1 |_ig ml'1 were used and a residue-free tissue 
sample was included with each assay. Table 2.3 shows the intra-variation for five samples 
fortified at two levels (40 and 100 ng g"1) and assayed by post-column derivatisation, with 
detection at 450 nm. Figure 2.10 shows the chromatogram for a porcine muscle sample 
fortified at 100 ng g 1 and assayed using post-column deiivatisation. Results using post­
column derivatisation showed high mean recoveries, with inflated values for 
sulphadiazine. The standard deviations within a single assay were lower, compared to 
those when direct UV at 280 nm was used. However, using the derivatisation conditions 
described, it was necessary to clean the detector cell with an acidic solution regularly 
(between runs) to achieve an acceptable baseline, the system required an equilibration time 
of approximately 90 minutes, and this resulted in a method less robust than that using UV 
detection at 280 nm. Use of peek fittings (mixing tee and reaction coil) may assist in 
overcoming the problems encountered with derivatisation over time.
The method proved successful initially, but attempts to evaluate the method by carrying 
out an inter-assay variation study showed the system to be non-reproducible. Baseline 
instability and detector fouling presented problems over time. Baseline instability may be 
due to lack of a consistent back-pressure on the pump delivering the coloured 
derivatisation reagent. The flow cell in the detector appeared to become contaminated
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over time due to precipitation. The precipitant may be the product formed when the 
DMAB reacts with the sulphonamide or may be simply due to the derivatising agent itself 
precipitating when combined with the 50 mM buffered mobile phase. Stringham et ul.M 
reported baseline instability problems when using this method. They also reported that 
use of a deuterium lamp contributed to baseline instability due to the dramatic drop off in 
lamp energy output at increased wavelengths. A deuterium lamp was employed in this 
study. In a later publication86 they halved the derivatisation agent concentration to 0.75 % 
and provided a list of possible causes for baseline noise, which included pump pulsations, 
leaking valves, detector lamp instability and air bubbles in the detector or reagents. Aerts 
et cd.2} reported a reduction in the limit of determination using post-column derivatisation 
in comparison to detection at 280 nm, due to baseline noise.
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Table 2.3 Intra-assay variation for the determination of nine sulphonamides in 
muscle by automated dialysis-HPLC with post-column derivatisation 
and detection at 450 nm (n = 5).
Recovery (%) of sulphonamides (Mean ± SD) 
Fortification level: 40 ng g 1 100 ng g'1
SD 173 ±10.6 160+10.3
STh 86 ±4.1 82 ±5.
SPR 100 ± 13.2 99 ± 6.3
SME 97 ± 4.4 99 ±5.3
SMI 75 ± 4.3 74 ±5.5
SMZ 93 ± 4.9 79 ± 3.4
SMP 97 ± 4.9 69 ±5.0
SCPR 53 ± 6.6 56± 5.8
SFX 74 ±5.3 94 ± 6.7
Sulphonamides: Sulphadiazine (SD), Sulphathiazole (STh), Sulphapyridine (SPR), Sulphamerazine (SMIi), 
Sulphamethiazole (SMT), Sulphamethazine (SMZ), Sulphamethoxypyridazine (SMP), 
Sulphaehloropryidazine (SCPR), Sulphafisoxazole (SFX)
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Figure 2.10 Chromatogram for a muscle sample extract, fortified at 100 ng g '1 and
detected, following post-column derivatisation, at 450 nm.
115
Aerts et al.23 analysed sulphonamide antibiotics in millc, meat and egg using dialysis and 
trace enrichment. They concluded that dialysis followed by trace enrichment was not 
suitable when using direct UV detection and found it necessary to investigate post-column 
derivatisation using DMAB. hi the procedure described by the authors, 8 ml of sample 
was required for dialysis. In this study, it was observed that large sample volumes 
resulted in poor dialysis performance for the next sample injected, as the washing protocol 
was insufficient to remove the non-dialysed material on the surface of the membrane. The 
method developed here has been validated, to assess and confirm its ability to perform 
reproducibly over time, and recoveries for nine sulphonamides are presented. In this 
study, once the sample has mixed in the stomacher, it is subject to 11.1 min dialysis, 
followed by backflushing for 1 min. While the sample is being chromatographed, the next 
sample is dialysed and enriched, hi the method of Aerts et al. the dialysis and trace 
enrichment procedure required 29 min per sample (24 min dialysis and 5 min 
backflushing following trace enrichment). Therefore, it can be concluded that this method 
offers significant advantages over previously reported dialysis methods for 
sulphonamides.
These results demonstrate that the ASTED™ system is a suitable sample preparation 
procedure for determination of sulphonamide residues in tissue. The system allows for 
high sample throughput, while minimising the use of solvents and operator time, when 
compared to other separation methods. The success of the system lies in the capacity to 
apply dialysis as a separation tool to remove proteins, lipids and other cell debris, without 
the need for extensive off-line sample preparation steps, and still result in an adequately
2.5 CONCLUSION
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Iconcentrated sample for direct injection onto a chromatographic column. Dialysis is a 
non-specific technique, allowing movement of all molecules below a particular size limit, 
and so is not specific for the analytes of interest. Despite its non-specificity, dialysis 
followed by trace enrichment and on-line HPLC with UV detection provided a method 
capable of determining nine sulphonamide residues in porcine tissue, with good recovery. 
Application of post-column derivatisation to detection of the extracted residues served to 
increase the specificity of the method, when compared with direct UV detection at 280 
nm. The small improvement in the limit of determination reported using post-column 
derivatisation is a result of employing a dialysis block capable of dialysing a larger 
volume of sample extract. However, operational problems arose with this highly 
automated arrangement, therefore UV detection at 280 nm proved more successful.
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M U L T I-R E SID U E  A N A L Y SIS  
O F PE N IC IL L IN  R E SID U E S  
IN  A N IM A L TISSU ES
CHAPTER 3
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Alexander Fleming was responsible for one of the greatest advances in medicine, when, in 
1929, he discovered penicillin. He isolated a compound from the mould of Penicillium, 
which exhibited toxic effects on bacteria. Since the introduction of penicillin as an 
antibiotic in the 1940s, there has been a dramatic decline in the number of deaths due to 
pneumonia, tuberculosis and other previously fatal infections.
Penicillins are one of three naturally occurring classes of compounds belonging to the 
group of antibiotics collectively referred to as (3-lactams. This group is comprised of 
penicillins, cephalosporins and cephamycins, all of which posses a (3-lactam ring, the 
cyclic amide shown in Figure 3.1. The primary distinguishing structural feature of 
penicillins is the thiazolidine (five membered) ring coupled to the [3-lactam ring to form 
what is referred to as the penam ring structure.
3.1 INTRODUCTION
Penam Ring
Figure 3.1 Penicillin central structure
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Penicillin G (benzylpenieillin) and penicillin V (phenoxymethylpenicillin), produced 
metabolically by Penicillium moulds, are the natural penicillins and the amino 
(amoxicillin and ampicillin) and isoxazoyl (cloxacillin and dicloxacillin) derivatives are 
semisynthetic. Penicillins are administered by various methods for the treatment of 
mastitis in cows and for treating respiratory and gastrointestinal tract infections in all 
animals. They are also used prophylactically at subtherapeutic dose levels by addition to 
pig feed and poultry drinking water.
3.1.1 Mechanism of action
p-lactams elicit their antibiotic effect by preventing cell wall synthesis in bacteria. They 
bind to the enzyme peptidoglycan transpeptidase, thereby inhibiting its cross-linking role 
in building new cell walls1. This causes poor cell rigidity and cells undergo lysis. Over­
exposure or misuse of penicillins is thought to bring about bacterial resistance, whereby 
the antibiotic is prevented from reaching its target (the infection site). The bacteria can 
modify their penicillin binding sites, thereby preventing or reducing their interaction with 
the antibiotic. Also they can produce enzymes, such as penicillinase, capable of 
modifying or lysing the drug molecule.
Allergic responses to penicillin residues have been widely documented, but very few 
incidences have been linked to the presence of the analytes as residues in food2. 
Anaphylactic reactions are observed only in individuals hypersensitive to penicillins. In 
vivo, degradation of the penicillin molecule occurs rapidly after administration, by rupture 
of the p-lactam ring. The resulting product reacts easily with proteins in the body, and the
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protein-drug complex must be recognised by specific antibodies initiating the classical 
immune response suffered by individuals hypersensitive to penicillin.
3.1.2 Physical/chemical properties
Penicillins, as members of the p-lactam family, are polar in nature and therefore generally 
readily soluble in water. They are frequently formulated as salts, assisting their water 
solubility. P-lactam antibiotics exhibit limited stability in aqueous solutions, where they 
are susceptible to nucleophilic attack. They degrade rapidly at extremes of pH and are 
most stable in neutral pH media. Samples must be stored at very low temperatures (-76 
°C) to prevent degradation3. The presence of the P-lactam ring causes the penicillins to be 
susceptible to methanolysis, where breaking of the ring results in the formation of 
penicilloic esters. Other organic solvents (acctonitrile, ethanol) also promote degradation 
of the molecules, but at a slower rate.
3.2 ANALYTICAL METHODS FOR DETERMINING PENICILLINS
As with most other classes of antibiotic, routine analysis of penicillin residues is usually 
performed by microbial inhibition tests. As discussed in Chapter 1, microbial inhibition 
tests suffer from a number of limitations, being suitable only for initial screening and, 
therefore, chemical methods of analysis have become more prominent. The majority of 
chemical methods reported have focussed on the determination of penicillins in milk. 
More recently, penicillin residues have been analysed in a wide range of matrices, such as 
animal tissue and body fluids, eggs, milk, yoghurt and cottage cheese. There are a number
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of spectrophotometric and liquid membrane based methods that will not be included in 
this discussion as they have only been applied to the analysis of pure drug solutions4,5.
Kidney is the target tissue for penicillin residue analysis, as residues tend to accumulate 
there during metabolism. Muscle, liver and spleen are also analysed, in addition to serum, 
plasma and milk samples. As with many other veterinary drugs, residues persist in the 
injection site long after they are depleted from other body tissues6. Depletion rates of 
penicillin residues from blood, muscle and kidney were examined and detectable levels 
persisted for up to 36 hours after administration7. The persistence of penicillin residues in 
tissues also depends on the dosage forms. Penicillin in the non-salt form degrades rapidly 
in the blood stream. Veterinary preparations of penicillin frequently employ a salt to 
retard the release of the drug in the body. Of the preparations employing a salt, sodium 
and potassium preparations are released most quickly and so are used as a rapidly acting 
treatment. Procaine penicillin, which is used intramuscularly, can be detected in the blood 
stream at levels in excess of the MRL for up to 24 hours after administration for 
therapeutic purposes. Benethamine penicillin, which is rarely used, persists for a number 
of days and benzanthine penicillin is retained markedly longer, exhibiting activity for 
seven days.
Storage of samples prior to analysis is an important factor in penicillin residue analyses. 
The presence of the P-lactam ring causes molecular instability. Weise and Martin8 
reported depletion of penicillin G in fortified bovine plasma after one month storage at —
127
70°C. Boison9 recommended blending of muscle samples only on the day of analysis and 
prior storage of the unblended sample should be at -80°C.
3.2.1 Screening techniques for penicillin analysis
The “Penzyme” assay is used routinely for the determination of p-lactam antibiotics in 
food10. This uses the enzyme carboxypeptidase which releases alanine from a synthetic 
peptide substrate. Hydrogen peroxide and pyruvic acid are produced and the hydrogen 
peroxide oxidises a colourless chromogen to a coloured compound. Penicillin inhibits the 
carboxypeptidase enzyme, therefore no coloured compound is produced where penicillin 
residues are present. Other enzyme assays use ^-lactamase or penicillin acylase. Medina 
et al.11 described the screening of liver and kidney samples for p-lactams (penicillins and 
cephalosporins) using commercially available ldts that were based on these enzymatic 
reactions. The assays were quick and easy to perfonu, with little sample preparation, but 
subsequent chemical determination showed a number of false negatives. While bioassay 
procedures can distinguish penicillin residues from other antibiotics by use of enzymes 
such as penicillinase, they cannot distinguish penicillins from one another, so bioassay 
techniques are commonly employed as an initial screening step, and chemical assays used 
for more specific analysis.
Penicillin residues in milk and tissue have been traditionally analysed by microbial 
inhibition tests. These techniques, similarly to the enzyme based methods, are incapable 
of distinguishing between the various members of the penicillin class, therefore they can 
only be used as screening techniques. The Four-plate test has been employed as a
128
screening test for the analysis of penicillin residues. This method has a limit of 
determination of 30-60 ppb for benzylpenicillin, ampicillin and amoxicillin and 300 ppb 
for oxacillin and cloxacillin12. Ang et aV3 reported a study to establish the correlation 
between a liquid chromatography (LC) method with pre-column derivatisation allowing 
fluorescence detection and a microbial inhibition method for the analysis of amoxicillin 
residues in incurred and fortified fish muscle. They measured the percentage recoveiy and 
percentage co-efficient of variation for the two methods. They concluded that there was 
no statistically significant difference in the percentage recoveiy or variation in recoveiy 
between the two methods, but LC offered increased sensitivity and specificity. Zomer at 
al.]4 described a method for the identification and quantitation of (3-lactams in milk using 
HPLC with detection by microbial receptor assay. Recoveries in the range 50-80 % were 
obtained and p-lactams were quantified at 10 ppb. This was achieved by collecting 
fractions from HPLC and analysing them using the Charm II test. Moats15 also described 
the use of commercial test kits for the analysis of P-lactams in milk samples. He 
described a procedure where a penicillinase enzyme and a P-lactamase enzyme could be 
used to distinguish between penicillins and cephalosporins. The presence of 
cephalosporins will not be detected by penicillinase and will be detected by P-lactamase, 
as the penicillinase enzyme is only capable of hydrolysing the 6-aminopenicillanic acid 
ring of penicillin molecules and is inactive towards the 7-aminocephalosporinanic acid 
moiety of cephalosporin compounds. Several rapid screening tests have now been 
described for detection of penicillin residues. Table 3.1 demonstrates the determination 
limits for some screening methods employed for penicillin analysis16.
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Table 3.1 Determination limits for some penicillin antibiotics in milk by various 
microbial inhibition and enzymatic screening procedures.
Test Sensitivity (ng m t‘)
Antibiotic (MRL) LacTek17 Delvo test17 Penzyme1 7 Charm II16
Penicillin G (5 ppb) 5 3 5 2
Ampicillin (10 ppb) 8 10 10 5
Cloxacillin (10 ppb) 8 30 80 35
ND = Not detectable
In 1981, Johnston et al.n published a screening method, the Swab Test On Premises 
(STOP), for the determination of antibiotic residues in meat and poultry tissue, with a
determination sensitivity of 12.5 ng g ' for penicillin G. The STOP test requires overnight 
incubation while many other screening methods allow results to be available in a few 
hours. STOP is based on the classical microbial inhibition test system.
Baker19 described a spectrophotometric method for the determination of benzylpenicillin, 
methicillin and ampicillin. The method was developed for the determination of penicilloic 
acids in pharmaceutical preparations; these acids are reported to be responsible for the 
allergic response of many individuals to penicillin. The penicillin molecules were reduced 
to penicilloates, which are capable of reducing copper(II) to copper(I) more rapidly than 
penicillin. The copper(I) formed a complex that was readily detectable at 450 nm. 
Everest et al.w described a spectrophotometric screening method for the determination of 
P-lactam residues in kidney samples. The limit of determination was 50 ppb for penicillin
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G. Recoveries of 84 % (with standard deviation of 4.0) were obtained. This enzyme- 
based assay utilises the inhibition of carboxypeptidase enzyme by (3-lactam antibiotics. 
Sample preparation was limited to homogenisation and centrifugation.
An enzyme immunoassay (EIA) has been described for the detection of isoxazoyl 
penicillins (oxacillin, cloxacillin and dicloxacillin), using polyclonal antibodies that were 
raised against these antibiotics. Direct and indirect competitive assays were investigated 
using horseradish peroxidase and glucose oxidase as labels. 10-30 ng ml'1 were detectable 
in milk. Penicillin G has also been detected by EIA with a determination limit of 10 ng 
ml'1 in milk20. Wal and Bories21 reported on the application of a radioimmunoassay 
method for the determination of penicillin G in milk, serum and urine. Antibodies were 
raised against the penicilloyl groups formed, on rupture of the (3-lactam ring in the 
penicillin molecule.
3.2.2 Sample extraction/residue isolation methods
For the analysis of residues in biological matrices, the preliminary step in extraction 
methods is deproteinisation. Protein binding for penicillins has been reported as being 
significant, primarily to albumin. Binding is estimated to be 60 % for penicillin G, 20 % 
for ampicillin and amoxicillin and in excess of 90 % for isoxazoyl penicillins9. However, 
the absorption and elimination characteristics of penicillins in food animals indicate that 
penicillins would be found mainly in a non-covalently bound state in the tissues.
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Organic solvents, such as methanol and acetonitrile, have been used to free non-covalently 
bound penicillins from macromolecules. Moats reported methanol to be less effective for 
deproteinisation, as P-lactams can undergo methanolysis16. He used acetonitrile to 
deproteinate milk and found the technique to be unsuitable for amphoteric penicillins 
(amoxicillin and ampicillin) but it gave 90-100 % recovery for monobasic penicillins 
(penicillin G and eloxacillin). Further clean-up steps were necessary to allow HPLC-UV 
detection. Trichloroacetic acid (TCA) was used by Verdon and Couedor22, and Ang and 
Lou23, for protein precipitation in the analysis of ampicillin in milk. The use of aqueous- 
based precipitation reagents proved beneficial for analysis of whole milk samples as the 
fatty layer remaining after centrifugation could be removed from the supernatant surface. 
Boison et al.2A used air aqueous extraction method for the analysis of penicillin G residues 
in liver, kidney and muscle tissue. Cl 8 solid phase clean-up was necessary to allow pre- 
column derivatisation and HPLC determination. Boison9 reported that buffer extraction is 
more efficient for removing unwanted matrix components than organic solvents, as only 
the water-soluble, polar components are partitioned into the aqueous phase, as opposed to 
both polar and non-polar endogenous components being partitioned into an organic 
solvent. This is due to the fact that most organic solvents have a wider distribution of 
partition constants. Using organic solvent extraction, further clean-up is required. This 
has been demonstrated by Hormazabal and Yndestad25, who used acetone for the 
extraction of penicillin G and other P-lactams from plasma and tissues. The authors found 
it necessary to add 0.15 % trichloroacetic acid to the acetone to influence extraction of the 
residues from tissue. In addition a further SPE step was necessary to clean-up the extracts 
prior to LC-MS determination.
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Sodium tungstate and sulphuric acid have been used as deproteinising agents in the 
extraction of penicillin residues. In the analysis of milk, Moats26 reported the loss of 
monobasic penicillins due to binding to proteins when using tungstic acid as the 
precipitant, but minor losses occurred if acetonitrile was used in a 2:1 ratio of 
acetonitrile:milk. Recoveries of 85-100 % were achieved. The author favoured the use of 
acetonitrile due to the fact that extremes of pH are avoided, which may cause penicillin 
degradation. Back extraction of the penicillins into a buffered solution was necessary to 
allow a clean-up step. Boisson et al.21 used sulphuric acid and sodium tungstate to 
deproteinise tissue for the analysis of penicillin G. They avoided the use of organic 
solvents in the extraction step and reported recoveries of 85-91 %. They employed an 
SPE clean-up technique and pre-column derivatisation.
Zomer et al.u used heat to deproteinise milk samples prior to the determination of 
penicillin residues. Ultrafiltration was used by Voyskner28 for protein elimination in the 
analysis of penicillin G, cloxacillin, ampicillin and amoxicillin in milk. This extraction 
technique required no clean-up step prior to HPLC separation with UV photodiode array 
detection, but samples were fortified at high levels and the assay had a limit of 
determination of 100 ng g'1. The same authors reported the recovery of penicillin G from 
milk to be less than 50 % when water or aqueous buffer was used for extraction, without 
addition of organic solvents, and reported a recovery of 80 % using an aqueous mixture of 
acetonitrile (40 % v/v) and methanol (20 % v/v)29.
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Munns et al.30 used enzymatic hydrolysis of the [3-lactam ring to form penicilloic esters of 
eight neutral penicillins in the determination of penicillin residues in milk. The authors 
described the hydrolysis of penicillin molecules to their ester derivatives to expand the 
number of analytes that can be separated under similar chromatographic conditions. 
Hydrolysis of the (3-lactam ring can be easily achieved using sodium hydroxide, but the 
authors reported low recoveries using this method due to binding of analytes to proteins. 
They employed penicillinase to hydrolyse the (3-lactam ring, which operates at the normal, 
slightly acidic pH of milk, and protein binding was not significant at this pH. Acetonitrile 
was used to precipitate proteins, and lipids were removed using methylene chloride. Since 
the formation of fluorescent derivatives was desired, it was necessary to liberate the side 
chain that has a terminal aldehyde, to allow its participation in the derivatisation reaction. 
This was accomplished by reacting the ester with mercuric chloride, following extraction.
3.2.3 Clean-up methods for penicillin analysis
Since the aqueous or organic extract resulting after deproteinisation may be very dilute 
and contain co-extractives, which inhibit analyte detection, a combined concentration and 
clean-up procedure is usually necessary. As previously mentioned in Chapter 1, liquid- 
liquid partitioning and solid phase extraction are frequently employed to clean-up sample 
extracts prior to chromatographic analysis.
Solid phase extraction has been the most popular clean-up technology applied to the 
analysis of penicillins. Nagata et a/.31 have used Florisil columns in the clean-up of
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ampicillin from fish tissues. A methanol extraction step preceded SPE. The normal phase 
(silica) SPE column allowed the amphoteric analyte to be retained while non-polar 
interferences were removed using acctonitrile and diethyl ether. Munns et a/.30 used 
solvent extraction followed by silica gel clean-up for the extraction of eight neutral 
penicillins from milk. Cl 8 SPE has been the most widely used packing in penicillin SPE 
analysis. Terada and Sakabe32 extracted ampicillin, penicillin V and penicillin G, by the 
passage of undiluted milk through a C l8 SPE column. Analytes were eluted using 
methanol. Boison et al.33 used Bond Elut™ C l8 columns whereas Terada et al.34 used 
Sep-Pak™ C18. The latter columns had less than 14 % carbon loading and the Bond 
Elut™ had a carbon loading of 18 %. Boison et al. found that a minimum carbon loading 
of 17 % in the packing bed was necessary to achieve greater than 70 % recovery using 
reversed-phase SPE. This is an important point to consider when applying C l8 SPE to 
penicillin residue analysis.
Ion-exchange chromatography was employed by Petz and Meetschen35 for the clean-up 
and concentration of derivatised penicillins extracted from liver and kidney tissues. The 
authors employed GC determination for the analysis of seven penicillin residues. Solid 
phase extraction disk columns were employed by Ishida et al. for the extraction of 
ampicillin from serum36. Styrene divinylbenzene was the sorbent employed, which 
possesses both reversed-phase and ion-exchange characteristics. Ibach and Petz37 
employed SPE with restricted access packing for the determination of the isoxazoyl 
penicillins in mi 11c. Alkyl-diol silica was used, with the internal surface of the particles 
being C l8 and so capable of trapping the analytes while the external surface was
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hydrophilic. Size exclusion interactions with this sorbent also assisted in excluding matrix 
co-extractives.
Liquid-liquid partitioning has also been reported for clean-up of penicillin residues. 
Verdon and Couedor38 used a phosphate buffer/isooctane medium while homogenising 
muscle tissue. Following centrifugation, the lower aqueous layer, containing the penicillin 
residues, was subject to C l8 SPE clean-up, while the fats and any other non-polar tissue 
constituents were removed in the organic layer. A similar approach was taken by 
Fletouris et a l y) for the analysis of milk. Dichloromethane was employed as the organic 
solvent to remove the non-polar constituents, while the penicillin residues partitioned into 
phosphate buffer. The authors report further clean-up resulting when the penicillin anions 
were converted to ion-pairs with tetrabutylammonium (TBA) cations, since the foimed 
pairs were readily extracted into chloroform. Recoveries of 82.9 % were determined with 
relative standard deviation between 3.8 and 6.6 % for penicillin G, penicillin V, oxacillin, 
and cloxacillin. Blanchflower et al.M also used tertabutylammonium hydrogensulphate to 
assist the partitioning of extracted residues from buffer into dichloromethane. Partitioning 
into dichloromethane was most efficient when samples were acidified, to suppress the 
ionisation of the carboxylate moiety. However, at low pH values, degradation of the [3- 
lactam ring occurred, therefore it was necessary to reduce the polarity of the molecules 
using an ion-pair. Moats41 also reported increased recoveries when tetraethylammonium 
chloride was added to milk extracts containing ampicillin and amoxicillin. Moats40 
employed liquid-liquid partitioning in the clean-up of beef and pork tissue, during the 
analysis of penicillin G and cloxacillin residues. Acetonitrile was used to precipitate
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proteins and the resulting extract was partitioned between dichloromethane and pH 2 
buffer followed by partitioning into pH 7 buffer.
Automated liquid chromatographic clean-up has been described by Moats41 for the 
determination of amoxicillin and ampicillin in milk. Milk samples were deproteinated 
using acetonitrile prior to LC fractionation on a reversed-phase column. The collected 
fractions were concentrated prior to HPLC analysis using a similar column, but with ion- 
pair chromatography and UV detection.
3.2.4 Quantitative techniques
In addition to the non-specific spectrophotometric techniques already discussed, 
chromatographic techniques have been the most widely applied residue quantitative 
techniques for penicillins. Capillary electrophoresis has been employed by Tsikas et al.42 
for the separation of six penicillin and four cephalosporin residues in pharmaceutical 
preparations. Isotachophoretic analysis was employed to achieve separation and 
concentration. No capillary electrophoresis methods have been reported to date for the 
analysis of penicillin residues in milk or animal tissue.
Thin layer, gas and liquid chromatography have all been reported for the analysis of 
penicillin drug residues in biological matrices. HPLC has proved to be the most popular 
method; using HPLC, the drugs can be directly detected due to their physiochemical
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properties while GC analysis requires the formation of volatile thermally-stable 
derivatives.
3.2.4.1 Gas chromatographic techniques
Petz and Meetschen35 reported a gas chromatography (GC) method using nitrogen 
phosphorus detection. The penicillins were extracted from milk using acetonitrile and 
extensive clean-up was performed by partitioning between buffer and organic phases prior 
to methylation with diazomethane. The method had sensitive detection limits (2 ppb), but 
it could not be used to determine amino penicillins, such as ampicillin and amoxicillin 
(which are used in veterinary medicine43), due to problems associated with their 
derivatisation. Mineo et a/.44 have published a GC method with flame ionisation detection 
to determine ampicillin, amoxicillin, penicillin G, penicillin V, oxacillin, cloxacillin and 
dicloxacillin, in addition to 15 other antibiotics in tissue. This method requires the 
formation of trimethylsilyl derivatives and many analytes co-eluted under various GC 
conditions. The limit of detection was 100 ppb for the penicillin residues. Tissue samples 
were extracted using trichloroacetic acid and extracts cleaned-up using Amberlite XAD-2 
SPE.
3.2.4.2 Thin layer chromatography techniques
Planar chromatography has been described for the quantitative determination of ampicillin 
residues in milk and muscle45. Sodium hydroxide hydrolysis of the P-lactam ring was 
carried out which allowed a reaction with mercuric chloride, resulting in a fluorescent
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compound. This compound was extracted from the matrix and concentrated on a silica 
column before being deposited on a silica TLC plate. The method allowed determination 
of ampicillin residues in milk and muscle fortified at 4 and 50 ppb, respectively. Salisbury 
et al.Ab have described a multiresidue TLC method coupled with bioautography for the 
determination of various antibiotic residues including penicillin G in animal tissue. A 
multi-step solvent extraction method was employed. The authors reported on growth 
inhibition of the micro-organism with some antibiotic media. Penicillin residues were 
readily identifiable based on the Rf value and the characteristic serrated-edge zone of 
inhibition. Milk was spotted directly onto TLC plates for penicillin analysis, without prior 
extraction47. Silicone TLC plates were employed and bioauto graphic determination was 
achieved by overlaying the TLC plates with agar seeded with B. stearothermophilus 
spores, followed by incubation.
3.2.4.3 Liquid chromatographic techniques
Liquid chromatography has been the method of choice for determination of most 
antibiotics, and (3-lactams are no exception. Detection methods employed include direct 
detection of the native analyte, such as by UV, amperometric, conductimetric and 
spectrometric detectors, or fluorescence detection, which requires pre- or post-column 
derivatisation. Most HPLC methods employ reversed-phase C8 or Cl 8 columns for 
separation of the analytes from each other and from matrix co-extractives. The presence 
of the carboxyl group (COOH) on all the analytes and the amino groups on the amphoteric 
penicillins render them polar analytes, suitable for reversed-phase separation. Elution is 
frequently achieved using buffers ranging from pH 2 to 7, in the presence of organic
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modifiers (methanol and aeetonitrile). The pfCa of the acidic groups is in the region 2.6- 
2.76 for all penicillins and the pKa of the amino group is 7.25. Therefore, at pH's below 7 
the amino groups, when present, are protonated, and the carboxyl groups are unprotonated, 
conveying polarity to the molecule resulting in earlier elution.
Moats52 described a method employing a polymeric column for the HPLC determination 
of penicillin G in milk. The same column was used for LC fractionation clean-up. 
Various techniques were applied in an attempt to alter the retention times of analytes 
relative to other matrix co-extractives present. The nature and concentration of the 
modifier had little effect. Changing pH to convert the compound from the salt form to the 
acid form delayed retention. Inclusion of an ion-pair in the mobile phase also increased 
retention. Moats41 also used ion-pair to achieve adequate chromatography during the 
analysis of amphoteric penicillins in milk. Tetrabutylammonium hydrogen sulphate39 has 
been employed as an ion-pair for the isocratic resolution of penicillin G, penicillin V, 
oxacillin and cloxacillin. The inclusion of ion-pairs was investigated when attempting to 
develop a multiresidue, isocratic method that avoided mobile phase buffers of low pH, 
which can cause instability problems for penicillin analysis. Blanchflower et a lM used 
ion-pair chromatography to minimise the differences in retention of standards relative to 
sample extracts. Takeba et a lw used ion-pair chromatography for the determination of 
five penicillin residues in milk. To achieve retention of amoxicillin on a reversed-phase 
column, the authors tested the performance of five different allcylsuphonate salts and 
reported that decanesulphonic acid gave optimum retention. Ion-pair chromatography has 
been described by Voyksner et al.49. The authors used a variety of alkylsulphonates for 
the separation of a number of penicillins extracted from bovine milk. Both C8 and C12
alkylsulphonates were used individually or in combination. The choice and concentration 
of ion-pair reagent affected the sensitivity of the method. Photo diode array (PDA) 
detection was used, the authors reporting that sensitivity using UV-PDA was superior to 
thermospray MS.
HPLC with direct UV detection between 200-285 nm has been well documented for 
penicillin residues with detection limits in the region of 30-50 ppb50, 51, 52,53. However, the 
chromatograms presented in many papers are relatively complex with a number of matrix 
peaks evident. Moats52 concluded that it was necessary to inject the equivalent of 1 ml of 
milk to achieve the required sensitivity (10 ppb), using HPLC-UV. This demanded an 
assay with concentration and clean-up capabilities. An additional factor in UV detection 
of penicillin residues is the form in which the antibiotic is administered. As discussed 
earlier, penicillin G is frequently administered as procaine penicillin, to provide a slow 
release mechanism. Procaine is a ring structure, capable of UV absorption, therefore, 2 
peaks are observed in the UV spectrum, one from procaine and one from the active form 
of the drug.
Liquid chromatography combined with electrochemical detection of penicillins in milk 
has been described by Kirchmann et al,54. Pulsed amperometric detection (PAD) using a 
gold electrode resulted in a detection limit of 6.6 ppm for penicillin G. Similar 
sensitivities were obtained for ampicillin, amoxicillin, cloxacillin, dicloxacillin, 
methicillin, nafcillin, oxacillin and penicillin V. Pulsed electrochemical detection has also 
been described by LaCourse and Dasenbrock55 following reversed-phase chromatography
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for the direct detection of (3-lactams and lincomycin. Detection limits were typically 10 
ppb and the method was applied to the analysis of chicken feed and pharmaceutical 
preparations.
Many HPLC detection techniques for penicillins minimise matrix interferences in an 
attempt to enhance detection sensitivities by employing derivatisation techniques that 
allow UV detection at longer wavelengths or fluorescence detection. Derivatisation may 
be pre- or post-column, and result in the formation of stable derivatives with strong 
absorbance properties. The most commonly used pre-column technique for penicillin 
residues is the formation of mercaptide complexes of penicillanic acids. This method was 
employed in the study reported in this chapter and involves the use of mercuric chloride 
and 1,2,4-triazole to form mercury mercaptide derivatives with UV absorption at 325 nm. 
Pre-column derivatisation with 1-hydroxybenzotriazole is a slight modification of this 
reaction in which benzoic anhydride is used instead of acetic anhydride for initial 
acetylation of the amino containing penicillins. This method has been employed by Shah 
et al.5b in fermentation media analysis. Most methods reported using this form of 
derivatisation employ EDTA or sodium thiosulphate as ion-pairs in the mobile phase to 
promote chromatographic efficiency.
Complexing with copper(II) acetate has been used to determine benzylpenicillin in 
pharmaceutical preparations. Copper reacts in a stochiometric ratio of 2:1 to form a green 
complex with a maximum absorbance at 650 nm. However, this method has not been 
employed routinely for the analysis of penicillin residues in food, as the complex is only
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stable for up to 25 min. Aslcal et al.sl described a method in which 2,3-dichloro-5,6- 
dicyano-p-benzoquinone (DDQ) or 7,7,8,8-tetracyanoquinodimethane (TCNQ), acting as 
electron-acceptors, react with several penicillins which behave as electron donors to 
produce highly coloured radical ions. With DDQ an orange-red complex is formed with a 
strong absorbance at 460 nm or with TCNQ a complex with an absorbance maximum of 
842 nm is formed. This method has not been reported for determining penicillin residues 
in food.
Pre-column derivatisation frequently allows fluorescence detection of penicillin residues. 
Reaction of penicillins with dansylaziridine results in highly fluorescent derivatives and 
has been used to detect eight neutral penicillins in milk by Munns et al.30. In this 
procedure, the (3-lactam ring was hydrolysed to form a penicilloate that reacted with 
mercuric chloride to liberate a penicilloaldehyde product, which was extracted into 
methylene chloride. In this medium, it reacted with dansylaziridine forming a fluorescent 
compound, which was measured at an excitation wavelength of 254 nm and an emission 
wavelength of 500 mu. The method had a limit of determination of 25 ng g"1 but showed 
low recoveries (13 to 34 %) for cloxacillin and dicloxacillin due to incomplete hydrolysis. 
Coefficients of variation were high (21 to 34 %) due to variation in the hydrolysis step.
Pre-column derivatisation with 9-fluoroenylmethyl chloroformate in borate buffer has 
been applied to the analysis of penicillins containing an amino side chain. This method 
was employed by Shah and Adlard58 for detecting penicillins in fermentation media, with 
determination limits of 10-50 pg ml'1. Fluorescent detection of amphoteric penicillins in
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milk, those containing an amino group, has been described by Ang and Luo using 
formaldehyde59 and using salicaldehyde60. The degradation products of the penicillins 
using these aldehydes have fluorescent properties when excitation wavelength of 354 nm 
and emission wavelength of 445 nm were used and limits of detection of 1 ng ml"1 were 
reported.
Berger and Petz reported a method that uses 4-bromomethyl-7-methoxycoumarin 
(BrMmC) to form stable esters using 18-crown-6-ether as a catalyst for the determination 
of several penicillins in milk61. In non-aqueous media, 18-crown-6-ether catalyses the 
esterification of the carboxyl group on penicillin molecules. The ether reacts with the 
penicillin molecule, rendering the carboxylic acid group very reactive and unstable. This 
subsequently reacts with BrMmC to yield a product that can be detected fluorimetrically 
with an excitation wavelength of 320 nm and an emission wavelength of 400 nm. The 
reaction goes to completion when a 3-fold excess of BrMmC is present, so samples of 
very high residue concentration required dilution.
3.2.4.4 Liquid chromatography with mass spectrometric detection
Fundamental studies have been conducted to characterise the fragmentation pattern of 
penicillins using various MS ionisation techniques62. Using thermospray MS, (3-lactams 
show intense ions with little or no fragmentation, as opposed to electrospray MS where 
fragment ions are easily induced1. A characteristic ion is frequently observed ([M + H -  
26]+), which is attributed to the thermally induced hydrolysis of the (3-lactam ring, 
followed by loss of C 02.
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LC-MS has more recently been reported for the analysis of penicillin residues in milk and 
tissue. Voyskner et a l49 were the first to report a method for the determination of 
amoxicillin, ampicillin and cloxacillin in milk. These authors described a conventional 
HPLC method employing ion-pair in the mobile phase for the determination of native 
analytes in milk. Development of a confirmatory procedure using thermospray-MS 
necessitated the introduction of an alternative LC method that was compatible with MS 
detection. The authors also reported problems with the MS detection of ampicillin due to 
matrix interference effects, resulting in the inclusion of an additional clean-up step, which 
allowed determination down to 200 ppb. The LC-MS method developed was further 
applied to investigate the degradation products of cloxacillin in various organic solvents63.
Electrospray MS has been described by Blanchflower et al.64 for the analysis of penicillin 
G, penicillin V, oxacillin, cloxacillin and dicloxacillin in muscle, kidney and milk. 
Liquid-liquid extraction was employed followed by negative ion, full scan electrospray 
MS confirmation. In contrast to many other MS methods for antibiotic residue analysis, 
the authors reported lower sensitivities when positive ion monitoring was employed. 
Single ion monitoring was used and chromatograms were relatively free from interference 
for all analytes except penicillin V. However, the authors do report ion-suppression, 
where buffer ions present compete with the extracted analyte ions for ionisation, causing a 
decrease in the signal. Nevertheless, determination limits were in the region of 25 ng g"1 in 
meat and 2 ng g'1 in milk for penicillin G and oxacillin, and 50 ng g"1 and 5 ng g 1 for 
penicillin V and cloxacillin in meat and milk, respectively. Hurtaud et al.65 used particle 
beam LC-MS with negative ion chemical ionisation (NICI) for the confirmation of 
oxacillin, cloxacillin and dicloxacillin residues in bovine muscle tissue. The authors
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concluded that NICI was more sensitive than electron impact, and single ion monitoring 
allowed detection sensitivities of 40 ppb for oxacillin and 50 ppb for cloxacillin.
3.2.5 Summary
There are a number of methods reported for the determination of benzylpenicillin in 
tissues and biological fluids. However, there is a lack of multi-residue methods, 
particularly methods capable of determining the amphoteric (ampicillin, amoxicillin), 
isoxazoyl (cloxacillin, dicloxacillin) and natural penicillins (penicillin G, penicillin V) in 
one analytical procedure. The methods that are available frequently employ labour 
intensive techniques, that use large quantities of organic solvents. For many of the 
methods published, no validation data is presented. Therefore, the aim of this study was to 
investigate the development of a multi-residue method for the determination of penicillin 
antibiotics used in veterinary medicine. MSPD provided a simple extraction procedure, 
which was low on chemical consumption and did not require elaborate equipment. The 
resulting extract was cleaned-up using SPE, which allowed fast and efficient extract clean­
up and concentration. Pre-column derivatisation was employed, which increased the 
sensitivity and specificity of the method, and allowed reversed-phase chromatography 
without the need for ion-pair reagents. The present study incorporates five penicillin 
residues (penicillin G, amoxicillin, ampicillin, cloxacillin and dicloxacillin) and a method 
was developed for their determination in porcine tissue. The method was validated at 
levels below the MRL for the residues in muscle tissue.
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3.4 EXPERIMENTAL
3.4.1 Introduction
The aim of this study was to develop a multiresidue method for the analysis of penicillins 
in animal tissue. Chromatographic systems were initially evaluated on the basis of 
multiresidue separation, peak profde and sensitivity. Pre-column derivatisation methods 
were investigated using both UV and fluorescence detection. A pre-column derivatisation 
technique using 1,2,4-triazole was chosen. Gradient elution was necessary to elute 
amoxicillin, ampicillin, penicillin G, cloxacillin and dicloxacillin derivatives from a Cl 8 
reversed-phase column using a phosphate buffer/acctonitrile mobile phase. The structures 
of these drugs are illustrated in Figure 3.2. Initial studies focussed on optimising the 
derivatisation reaction. Extraction of the five drug residues was performed using MSPD. 
The resulting extract contained interferences that prevented derivatisation of the residues 
present, therefore, a clean-up step was required. C l8 SPE proved to be the most beneficial 
method, applying the sample to the column using phosphate buffer and eluting in 
acetonitrile.
3.4.2 Chemicals and materials
All solvents were of analytical HPLC grade and purchased from Merck Ltd., Dorset, U.K.
a) Preparation o f standard solutions
Benzylpenicillin (Pen G), Ampicillin (Amp), Amoxicillin (Amox), Cloxacillin (Clox) and 
Dicloxacillin (Diclox) were purchased from the Sigma-Aldrich Company Ltd., Dorset, 
U.K. Stock solutions of 1 mg ml"1 were prepared monthly in HPLC grade water and
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stored at -20°C. Dilutions were prepared daily in 100 % HPLC grade water. Buffer salts 
were of Analar grade and purchased from Merck Ltd., Dorset, U.K. These were prepared 
with HPLC grade water as required.
b) MSPD materials
Isolute® bulk end-capped C l8 MSPD grade sorbent with mean particle size of 40-70 fim 
was used (International Sorbent Technology, Hengoed, Mid-Glamorgan, U.K.). The 
sorbent was prepared by washing with three volumes of hexane followed by three volumes 
of methanol in a 25 ml plastic syringe barrel. Pestles and mortars (external diameter 75 
mm; capacity 70 ml), used for MSPD extraction, were made of glass and obtained from 
Fisons Scientific (Loughborough, UK). The syringe filters employed for filtration of the 
tissue extract in buffer were made from cellulose and were 0.45 (im porosity and 25 mm 
diameter (Sartorius, Gottingen, Germany).
c) SPE materials
For SPE, Bond-Elut™ C l8, 3 cc, 500 mg columns were used (Varian, Harbor City, CA, 
U.S.A.). 0.2 M phosphate buffer was prepared by dissolving 6.23 g Na2HP04.2H20  and 
10.405 g NaH2P 0 4.H20 in 300 ml HPLC water. This was stirred to dissolve the salts and 
made up to a final volume of 500 ml. The pH of this buffer was 6.5 on preparation.
d) Derivatisation reagents
0.2 M acetic anhydride was prepared by making 200 jil 98 % acetic anhydride (Sigma- 
Aldrich Company Ltd., Dorset, U.K) up to 10 ml with acetonitrile. 1 M 1,2,4-Triazole 
(Fluka, Dorset, UK) was prepared by dissolving 6.89 g in 25 ml water, 10 ml 101 M 
mercuric chloride (0.136 g in 50 ml HPLC water) was added, the pH adjusted to 9.0 with 
5 M NaOH and the solution made up to 50 ml with water.
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3.4.3 Instrumentation
A Waters 616 pump (Waters Chromatography, Milford, MA, U.S.A.) was used in gradient 
mode to deliver the mobile phase through a Waters Symmetry® C l8, 5(xm, 100A, 4.6 x 
250 mm analytical column. A Waters 486 tunable absorbance detector was set at 325 lim. 
A Waters 717 autosampler was used to inject samples and standards. A Jones 
Chromatography column heater (Hengoed, Mid Glamorgan, U.K.) was used to maintain 
the column temperature at 30°C. Chromatograms were acquired and processed using 
Waters Millennium® software, version 2.15. A water bath set at 60°C was employed for 
derivatisation.
3.4.4 Methods
Sample fortification, extraction and clean-up procedures are described in the following 
sections. Derivatisation and chromatographic details are also described and the protocol 
undertaken for method validation is outlined. A schematic presenting a brief overall view 
of the method is presented in Figure 3.3.
3.4.4.1 Tissue fortification
All muscle samples were stored at -20°C and thawed to 4°C prior to analysis. Muscle 
tissue from animals certified as not being treated with antibiotics was used for 
fortification. After weighing the tissue (1.0 g), samples were fortified by pipetting an 
aqueous solution of the drugs (20 fil) onto the tissue. The samples were held at room
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temperature for 15 min prior to extraction to ensure the sample had absorbed the 
fortification solution.
3.4.4.2 MSPD extraction
1.0 g of fortified pork muscle tissue (see section 3.4.4.1) was weighed out into a glass 
mortar and 3 g of pre-washed C l8 sorbent (see section 3.4.2 b) was added. The muscle 
and sorbent were blended using a glass pestle for 30 sec. The resulting mixture was 
removed from the mortar using a stainless steel spatula and transferred to a 10 ml plastic 
syringe barrel containing two filter paper discs. The syringe barrel was tapped to settle the 
mixture and two filter paper discs were placed at the head of the column. The mixture was 
compressed to a volume of 7.5 ml with a syringe plunger (from which the rubber seal has 
been removed). A 100 ul pipette tip was attached to the syringe outlet to control flow of 
eluate off the column. The column was washed with 10 ml hexane. After the solvent had 
passed through the column, a positive pressure was applied with a pipette bulb to remove 
any remaining solvent. Penicillins were eluted from the column using 12 ml methanol. 
The pipette bulb was used as before to initiate the flow and to subsequently remove any 
remaining methanol when the flow had ceased. The methanol extract was centrifuged at
15.000 rpm for 15 min at 4°C. The supernatant was evaporated under nitrogen at 40°C.
150
Figure 3.2 Structural features o f the penicillins.
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3.4.4.3 C l 8 SPE procedure
The residue was reconstituted in 6 ml phosphate buffer (see section 3.4.2 c) by vortexing 
for 30 sec and sonicating for 5 min to ensure complete dissolution of the residue. After 
filtering through a 0.45 |j.m syringe filter, this solution was applied to the C l8 column (see 
section 3.4.2 c) which had been conditioned previously with 2 ml methanol, 2 ml water 
and 2 ml phosphate buffer (0.2 M). Initially the extractant was allowed to flow through 
the column under gravity for approximately 60 min after which time a slight vacuum (100 
mm Hg) was applied. Following sample application, a water wash of 3 ml was applied to 
the SPE column, after which the penicillins were eluted using 4 ml acetonitrile. The 
acetonitrile was evaporated under nitrogen at 40°C prior to reconstitution in 400 p.1 water.
3.4.4.4 Derivatisation conditions
20 fa.1 acetic anhydride (see section 3.4.2 d) was added to 400 jil standard or sample. This 
solution was vortexed for 20 sec. After 5 min, 400 fil of the derivatisation agent (see 
section 3.4.2 d) was added, the tube vortexed again for 20 sec before being incubated for 
150 min at 60°C.
3.4.4.5 Chromatographic conditions
Phosphate buffer was prepared as follows: 0.075 M monobasic sodium phosphate (11.70 g 
NaH2P 0 4.2H20) and 0.035 M dibasic sodium phosphate (6.229 g Na^EfPC^H^O) 
containing 0.0157 M sodium thiosulphate (3.896 g N a ^ O j .5H20 ) were dissolved in 600 
ml of HPLC grade water. This was stirred to dissolve the salts and then made up to 1000
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ml with water. Buffer and aeetonitrile were vacuum filtered through 0.45 urn filter and 
degassed for 20 min in an ultrasonic bath. Buffer was replaced with freshly filtered and 
degassed HPLC water for system washing.
The following gradient system was used:
80 % buffer/20 % aeetonitrile up to 13 min ; 75% buffer/25% aeetonitrile up to 25 min ; 
80 % buffer/20 % aeetonitrile up to 60 min. The flow rate was 1.0 ml min'1. A 100 |il 
aliquot of sample or standard was injected and a run time of 60 minutes employed. Re­
equilibration time of 15 minutes was allowed before the next sample was injected. The 
column temperature was set at 30°C and the detector wavelength was set at 325 nm.
3.4.4.6 Validation
The linearity of the method was assessed between 0 and 0.8 |jg m l1. The method was 
tested for intra- and inter-assay variation. The limit of detection of the method was based 
on the lowest standard detectable using the derivatisation technique employed, with a 
coefficient of variation of 3 %. The limit of determination was established at twice the 
lowest standard detectable. For method validation purposes, samples were fortified at 
twice the limit of detection and ten times the limit of detection. This provided validation 
data for samples fortified at a high level of fortification and a low level of fortification. 
For the intra-assay variation study, five samples were fortified at two different levels and 
each level analysed within the same assay. For the inter-assay variation study, samples 
were fortified at two different levels and each level was assayed over five separate assays. 
The percentage recovery was calculated using a six point standard curve. Standards were
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prepared in water and derivatised and chromatographed alongside samples. The variation 
in percentage recovery was calculated at each level of fortification, within one assay 
(intra) and over several assays (inter).
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1 g Tissue + 3 g CIS Sorbent 
MSPD blend
1) 10 ml Hexane wash
2) 12 ml Methanol elution
t
Methanol extract
1) Centrifuge @ 50,000 g
2) Evaporate @ 40°C, under N,
3) Reconstitute in buffer and filter
C l8 SPE
Condition with
1) 2ml Methanol
2) 2 ml water
3) 2 ml buffer
<  Tissue extract in 6 ml buffer
<  3 ml water wash
T
4 ml Acetonitrile
Evaporate @ 40°C under N2
Reconstitute and derivatise
Figure 3.3 Schematic o f procedure developed.
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3.5 RESULTS AND DISCUSSION
The results for the extraction, clean-up, derivatisation and chromatographic techniques 
employed are presented in this section. Method optimisation is discussed and the results 
of method validation are presented.
3.5.1 MSPD extraction
The dispersion of tissue onto the Cl 8 sorbent involves a mechanism whereby the tissues 
are disrupted by two methods. Firstly, mechanical forces resulting from the abrasive 
action of the Cl 8, physically disrupts the tissue structure thereby dispersing the cells on 
the sorbent material. The tissue cells are also disrupted by hydrophobic forces. The 
sorbent material consists of long chains of carbon atoms, therefore the material is non­
polar and hydrophobic in nature. Electron microscopy studies show that tissue cell 
membranes have a structure composed of a polar lipid bilayer (Figure 3.4). The bilayer is 
fluid because the hydrocarbon, non-polar tails consist of a mixture of saturated and 
unsaturated fatty acids that are fluid at body temperature. The integral proteins of the 
membrane have hydrophobic amino acid groups on their surfaces that allow the proteins to 
associate in the central hydrophobic portion of the bilayer. The peripheral proteins, on the 
other hand, have hydrophilic groups on their surfaces that are bound by electrostatic 
attraction to the hydrophilic polar lipid heads in the bilayer. No covalent bonds are known 
to exist between lipid molecules of the bilayer or between the protein components and the 
lipids. The absence of strong covalent forces allows the membrane to be disrupted more 
easily. The peripheral proteins are thought to float on the surface of the bilayer.
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Therefore, the grinding movement of the tissue and the sorbent, using a mortar and pestle, 
disrupts the structure allowing the non-polar, hydrophobic Cl 8 material access to the non­
polar, hydrophobic bilayer and integral proteins, thereby unfolding the tissue cell 
structure. The more hydrophilic peripheral proteins and lipid heads now face inwards, 
with the hydrocarbon lipid tails extending outwards into the C l8 sorbent. Adequate 
blending results in a uniform distribution of cellular components allowing the non-polar 
lipid constituents to be selectively eluted with hexane prior to eluting the penicillins with 
methanol.
Polar Head 
Non-Polar Tail 
Integral Protein
Peripheral Protein
Figure 3.4 Diagrammatic representation o f the cell membrane.
3.5.1.1 MSPD elution
Initial investigations carried out by Barker et a lbb on the extraction of various classes of 
drug residues, including penicillin and ampicillin, using MSPD, involved evaluation of a 
range of elution solvents, such as hexane, benzene, ethyl acetate, and methanol. 
Application of similar solvents in this work to the elution of the five penicillins, at a 
concentration of 4 ppm, showed elution of analytes in both ethyl acetate and in methanol,
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but at apparently very low recoveries. Attempts to elute the analytes in just one of these 
solvents continued to result in very poor measurable recoveries (2-10 %), with methanol 
proving to be very slightly better. Results for extracts spiked after the entire MSPD 
procedure also showed similar very low recoveries, demonstrating that matrix components 
were inhibiting the derivatisation reaction. Therefore, it was necessary to investigate a 
clean-up step. The inclusion of a C l8 SPE step proved appropriate for removing 
derivatisation inhibitors.
Penicillin elution off the MSPD Cl 8/tissue blend was also investigated using acetonitrile. 
Using MSPD extraction followed by derivatisation (that is exclusion of any clean-up step), 
recovery of penicillin G, cloxacillin and dicloxacillin was better using acetonitrile than 
when methanol was employed, but recoveries were only in the range of 31 to 49 %. 
Extracts that were spiked and then derivatised after the entire MSPD procedure (with 
elution in acetonitrile) showed recoveries of 30 to 55 % for penicillin G, cloxacillin and 
dicloxacillin. This proved that acetonitrile was less likely to elute the matrix components 
responsible for inhibiting the derivatisation reaction, but some inhibition still occurred. 
Therefore, similar to methanol elution, using acetonitrile MSPD elution, derivatisation of 
the extracted penicillins was not possible without the inclusion of a clean-up step. 
Investigation of MSPD elution followed by SPE clean-up resulted in recoveries that were 
consistently higher using methanol as the MSPD elution solvent. Table 3.2 shows that 
methanol promoted better recovery of the penicillins. This is likely due to its higher 
polarity and higher solvating power, compared with acetonitrile. The SPE clean-up step 
had not been optimised fully at this stage of the study, thereby accounting for the low
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recovery of the analytes, but conditions for each sample were consistent so the results in 
Table 3.2 are comparable.
Table 3.2 Recovery (%) from samples fortified at 4 (ig g'1 using methanol and 
acetonitrile as the MSPD elution solvents followed by SPE, (n=2).
Mean Recovery (%)
Amox Amp Pen G Clox Diclox
Methanol 10 25 50 50 49
Acetonitrile 6 10 36 34 32
Various buffers were also investigated as MSPD elution solutions. This would allow the 
evaporation step after MSPD to be omitted and analytes could be applied directly onto the 
SPE column following SPE. Phosphate buffer at pH 2 resulted in a heavy white 
precipitate, which gave low analyte recoveries (15 to 19 % for the amphoteric penicillins 
and less than 10 % for the others) and blocked the SPE column. At pH 7, less precipitate 
was obtained, but amoxicillin was not recovered, ampicillin was recovered very poorly (3 
%) and recoveries for penicillin G, cloxacillin and dicloxacillin ranged from 37-59 %. In 
addition to poor recoveries, buffer elution was lengthy and the SPE columns tended to 
become blocked.
Recovery from the standard MSPD procedure alone (that is, with no SPE step included) 
was assessed by developing a gradient LC method for separation of non-derivatised
159
standards with UV detection at 210 nm. The MSPD extract was evaporated as usual, 
reconstituted in mobile phase and chromatographed. Recoveries from tissue samples 
fortified with the 5 drugs at 4 jig g'1 are presented in Table 3.3. Results are not presented 
for amoxicillin and ampicillin as these peaks were hidden among matrix interferences. 
Recoveries for penicillin G and the isoxazoyl penicillins from MSPD extraction were 
reasonably high.
Table 3.3 Recovery (%) from a tissue sample fortified with five drugs at 4 ¡ig g 1
and extracted by MSPD with no further clean-up, (n=2).
Mean Recovery (%)
Amox Amp Pen G Clox Diclox
ND ND 81 88 83
ND : Not detectable due to matrix interferences
Figure 3.5 illustrates optimisation of the elution of penicillin G, cloxacillin and 
dicloxacillin from the tissue-sorbent blend, using methanol (with UV detection at 210 
nm). Because amoxicillin and ampicillin are more polar than the other penicillins, due to 
the presence of NH2 groups (Figure 3.2), lower volumes of methanol would be required to 
elute them from the Cl 8-tissue blend. Therefore, it was assumed that 6 ml methanol 
would be sufficient to elute all five penicillin residues. Initial MSPD investigations were 
conducted using 0.5 g tissue with 2 g sorbent. Subsequently, it was found necessary to
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employ 1 g of tissue and 3 g sorbent so the MSPD wash and elution volumes optimised 
were increased to account for the larger void volume.
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Recovery 80
mPENG 20 
b CLOX 0 
□  DICLOX
2 ml 4 ml 6 ml 8 ml 
Methanol volume (ml)
Figure 3.5 Optimisation o f the elution volume required to elute analytes from MSPD.
3.5.1.2 MSPD wash
Initially, hexane, ethyl acetate and diethyl ether were investigated for use as MSPD wash 
solvents. Ethyl acetate proved capable of eluting some of the residues and when diethyl 
ether was employed as a wash solvent, very low recovery resulted. Hexane proved best 
for removal of non-polar fats. The volume of hexane used to wash the tissue blend was 
varied. 6 ml hexane was employed as volumes less than 6 ml resulted in lower recoveries 
and volumes greater than 6 ml showed no significant increase in recovery or removal of 
matrix. A water wash (4 ml) prior to methanol elution resulted in a visually much cleaner 
methanol extract but ampicillin and amoxicillin were not recovered and recoveries were 
reduced for the other analytes, possibly due to the elution of analytes in the polar water 
wash.
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The MSPD extract was seen to contain white proteinaceous material. This protein was 
likely to react with the 1,2,4-triazole preventing it from reacting with the penicillin 
residues extracted. Also, the mercuric chloride necessaiy for the derivatisation reaction 
was likely to react with the protein. Initial clean-up investigations were concerned with 
the removal of these proteins using trichloroacetic acid (TCA) and ammonium sulphate, 
following MSPD. Using TCA, dicloxacillin was not recovered and no significant 
improvement was observed for the other analytes. Using ammonium sulphate, ampicillin 
and penicillin G were not recovered. These reagents also altered the pH of the extract to a 
more acidic extract, which was undesirable for derivatisation. The most commonly used 
clean-up step previously reported, C18 SPE, was investigated.
The method was investigated initially using control samples spiked following the MSPD 
extraction procedure. Following MSPD, the residues were in methanol. Due to the polar 
nature of this solvent it was not a suitable matrix in which to apply the extracted residues 
onto a reversed-phase SPE column. Therefore, the methanol was evaporated at 37°C 
under nitrogen. While higher temperatures resulted in quicker evaporation of the solvent, 
some loss of analytes was noted, particularly when the temperature was increased to 60°C. 
Degradation of penicillin molecules on evaporation has been reported by Moats15. Table
3.4 shows the recoveiy resulting from the evaporation of 8 ml methanol spiked with 20 (il 
of a 10 jog ml'1 standard drug solution. Penicillin G and cloxacillin appeared to be the 
most resistant to degradation, while ampicillin was the most susceptible. It is also worth 
noting that evaporation of this methanolic solution was likely to proceed more quickly 
than when matrix was present, due to increased water content, therefore losses in the
3.5.2 Solid Phase Extraction (SPE) clean-up
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presence of matrix may be even greater. To avoid losses on evaporation, the process was 
carried out until "near" dryness.
Table 3.4 Recovery (%) of penicillins resulting from the evaporation of 
methanol, spiked with a standard drug solution, at 37°C, (n=3).
Mean Recovery (%)
Amox Amp Pen G Clox Diclox
81 79 90 90 81
Following evaporation of MSPD extracts, samples were reconstituted in buffer in 
preparation for SPE. Initially potassium phosphate buffer (0.25 M, pH 7.0) was 
employed, similar to that used by Moats41. Sodium phosphate buffer (0.156 M)27 was 
subsequently found to give higher recoveries. This buffer was not pH adjusted and had a 
pH value of 6.5 on preparation. It has been postulated that potassium ions perform better 
than sodium ions at suppressing any residual silanol groups that exist on the C l8 
column67. Therefore, when sodium phosphate was employed, the silanols may have 
played a role in retaining the analytes on the column. Figure 3.6 compares the recovery 
from tissue samples fortified at 4 fig g"1 using the two buffers in the SPE step. Moats and 
Romanowski68 reported instability problems when potassium phosphate buffer, pH 6.0 
was employed during LC fractionation and found the addition of sodium phosphate buffer 
improved stability.
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Figure 3.6 Recovery o f the fi-lactams from tissue samples fortified at 4 fig g~! and
reconstituted in different buffers before SPE.
The optimum pH of the SPE buffer was established by reconstituting blank tissues 
extracted using MSPD, in sodium phosphate buffers of various pH values between 2 and
8. Samples were spiked with all five analytes after reconstitution and prior to SPE. 
Columns were conditioned in the appropriate buffer prior to loading. Figure 3.7 
demonstrates that pH 6.5 buffer gave highest recovery for all the analytes. This was the 
pH of the buffer on preparation, therefore no adjustment was necessary. At a pH value of 
2.0, the acidic environment may cause degradation of the penicillin molecules resulting in 
the low recoveries. At pH 4.0 the low recoveries for amoxicillin and ampicillin may be 
due to protonation of the amino groups causing these analytes to be removed in the water 
wash; recoveries for penicillin G, cloxacillin and dicloxacillin were at 80 % 
approximately, as the environment was not so acidic as to cause degradation of the lactam 
ring. At pH 6.5, the pH approaches the pKA of the amino group (-7.0), amoxicillin and 
ampicillin become more non-polar and are retained on the non-polar stationary phase. pH
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6.5 was observed to be sufficient to retain the residues, as increase in buffer pH, to pH 8.0, 
did not result in increased recovery.
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Figure 3.7 Effect o f the pH o f the loading buffer solution on the recovery o f/3-lactams
from the Cl 8 SPE step.
Conditioning of SPE columns proved important. The column was first washed with 
methanol to remove any interferences present as a result of the manufacturing process, and 
to solvate the packing material to ensure the sorbent reacts reproducibly with the analytes. 
A water wash was employed to prepare the column for loading. The water wash served to 
prepare the column for the conditioning step, which was composed of loading buffer, and 
removed any remaining methanol which may have caused buffer precipitation. Following 
conditioning in loading buffer (2 ml), the extracted residues were applied to the column in 
this loading buffer. Volumes of 2 ml were employed, which is around three times the 
volume of the packing material (670 (il). During method development, it was observed 
that recoveries were sometimes reduced if the SPE columns were allowed to run dry 
between conditioning and sample loading and between loading and washing.
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The effect of buffer volume for dissolving the sample extract was investigated. Figure 3.8 
shows that increasing the volume of buffer, up to 6 ml increased recovery, after which no 
increase was observed. This may be due to greater dilution of the matrix interferences at 
higher volumes resulting in some interferences being eluted off the column even at the 
application stage. The effect of varying the concentrations of the two buffer salts was also 
investigated. The concentration of buffer was seen to be more important for amoxicillin 
and ampicillin than for the other penicillins. When the concentration of dibasic sodium 
phosphate (Na2HP04.2H20 ) was dropped below 0.07 M, the recovery for these analytes 
also dropped. This may be explained by the fact that these amphoteric penicillins contain 
an NH2 group, and therefore need to be in a buffered environment to assist retention on the 
C l8 SPE column. Increase or decrease in either salt had no effect on penicillin G, 
cloxacillin and dicloxacillin recovery. Samples were loaded onto the SPE column and 
allowed to elute at approximately 1 ml min"1. Faster flow rates resulted in poor recovery 
for amoxicillin and ampicillin.
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Figure 3.8 Recovery offi-lactams from tissue sample extracts spiked at 4 pg g~l and
dissolved in various volumes o f buffer prior to SPE.
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To avoid precipitation of the buffer salts that might block the column and inhibit elution of 
the analytes, a water wash was included following sample application (in buffer) and prior 
to elution (in acetonitrile). Various volumes of water wash were investigated and 4 ml 
wash was found to be the most suitable (Figure 3.9). The SPE water wash (4 ml) was also 
collected and assayed, and was found to contain amoxicillin (26 %). As a result of these 
findings, a 3 ml water wash was employed, which resulted in better recovery for 
amoxicillin. Recoveries for penicillin G, cloxacillin and dicloxacillin were marginally 
better when a 4 ml water wash was employed. Therefore, attempts were made to retain 
the more polar amoxicillin and ampicillin on the Cl 8 SPE column using sodium 
pentanesulphonic acid as an ion-pair. However, when the ion-pair was included in the 
loading solution, recoveries for all analytes, particularly amoxicillin, were relatively 
reduced, even when an SPE elution volume of 30 ml was employed.
Figure 3.9 Optimisation o f the SPE water wash for the five drug residues isolated 
from a tissue sample fortified at 4 /jgg-1.
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To investigate elution of the penicillins off the Cl 8 SPE, control samples were extracted 
by MSPD and the extracts were spiked with the five antimicrobials (after MSPD 
extraction). Various volumes of acetonitrile were used to elute the residues off the SPE 
column. Table 3.5 shows that 5 ml acetonitrile was sufficient. Reduced recovery was 
evident when 10 ml acetonitrile was used for elution, probably due to elution of 
interferences that inhibit the derivatisation reaction. Methanol elution was also
investigated and recoveries were significantly reduced, indicating that methanol was 
capable of eluting the matrix co-extractives that inhibited the derivatisation reaction.
Table 3.5 Effect of SPE elution volume (acetonitrile) on the recovery of the five 
analytes (spiked at 4 ppm) in the presence of sample matrix.
Elution
Volume
(ml)
Recovery (%)
Amox Amp Pen G Clox Diclox
2 19 26 66 55 51
5 68 48 89 99 95
10 62 32 74 73 56
Finally, the acetonitrile elution volume was reduced to 4 ml, allowing faster evaporation 
with similar recovery. This volume evaporated quickly (20 min) at 40°C. The effect of 
evaporation at 40°C was investigated by evaporating 4 ml acetonitrile, spiked with the 
analytes of interest at a standard equivalent to 4 ppm. Penicillin G, cloxacillin and
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dicloxacillin exhibited small losses (3-8 %), while losses of 29 % and 9 % were observed 
for ampicillin and amoxicillin, respectively.
Prior to the SPE step the methanol eluate from the MSPD procedure was centrifuged, the 
supernatant evaporated and the residue reconstituted in buffer. Centrifugation at 3 speeds 
was investigated; high (15,000 rpm), medium (7000 rpm) and low (2000 rpm). The high 
speed centrifugation, at 15,000 rpm, resulted in higher recoveries probably due to removal 
of some of the proteins that inhibit the derivatisation reaction. Omission of the 
centrifugation step resulted in blockage of the SPE column, even when SPE columns of 6 
cc volume were employed. Following evaporation of the methanol and reconstitution of 
the extract in buffer prior to SPE, filtering of the extract was required. Where extracts 
were not filtered, broad peaks were obtained on the HPLC chromatograms, leading to 
higher variation. This was particularly evident for ampicillin.
Inclusion of 0.5 g Cl 8 material in the MSPD syringe barrel, under the tissue blend was 
investigated to determine if the sieving effect of the Cl 8 could allow for elimination of the 
SPE step. However, derivatisation of the penicillins without inclusion of a separate SPE 
clean-up step was not possible, as the methanol eluted the derivatisation inhibitors off the 
tissue blend and through the clean C l8 material. Various volumes of methanol were 
investigated to identify a volume capable of eluting the analytes without elution of the 
derivatisation inhibitors, but this could not be achieved.
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Derivatisation offers many advantages in residue determination, offering the possibility of 
increased specificity and sensitivity. It often eliminates the need for extensive sample 
clean-up procedures as detection wavelengths are sometimes beyond the range where 
matrix co-extractives absorb. Pre-column derivatisation of compounds can render 
residues separable by methods that are otherwise unsuitable. When UV detection is 
employed for penicillin determination, greatest sensitivity is normally achieved at 
wavelengths below 230 nm. At these wavelengths, selectivity is poor, resulting in high 
matrix interference when residues are determined in tissue samples. Therefore, 
derivatisation of penicillins is used, in order to form stable derivatives capable of detection 
at higher wavelengths and exhibiting enhanced absorption properties.
Pre-column derivatisation using BrMtnC to form fluorescent derivatives was investigated. 
This method proved to be unsuitable for the analysis of amphoteric penicillins 
(amoxicillin and ampicillin). It also necessitated the use of a phase transfer catalyst in the 
extraction procedure to allow the derivatisation reaction to occur and required the use of 
dried solvents to obtain clean chromatograms. Pre-column derivatisation using 1- 
hydroxybenzotriazole was investigated but solubility problems were experienced with the 
derivatising agent. Derivatisation with triazole was chosen as it was previously used in 
residue analysis and it was possible to derivatise all the penicillins of interest in this study. 
It offered sensitivity superior to some of the other methods investigated, such as UV 
detection at 210 nm, and used inexpensive reagents.
3.5.3 Derivatisation reaction
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The method used in this study, involving derivatisation with 1,2,4-triazole, is based on the 
imidazole-catalysed isomerisation of penicillin G described by Hans Bundgaard69. In the 
presence of mercuric chloride, a self-catalysed nucleophilic attack by the imidazole base 
occurs on the P-lactam ring. The intermediate product formed then reacts with mercuric 
chloride to form a stable mercuric mercaptide complex. In this study, the imidazole is 
replaced with 1,2,4-triazole as the base. Reaction rates of penicillins with 1,2,4-triazole 
and mercuric chloride are faster than those with imidazole3. The initial step of the 
derivatisation reaction involves an acetylation step. Acetic anhydride, pH 9.0, acetylatcs 
the side chain ammo group in the amphoteric penicillins, ampicillin and amoxicillin, to 
form N-acetylampicillin and N-acetylamoxicillin, respectively. These compounds then 
react with 1,2,4-triazole in a similar fashion to the other penicillins. Failure to protect the 
amino groups of the amphoteric penicillins results in their reaction with 1,2,4-triazole, 
inhibiting the formation of the mercaptide derivative. The reaction scheme for acetylation 
of ampicillin is depicted in Figure 3.10. Figure 3.11 shows the reaction mechanism for the 
P-lactam ring reaction with 1,2,4-triazole.
3.5.3.1 Acetylation/Benzolylation o f amphoteric penicillins
The initial step in the derivatisation was the acetylation reaction. In this study, reaction 
time was set at 5 min, with the reaction proving linear up to this point where it levelled 
off. Most references allow only a 3 min reaction time. The volume and concentration of 
acetic anhydride used were 20 f_il of 0.02 M solution. Higher volumes resulted in excess 
reagent peaks and higher concentration did not lead to an increased response. Acetylation,
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using acetic anhydride that was prepared more than 48 hours before use, resulted in an 
interfering peak that eluted at a similar retention time to ampicillin.
Figure 3.10 Acétylation o f ampicillin
De-activation o f the amino side chain using benzoic anhydride was also investigated. This 
method was in itia lly described by Tutt and Schwartz70. Benzoic anhydride is capable o f 
NH2 protection by a similar mechanism to acetic anhydride. When dibasic penicillins are 
acetylated prior to the formation o f their mercaptide derivatives, it was found that
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acetyl ami do penicillins still have significant differences in their elution characteristics on a 
reversed-phase column compared with their monobasic analogues, such that it was 
necessary to use gradient elution conditions to resolve them. The increased polarity o f the 
acetylamido mercaptide derivatives (compared with the mercaptide derivatives o f 
penicillin G, cloxacillin and dicloxacillin) accounts for the need for gradient elution. 
However, modification to the chemical derivatisation reaction by using benzoic anhydride 
enabled resolution under isocratic conditions. Benzoylation confers similar elution 
characteristics to the benzoylamido mercaptide derivatives o f amoxicillin and ampicillin, 
as the mercaptide derivatives o f the monobasic penicillins (penicillin G, cloxacillin and 
dicloxacillin), allowing isocratic separation. The benzoylamido mercaptide derivatives are 
less polar and so can elute in a similar time frame to the mercaptide derivatives o f 
penicillin G, cloxacillin and dicloxacillin. A  higher acetonitrile content was required in 
the mobile phase to elute the benzoylamido mercaptide derivatives, compared to the 
acetylamido derivatives. This is due to the presence o f an additional aromatic ring which 
is retained to a greater extent on the C l 8 stationary phase. The ring adds a more bulky 
side-chain, causing it to be delayed on the column. Figure 3.12 depicts the postulated 
mechanism of reaction for benzoylation. While isocratic elution, following derivatisation 
with benzoic anhydride, resulted in improved peak shape and decreased variation in 
chromatography, it proved similar in sensitivity. In this study, derivatisation using 
benzoic anhydride was rejected when it was observed to produce matrix interferences in 
the chromatograms at similar retention times o f some o f the penicillin derivatives.
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Figure 3.12 Benzoylation o f  ampicillin.
3.5.3.2 Conditions fo r derivatisation with triazole
The pH of the triazole solution was adjusted to pH 9.0, as basic conditions were necessary 
to ensure that the triazole molecule was unprotonated so that the reaction w ith the (3- 
lactam ring (depicted in Figure 3.11) would occur. Also, at an acidic pH, the acétylation 
reaction would fail to take place as the amino (-NH2) group would become protonated. 
Mercuric chloride, which stabilises the product formed when the triazole is reacted with
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the penicillin, forming penicillanic acid mercury mercaptide, is also known to complex 
with proteins. This may have been one o f the reasons for the problems experienced when 
attempting to derivatise residues in MSPD extracts. The centrifugation step included after 
MSPD elution, removed some of the proteins eluted from the MSPD step, however, the 
supernatant resulting still contained some dissolved proteins. Prior to the introduction o f 
the SPE step, attempts to remove the proteins from the supernatant involved the 
introduction o f acidic pH. However, acidic pH can hydrolyse the P-lactam ring and inhibit 
the derivatisation reaction. Experiments were earned out to separate the 1,2,4-triazole 
reaction from the mercuric chloride reaction so that the proteins could be removed before 
mercuric chloride addition. However, this failed likely due to the instability o f the product 
formed on reaction o f the penicillin with 1,2,4-triazole.
The purity o f the triazole employed for derivatisation proved important. Triazole o f less 
than 99 % purity resulted in the formation o f small interfering peaks which eluted partially 
resolved from ampicillin and a larger non-retained solvent front caused amoxicillin to 
elute as a shoulder peak. Derivatisation was carried out at various concentrations o f 
triazole between 1 M  and 5 M. Even at high analyte concentrations (20 ppm), the 1 M 
reagent did not become limiting. Various concentrations o f mercury (II) chloride were 
also investigated. Below 0.005 M, chromatograms showed numerous ghost peaks and 
reduced peak intensity for amoxicillin and ampicillin. No substantial differences were 
observed in peak intensity, peak shape or the chromatograms resulting when various 
mercuric chloride solutions between 0.05 and 0.02 M were employed.
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The effect o f varying the incubation time for the derivatisation reaction was investigated. 
Using a penicillin solution o f 1 ¡ig m l'1, after 10 min no peaks were apparent for any o f the 
penicillin residues and at 20 min no peaks were evident for ampicillin and amoxicillin . By 
30 min all peaks were apparent and responses increased slightly up to 150 min, at which 
time the reaction appeared to level off. From these experiments, an incubation time o f 150 
min was selected. Derivatisation was investigated using standards in different media 
(water, acetonitrile and combinations o f these). Standards prepared in water gave the 
highest peak intensity. The effect o f standard diluent was especially significant for 
ampicillin. When acetonitrile was incorporated in the diluent, the peak shape was broad 
and tailing. Kubalec et a l11 reported a decrease in the derivatisation reaction speed when 
the diluent contained 45 % v/v acetonitrile. Therefore, following SPE, samples were 
reconstituted in water.
Sorensen et al.12 reported the need to employ silanised glassware to avoid irreproducibility 
in derivatisation, when employing triazole derivatisation for the determination o f 
penicillin residues in milk. On comparing the derivatisation results o f standard drug 
solutions in silanised and non-silanised glassware in this study, no significant difference 
was observed, so non-silanised glassware was employed similarly to the majority o f 
reported methods. Boison et al.21 reported that it was necessary to maintain the derivatives 
in the presence o f matrix. He claimed the derivatisation o f standard drug solutions 
resulted in high variability due to instability o f the derivatives, but the presence o f matrix 
components has a stabilising effect in the derivatives, h i this study, the presence o f matrix 
was not seen to result in a more stable derivative. Samples were chromatographed over a 
period o f 12 hours and the derivatives showed similar stability both with and without
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matrix. In the method o f Boison et al.2\  the drug residues were derivatised in a 
buffer/acetonitrile solution. In this study, the presence o f acetonitrile caused poor peak 
shape and peak splitting for amoxicillin and ampicillin. It was found that the derivatives 
gave much sharper peak shape when prepared in an aqueous environment. Also, it was 
desirable to delay exposure o f the penicillins to organic solvents, which are reported to 
cause disruption o f the P-lactam ring.
Variation in the derivatisation reaction was assessed by derivatising the same standard 
solution five times. Table 3.6 shows the variation in the derivatisation o f a lpg  m l'1 
standard solution and the variation resulting when analytes were derivatised in a similar 
fashion, in the presence o f matrix. Slight tailing accounts for the relatively higher 
variation in the dicloxacillin derivative compared with the others. Variation was observed 
to be greater in the presence o f matrix.
Many authors have used penicillin V  as an internal standard, as this synthetic drug is not 
usually administered as a veterinary drug. Use o f penicillin V  as an internal standard was 
investigated to overcome the variation in derivatisation. However, the variation was found 
not to be sample specific; not all the penicillin residues in one particular sample were 
observed to be derivatised in a consistent manner. Therefore, an internal standard was not 
used, as it did not assist in overcoming the inter-sample variation.
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Figure 3.11 Reaction mechanism for the derivatisation o f penicillins using 1,2,4- 
triazole.
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Table 3.6 Variation in derivatisation of standard penicillins (l^g ml'1, n=5), as a 
standard solution and in the presence of matrix.
Penicillin CV (%) in standard 
solution
C V (% )in
matrix
Amoxicillin 2.4 24.6
Am picillin 7.8 8.8
Penicillin G 1.8 14.8
Cloxicillin 4.2 4.7
D icloxicillin 10.2 19.1
3.5.4 Chromatography
Since reversed-phase columns were employed in all previously reported studies, therefore 
a C l8 column was chosen for this work. Gradient elution was necessary to elute the 
derivatised penicillins in one chromatographic run. Initially, a HPLC method that could 
include nafcillin was investigated. The derivatised products o f nafcillin and cloxaeillin 
could not be separated on a C l8 column. Separation could be achieved using a phenyl 
column, because the aromatic nature o f the phenyl packing provides sufficient interaction 
with the highly conjugated aromatic penicillin derivatives, thereby allowing separation o f 
nafcillin  and cloxaeillin derivatives. However, this column proved unsuitable for the 
analysis o f tissue extracts. After employing the column for the analysis o f MSPD tissue 
extracts, resolution failed and peak shape deteriorated. The aromatic nature o f the column 
packing renders it more susceptible to degradation and column fouling. Therefore, the
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original C l8 column was re-employed and nafcillin omitted from further studies. Initia l 
studies investigating various HPLC mobile phases, showed nafcillin and cloxacillin could 
be separated on a C l8 reversed-phase column when an ion-pair (tetrabutylammonium 
hydrogensulphate) was employed in the mobile phase. This mobile phase was rejected as 
dicloxacillin eluted very late and the method did not succeed in delaying amoxicillin on 
the column any further than the current HPLC method employed. Using the mobile phase 
and gradient system chosen, described in section 3.4, it was necessary to increase the 
percentage acetonitrile from the initial conditions o f 20 % to 40 %, over 25 min, in order 
to elute the last 4 derivatives o ff the reversed-phase column. However, maintaining the 
acetonitrile at 40 % after 25 min resulted in co-elution o f the last two derivatives so, after 
25 min, their elution was retarded by reverting the gradient back to the initial conditions o f 
20 % acetonitrile, which was also ideal for preparation o f the column for the next sample.
The derivatives were analysed at various wavelengths between 300 and 350 nm. 
Maximum absorption for amoxicillin, ampicillin and penicillin G derivatives was found to 
be 325 nm, while cloxacillin and dicloxacillin derivatives showed an absorption maximum 
at 345 nm. Therefore, at 24 min, the wavelength was switched from 325 to 345 nm to 
maximise sensitivity for cloxacillin and dicloxacillin. Figure 3.13 shows the separation o f 
the five derivatives o f penicillins obtained for a standard solution, for a control muscle 
sample and for porcine muscle samples fortified at 40 and 200 ppb. A  residue free 
(control) muscle sample is also shown. The change in wavelength is responsible for the 
inflection in the baseline, observed at 24 min.
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The variation in the chromatographic response was assessed by injecting the same 
standard solution five times, with and without the presence o f sample matrix (Table 3.7). 
As w ith the variation in the derivatisation, greatest chromatographic variability exists with 
dicloxacillin and as expected the variation in chromatography is reduced relative to the 
variation in derivatisation.
Table 3.7 Chromatographic variation for a 400 ng g'1 solution of derivatised 
penicillins and a solution of derivatised penicillins in the presence of 
matrix (n=5).
Standard solution
% CV
in Matrix 
% CV
Amoxicillin 2.4 Z6
Ampicillin 4.2 2.3
Penicillin G 2.8 3.2
Cloxacillin 2.9 2.6
Dicloxacillin 7.1 4.1
0 .0 0  10.00 20 .00 30.00
0 .00  10.00 20 .00 30.00
M ia u ta a
O.OSug/ml standard
1 2 3 4 5
L i ------- A. . A I JL.
0 . 0 0  1 0 . 0 0  2 0 . 0 0  3 0 . 0 0
K L x m t a *
Figure 3.13 Chromatogram showing derivatised control muscle and muscle samples 
fortified at 40 and 200ppb, and a 0.05 /Jg m l'1 standard (equivalent to 40 
ppb).
1) Amoxicillin, 2) Ampicillin, 3) Penicillin G, 4) Cloxacillin and 5) Dicloxacillin
HPLC Conditions: 100 |il injection volume, Waters Symmetry C18 column, 5 |im, 100 A, 4.6 x 250
mm, Mobile phase and gradient as described in section 3.4, UV detection at 325 
nm up to 24 min and 345 nm after 24 min.
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Linearity o f the chromatographic method was established between 0 and 0.8 fig m l'1. The 
highest standard routinely included in this study was equivalent to 800 ppb (MRLs are in 
edible tissue are 50 for amoxicillin, amoicillin and penicillin G and 300 ppb for cloxicillin 
and dicloxicillin), therefore it was considered unnecessary to investigate linearity beyond 
this concentration. The lim it o f detection was 20 ppb and the lim it o f determination was 
40 ppb for the five analytes in porcine muscle. Method validation was carried out on 
samples fortified at 40 and 200 ppb.
The within assay (intra) variation and between assay (inter) variation for muscle samples 
fortified at 40 ppb as shown in Table 3.8. The mean recovery (percentage) and standard 
deviation are presented. Quantification was not possible for amoxicillin at 40 ppb due to 
the presence o f matrix interference. Ampicillin showed inflated recoveries and higher 
inter-assay variation as it eluted as a “ shoulder”  on a peak, caused by matrix interference. 
For integration purposes, a drop line was forced from the valley between the two peaks to 
the baseline. Recoveries for cloxacillin and dicloxacillin were low using the method 
developed. Hou and Poole73 have reported that the hydrolysis o f the P-lactam ring is more 
difficult to achieve for isoxazoyl penicillins than for the other members o f the group. The 
derivatisation technique employed in this study required hydrolysis o f the P-lactam ring. 
When control tissues were extracted and cleaned-up and extracts fortified prior to 
derivatisation, recovery for cloxacillin and dicloxacillin were approximately 74 and 68 %, 
respectively. Therefore, it is likely that in-complete hydrolysis causes low recovery for 
these two analytes in tissue extracts.
3.5.5 Method precision and accuracy
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The repeatability and reproducibility o f the method for samples fortified at 200 ppb is 
presented in Table 3.9. A t this level, some quantitation o f amoxicillin is possible, as it is 
more easily distinguished from the interfering matrix, due to the higher peak intensity. 
Variation for infra- and inter-assays is lower at the high level o f fortification and 
recoveries for cloxacillin and dicloxacillin are much improved, relative to that found for 
samples fortified at 40 pbb (Table 3.8). The improved recovery may be due to the fact that 
the concentration o f the analytes at the high level o f fortification greatly out-number the 
concentration o f derivatisation inhibitors, resulting in a higher recovery. A t both levels o f 
fortification, intra-assay variation is lower than inter-assay variation. Recoveries for 
penicillin G are consistently good and variation acceptable.
Table 3.8 Determination of penicillin residues in porcine muscle fortified at 40 
ppb, using MSPD with pre-column derivatisation (n=5).
Mean Recovery (%>) ± SD
Antibiotic Intra-assay Inter-assay
Amoxicillin NM* NM *
Am picillin 120 ±8.5 130 ±38
Penicillin G 74 ± 13.1 79 ± 15.1
Cloxacillin 43 ± 14.7 55 ±19.6
Dicloxacillin 25 ± 9.9 52 ±25
NM : Not measurable due to matrix interference
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Table 3.9 Determination of penicillin residues in porcine muscle fortified at 200 
ppb, using MSPD with pre-column derivatisation (n=5).
Mean Recovery (%>) ± SD
Antibiotic Intra-assay Inter-assay
Am oxicillin 23 ± 18.8 45 ± 16.6
Am picillin 85 ± 10.5 73 ± 9.4
Penicillin G 81 ± 1.2 76 ± 14.9
Cloxacillin 79 ±3.4 65 ± 13.1
Dicloxacillin 75 ±3.5 62 ± 11.9
3.6 CONCLUSION
The study demonstrates the effectiveness o f MSPD for the extraction o f penicillin drug 
residues from porcine tissue. Direct UV detection was not possible due to the low UV 
absorption characteristics o f the native penicillins. Therefore, derivatisation was necessary 
and the technique employed was specific to those compounds containing a penicillin 
nucleus, resulting in selective enhancement o f the signal. MSPD provides a simple, rapid 
extraction method for the five penicillin residues. The results show that the method was 
better suited to the analysis o f cloxacillin, dicloxacillin and penicillin G, particularly at 
low levels, due to matrix co-extractives interfering with ampicillin and amoxicillin.
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ANALYSIS OF 
AMINOGLYCOSIDE ANTIBIOTIC RESIDUES 
IN MILK AND TISSUE USING 
PAIRED ION CHROMATOGRAPHY, 
ION-EXCHANGE SOLID-PHASE EXTRACTION, AND 
IMMUNOAFFINITY CHROMATOGRAPHY.
CHAPTER 4
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4.1 INTRODUCTION
Gentamicin, neomycin and kanamyein are the analytes which are the subject o f this 
study. Analytical methods for the determination o f gentamicin and neomycin have been 
reported previously, but few methods are available for the analysis o f kanamyein, 
particularly in biological matrices. None o f the published methods are suitable for the 
analysis o f these three antibiotics or present evidence o f method validation.
The analysis o f aminoglycosides is complicated by the fact that commercial 
preparations o f these veterinary drugs contain various components, which often differ 
minimally in structure. It has been suggested that the various components may differ in 
toxicity and there is a trend towards development o f chirally pure pharmaceutical 
preparations. Therefore, it is desirable to have a method capable o f monitoring the 
various components o f each veterinary drug preparation. Furthermore, aminoglycosides 
do not possess any properties that facilitate their direct detection in that they are not 
inherently fluorescent, they lack chromophores for UV detection, and they are not 
volatile for GC analysis.
The purpose o f this study was to investigate methods o f analysis o f gentamicin, 
neomycin and kanamyein in biological matrices. A  chromatographic system was 
developed in itia lly, using ion-pair chromatography w ith OPA post-column 
derivatisation. Ion-exchange SPE was employed for the clean-up o f the three analytes 
from m ilk and the entire method was fu lly  validated. An immunoaffinity
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chromatography method was developed for the analysis o f gentamicin in m ilk and 
tissue and the developed method was also validated.
4.1.1 Classification
Aminoglycosides are antibiotics produced by Streptomyces species (mycins) and 
Micromonospora species (micins). Structurally these antibiotics consist o f amino 
sugars, attached via a glycosidic bond (sugar-O-R) to a central ring structure called an 
aminocyclitol. Aminoglycoside antibiotics are divided into 2 main groups, depending 
on the nature o f this central ring; those containing streptidine and those containing 2- 
deoxystreptamine, with the latter group being the most important. The 
deoxystreptamine central ring contains amines and hydroxyl groups, whereas the 
streptidine ring contains more basic guanidine groups (NH-C-(NH2)).
Deoxystreptamine antibiotics are further classified depending on the substituents 
attached. The neomycins and paromomycins form one class, where the substituents are 
at adjacent positions on the molecule, as opposed to the gentamicins and kanamycins 
where the substituents are isolated on nonadjacent positions o f the aminocyclitol moiety. 
As mentioned in the introduction, aminoglycoside producing micro-organisms produce 
a mixture o f active components; Seidl and Nerad1 have separated five components o f 
gentamicin designated Ci, C2, Cia, C2a and C2b (C2b is also known as sagamicin). O f the 
five components isolated, the first three are major fractions, present in approximately 
equal amounts, and the remaining two components represent about 4 % o f the total 
composition o f gentamicin.
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Figure 4.1 Structure o f  gentamicin and its different forms, Ci, C2, Cj„, C2a-
4.1.2 Mode of action and consequence of aminoglycoside residues in foods
Aminoglycosides are broad spectrum antibiotics, used in the treatment o f disease, since 
streptomycin was first identified in 1944. They act by inhibiting protein synthesis, 
thereby preventing the growth o f new bacterial cell walls. The 30S ribosomal subunit 
has multiple reaction sites for aminoglycoside interaction, resulting in inhibition o f 
peptide chain elongation, necessary for the formation o f n ew bacteria.
Aminoglycoside antibiotics are used to treat, control and prevent disease in food 
producing animals as well as for growth promotion. The presence o f residues o f these 
drugs in food is considered a high risk to the consumer. A ll aminoglycoside antibiotics 
are potentially toxic, and they are reported as being more toxic than penicillins. In
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clinical medicine, blood from patients treated w ith these antibiotics is carefully 
monitored, due to the toxic effects o f these antibiotics on auditory and nerve function 
resulting in irreversible damage2. Soltes reported that there is a small difference 
between the effective and toxic concentrations when these drugs are administered for 
treatment o f disease in humans3. Also, intravenous administration o f neomycin was 
reported to cause a marked loss o f calcium in the urine due to impaired reabsorption in 
the proximal tubules o f the kidneys4. However, there are no reports relating such toxic 
effects to the presence o f aminoglycoside residues in foods.
Aminoglycoside antibiotics are most commonly used in veterinary drug medicine in the 
treatment o f infections caused by aerobic gram-negative bacteria, such as mastitis5. The 
most common aminoglycosides used as veterinary drugs include gentamicin, 
streptomycin, dihydro streptomycin and neomycin. Kanamycin is also used as a 
veterinary drug though it has not yet received approval for use in food-producing 
animals.
4.1.3 General physical/chemical characteristics
Aminoglycosides are soluble in water, possess lim ited solubility in methanol, and are 
poorly soluble in other solvents. Aminoglycosides exhibit resistance to heat, acids and 
bases. Aminoglycoside antibiotics are polar and ionic in nature. They possess very low 
UV absorption (absorb poorly at 190 mn). Characterisation studies have employed 
optical rotation. Withdrawal times o f 3-63 days (depending on the antibiotic and animal 
in question) are recommended for the various aminoglycosides to reach a tolerable 
concentration in food intended for human consumption.
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4.2 CHEMICAL METHODS OF ANALYSIS
4.2.1 Introduction
Previously, aminoglycosides have been analysed by non-chromatographic methods 
including spectrophotometry, colorimetry, polarimetry, polarography and fluorescence. 
However, these techniques have been used for the analysis o f antibiotic levels in 
fermentation broths and pharmaceutical preparations and not for the analysis o f residues 
in biological tissues and fluids. Current methods for aminoglycoside analysis are 
primarily based on HPLC. GC methods have been reported, but the requirement for 
derivatisation has hampered its employment. TLC methods have also been reported, 
but the sensitivity required for quantification o f the analytes in biological matrices has 
resulted in HPLC becoming the most commonly used method. Most HPLC methods 
require the use o f ion-pair chromatography (IPC) on reversed-phase columns and 
derivatisation is employed for detection either in pre- or post-column mode. 
Derivatisation to produce fluorescent products has proven most popular, allowing 
sensitive detection o f analytes.
4.2.2 Spectrophotometry
A spectrophotometric method for the determination o f amikacin, neomycin, 
streptomycin and kanamycin at a minimum concentration o f 4 pg m l'1 in 
pharmaceutical syrups and injections has been described by Zakhari6. The method 
involves nitration o f the primary amino groups followed by reduction using 
cyanoacetamide at 100°C and UV detection at 270 nm. Colorimetric determination o f 
tobramycin, kanamycin, amikacin and gentamicin in pharmaceutical ointments has been
n
described by Ryan . The aminoglycosides were derivatised with 2,4-
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dintrofluorobenzene to form a coloured product w ith an absorbance maximum at 415 
nm. However, the derivative exhibited lim ited stability.
4.2.3 Capillary electrophoresis
Aminoglycoside analysis using capillary electrophoresis has been reported. Flurer and 
Wolnik8 separated gentamicin from injectable solutions, into three components using 
direct detection at 195 nm. The lim its o f detection were comparable to the more 
classical microbial methods (1 mg m l'1). Ackermans et al.9 described the analysis o f 
thirteen aminoglycosides using micellar electrokinetic capillary chromatography. 
Neomycin was determined in a medicinal eardrop solution to test the method. Human 
plasma has been analysed for amikacin by high performance capillary electrophoresis 
employing fluorescence detection10. The method involves ultrafiltration o f plasma prior 
to derivatisation with l-methoxycarbonylindolizine-3, 5-dicarboxyaldehyde. M icellar 
electrokinetic chromatography using SDS was employed for separation o f amikacin 
from the matrix. The authors also compared fluorescence detection o f the amikacin 
derivative w ith UV detection o f the derivative. Using UV detection, resolution was 
affected by reagent peaks and peak intensity was 1.7 times lower than that obtained by 
fluorescence detection (which had a lim it o f detection o f 0.5 p,g m l'1).
4.2.4 Sensors
Rizk et al.u  have described the fluorimetric determination o f aminoglycoside antibiotics 
using lanthanide ion probe spectroscopy. The technique was applied to the analysis o f 
neomycin, streptomycin, gentamicin, tobramycin, amikacin and kanamycin in 
pharmaceutical preparations. The method is based on the reaction o f aminoglycoside
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amino and hydroxyl groups with Eu III ions. The concentration o f antibiotic is 
proportional to the amount o f bound ligand, which has fluorescence intensity at 616 nm. 
Linearity was assessed between 0.2 and 1.0 mg aminoglycoside. The method was 
tested by analysing veterinary injectables.
Flow injection analysis has been employed in the determination o f kanamycin has been 
described by Alwarthan et al.n . The authors describe a technique based on the 
suppression o f the chemiluminescence o f lucigenin systems when kanamycin is the rate- 
lim iting reagent. The method was applied to the analysis o f pharmaceutical 
preparations. The authors also suggest application o f the system to other 
aminoglycoside antibiotics, but a separation step would have to be included in the assay, 
as the reaction is not specific.
4.2.5 Immunoassay
A substrate labelled fluorescent immunoassay for amikacin in human serum has been 
described by Thompson and Burd13. The method involves the labelling o f amikacin 
w ith a fluorogenic substrate for the enzyme P-galactosidase. The enzyme is capable o f 
hydrolysing the labelled analyte to form a fluorescent product. Cross reactivity was 
low, recovery was high (93-113 %) and inter-assay coefficient o f variation was 4.7 % at 
a level o f 5 p,g m l'1. Haasnoot et a l u  have recently described the immunochemical 
detection o f aminoglycosides in m ilk and kidney. Three ELISAs were described for the 
detection o f gentamicin, neomycin and dihydro streptomycin, w ith lim its o f 
determination o f 0.7, 3.6 and 5.1 ng m l'1 for gentamicin, neomycin and streptomycin 
respectively. Monoclonal antibody production and the development o f an ELISA for 
kanamycin, have been described by Watanabe et al.t5. The validated method had a lim it
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o f detection o f 0.2 ng ml"1 and standard deviation for the analysis o f m ilk, plasma and 
urine samples fortified at 4 ppb, was in the range 0.1 to 11 %. Brown et al.16 described 
the extraction o f gentamicin residues from tissues, using determination by fluorescence 
polarisation immunoassay. Sodium hydroxide digestion was compared w ith TCA 
precipitation. Tissue homogenisation with sodium hydroxide digestion produced 
recoveries o f 85-94 % with an inter-assay variation o f 7-8 %.
4.2.6 Chromatography
As w ith most methods for antibiotic analysis, chromatographic methods are the most 
popular for the analysis o f aminoglycosides in tissue. Liquid chromatography and thin 
layer chromatography have been described for analysis o f aminoglycoside residues in 
tissues and biological fluids. Gas chromatographic methods have also been reported, 
but mainly for the analysis o f pure drug solutions.
Thin layer chromatography-bioautography has been reported by Salisbury et a l} 1 for a 
variety o f different classes o f antibiotic residues, including streptomycin, 
dihydrostreptomycin, neomycin and gentamicin, in beef muscle. Residues were 
extracted from tissue by liquid-liquid extraction prior to spotting onto TLC plates. The 
authors reported co-elution o f some antibiotics on the silica gel TLC plate so 
microbiological confirmation was necessary. This made the assay lengthy and time 
consuming. Lim its o f detection ranging from 0.33 to 3.3 for the antibiotics o f interest 
were noted. Roets et al.' separated neomycin into its B and C components using TLC 
and fluorescence detection after derivatisation with 4-chloro-7-nitrobenzo-2-oxa-l,3- 
diazole. The lim it o f detection was 0.4 ppm.
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Kanamycin and paromomycin determination by gas-liquid chromatography has been 
reported by Tsuji and Robertson19. Aqueous solutions o f the antibiotics were silylated 
and separated on a packed, glass GC column and detected using flame ionisation 
detection. The method was capable o f separating the two peaks o f paromomycin and 
three components o f kanamycin. The components were confirmed by mass 
spectrometric analysis. Neomycin was also analysed using similar derivatisation 
procedures, but instability o f the derivatisation reagents can result in poor linearity and 
reproducibility.
Liquid chromatography has been described for the analysis o f aminoglycoside 
antibiotics in serum, plasma, blood, urine, liver, kidney and muscle. HPLC separation 
o f these very basic analytes has proved challenging for residue analysts. Reversed- 
phase chromatography is most commonly employed. Ion-exchange has also been 
reported for aminoglycoside separation. Fluorescence derivatisation is commonly 
employed to enhance the sensitivity o f the method.
Determination o f streptomycin and dihyrostreptomycin in animal tissue has been 
described20 using liquid chromatography. Tissue extracts, obtained by acid extraction, 
were subsequently cleaned up by ion-exchange solid-phase extraction. Ion-pair reagent 
was added to the eluate prior to on-line sample enrichment and separation on a C8 
reversed-phase stainless steel column. Post-column derivatisation, using 1,2- 
naphthoquinone-4-sulfonic acid was employed, allowing fluorescence detection. 
Streptomycin and dihydro streptomycin were partially resolved from each other and 
recoveries were in the range 46-72 %, from various tissues. The detection lim its were 
10 ppb for streptomycin and 20 ppb for dihydro streptomycin.
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Four components o f gentamiein, extracted from animal tissue and whole m ilk, were 
analysed by HPLC21. Liquid-liquid extraction was employed followed by ion-exchange 
solid-phase extraction. The extract was then subject to derivatisation using OPA and 
separated on a C l8 column with isocratic elution. The detection lim it for gentamiein in 
tissue was 1 ppm and 0.6 ppm in milk. Recoveries o f greater than 90 % were reported 
with coefficient o f variation no greater than 8.9 %. However, the chromatogram 
presented by the authors showed the peaks to be broad.
Strong cation-exchange was employed by Seidl and Nerad1 for the baseline separation 
o f five gentamiein components, with retention times o f less than 20 minutes. Two 250 
mm columns were required. Peak shapes displayed slight tailing and columns required 
regeneration after every 500 ml eluent had passed through. Cation-exchange after pre-
column derivatisation was employed by Walker and Coates for the analysis o f
22gentamiein, but the components were not separated successfully .
Sar et al.2i have described a HPLC method for the analysis o f gentamiein in calf tissues 
using ion-pair reversed-phase chromatography and post-column derivatisation with 
OPA allowing fluorescence detection. The method did not allow the separation o f the 
gentamiein peaks. Following deproteinisation with trichloroacetic acid, sample extracts 
were cleaned-up using ion-exchange gel columns. Recoveries ranged from 68 % in 
kidney to 98 % in liver, for samples fortified at 100 ppb and relative standard deviations 
were 12.7 and 11.8 respectively. The lim it o f quantitation was 50 ppb in muscle fat and 
100 ppb in liver and kidney. Agarwal24 has also described a HPLC method for the 
analysis o f gentamiein in animal tissue. The method involves liquid-liquid extraction o f 
muscle tissue, followed by deproteinisation, and solid-phase clean-up on silica and ion-
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exchange resin columns. The extract was derivatised by OPA on a silica SPE column. 
Gradient HPLC was employed to separate components o f gentamicin on a reversed- 
phase column prior to fluorescent detection. Recoveries ranged from 86-108 % and the 
detection lim it was 0.2 ppm.
OPA post-column derivatisation has been employed, allowing fluorescence detection for 
the determination o f neomycin residues extracted from animal tissues25. Liquid-liquid 
extraction was employed followed by heat deproteinisation. The extracts were analysed 
by reversed-phase HPLC and ion-pair chromatography. The method separates 
neomycin from streptomycin and dihydro streptomycin and could also be applied to 
muscle tissue. The recovery from kidney tissues was 96 %, w ith 9 % coefficient o f 
variation, for samples fortified at a 1 ppm.
Refractive index detection has been used with ion-pair, reversed-phase, isocratic HPLC 
separation o f eight aminoglycosides26. Several ion-pairing systems have been used for 
the separation o f aminoglycosides. The counter ions frequently used are o f the 
allcanesulphonate class, which are very d ifficu lt to remove from the sample and can 
cause deterioration o f HPLC columns over time. The authors’ report using volatile 
perfluorocarboxylic acid as the ion-pair agent, allowing separation o f eight 
aminoglycosides when two separate mobile phases were employed. After separation, 
recovery o f pure antibiotic is accomplished by lyophilisation o f the mobile phase eluent, 
so this method may be advantageous i f  HPLC fractions require further analysis by, for 
example, MS. The method has not been applied to the analysis o f residues in tissues. 
Refractive index detection has also been employed by Decoster et al.21, for the 
determination o f neomycin components. Ion-exclusion chromatography was employed
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for the analysis o f neomycin in pharmaceutical preparations and the authors report the 
use o f a resin o f a smaller granulometry, which resulted in reduced analysis time. There 
are no reports on the application o f refractive index detection for the analysis o f 
aminoglycoside residues in animal tissues or fluids.
Pulsed electrochemical detection has been reported for the analysis o f aminoglycoside 
antibiotics. The presence o f hydroxyl groups presents the possibility o f electrochemical 
detection. Aminoglycosides are anionic at high pH values and are oxidised on a gold
electrode. The gentamicin complex has been separated by anion-exchange ion
28chromatography on a carbohydrate column using gradient elution . The method was 
applied to the analysis o f medicinal injections and allowed the detection o f 20 ng 
gentamicin without derivatisation. Tobramycin has also been detected by pulsed 
amperometric detection using a gold working electrode29. Anion-exchange separation 
under alkaline conditions was also employed for this hydrophilic analyte.
Lasar-based polarimetric detection has been employed for the analysis o f gentamicin in 
m ilk30. The lim it o f detection was 7 [ig m l'1, well above the MRL (100 ppb). The 
authors claim to be the first to report a method capable o f detecting four gentamicin 
peaks without employing derivatisation. However, baseline resolution was not achieved 
and the lim it o f determination in m ilk was not addressed.
Derivatisation is common in aminoglycoside analysis. Pre-column derivatisation o f 
gentamicin has been described by Claes et a/. 31. Derivatisation w ith o-phthalaldehyde- 
mercaptoacetic acid reagent allowed UV detection at 350 mn. This derivatisation 
method required a 15 min incubation step at 60°C. Kanamycin, tobramycin, gentamicin
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and siscomicin have also been determined using pre-column derivatisation . The 
method described is based on the derivatisation o f the aminoglycosides w ith 2,4,6- 
trinitrobenzenesulphonic acid reagent allowing UV detection at 350 nm. This method 
also requires a 15 min incubation at 70°C. The stability o f the chromophore formed 
varies from compound to compound, but the addition o f acetic acid to the derivative 
ensured its stability for up to 10 h. The neomycin complex was analysed using pre­
column derivatisation with 2-napthalenesulfonyl chloride33. Relative standard 
deviations (RSDs) o f between 0.9 and 1.4 % were obtained using this method and 
linearity was observed between 20-40 pg m l'1. The derivatives were separated on a 
silica column.
Fluorescein pre-column derivatisation using 9-fluorenylmethyl chloroformate was used 
for the analysis o f neomycin in kidney34. Recoveries o f 80-120 % were reported from 
tissue fortified at 0.25-1.0 mg kg '1. Lim its o f quantitation were 0.125 mg leg'1. The 
extraction method described is lengthy and peak shape for the neomycin derivative is 
broad and tailing, when chromatographed on a C4 reversed-phase column.
4.2.7 Mass spectrometric techniques
There are few MS methods reported for aminoglycoside residues in fluids and tissues. 
No GC-MS method has been reported and few LC-MS methods are available, 
particularly for analysis o f biological matrices. The necessity to use ion-pair reagents 
for the separation o f aminoglycosides has hampered the use o f LC-MS as these non­
volatile reagents are not compatible with current interfaces. Mass spectrometry o f 
aminoglycoside pure drug standards has been reported. Various ionisation techniques 
have been employed and w ith ion-spray proving the most popular. Ion-spray may be
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considered suitable for aminoglycosides that are easily ionised, as severe conditions are
not necessary35.
Inchauspe et al.i(i used MS detection when investigating the selectivity o f perfluorinated 
ion-pairs for the chromatographic separation o f aminoglycosides. Field desorption-MS 
was employed and the study involved the analysis o f pure standards only. 
Thermospray-MS (TSP-MS) was employed by Getelc et a l 31 for the analysis o f 
gentamicin by reversed-phase HPLC. Trifluoracetic acid was used as the mobile phase 
ion-pair, separating gentamicin into 3 peaks (C21-., C2, and Ci). The authors report that 
the TSP-MS o f gentamicin in the positive ion mode produced low ion intensity for the 
[M  + H ]+ ions, but cleavage o f the glycosidic bonds resulted in fragments o f high 
intensity. They concluded that the low intensity for the [M + H ]+ ions was due to the 
thermal lab ility o f gentamicin, so it was necessary to monitor the ions produced from 
the purpurosamine fragment (the part o f the molecule that differs from other 
aminoglycosides) for low analyte concentrations. The lim it o f detection for the total 
gentamicin complex was 20 jag ml"1.
4.2.8 Extraction methods
The basic nature o f aminoglycoside antibiotics causes them to accumulate in the kidney
38tissue o f the body, where they bind to acidic phospholipids . Therefore, this is the 
target organ for analysis o f aminoglycosides, but many analysts choose to assay 
biological fluids, such as plasma, serum, m ilk and urine, as these matrices are easier to 
assay and the poor absorption o f aminoglycosides in the intestinal tract can result in 
substantial partitioning into biological fluids. The analysis o f aminoglycosides in 
biological matrices requires a deproteinisation step. Proteins can interfere w ith clean­
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up, chromatographic resolution, derivatisation and detection. Organic solvents such as 
acelomtrilc39 and methanol40, and acids have been used for extraction and/or 
deproteinisation. Haasnoot et al.14 used trichloroacetic acid for deproteinisation in the 
analysis o f gentamicin, neomycin and dihydro streptomycin from kidney samples. 
Perchloric acid has been employed by Gerhardt et a i'u for the analysis o f streptomycin 
and dihydrostreptomycin in milk. Phosphate buffer, pH 4, has been employed by 
Shaikh and Jackson42 for the extraction o f neomycin from kidney, w ith samples being 
deproteinised by immersion in boiling water. Biological fluids have also been 
deproteinised using ultrafiltration; Oguri el al. used this procedure for the analysis o f 
amikacin in human blood and plasma samples10. Following deproteinisation, the extract 
is usually buffered to an alkaline pH and undergoes further purification.
Brown et al,43 carried out a study to compare sodium hydroxide digestion o f tissue w ith 
trichloroacetic acid precipitation, with and without homogenisation. Kidney samples 
were subject to the following treatments; a) homogenisation in phosphate buffered 
saline (PBS), b) homogenisation in trichloroacetic acid (TCA), c) incubation in sodium 
hydroxide (NaOH), and d) homogenisation and incubation in sodium hydroxide. The 
authors concluded that recovery using NaOH digestion (treatment c) was significantly 
higher than for PBS or TCA treated samples. Recovery using NaOH with or without 
homogenisation was similar. Ultrasonic probe tissue disruption was compared w ith a 
rotary steel probe homogeniser and no significant difference in recoveiy was found. 
Gilbert and Kohlhepp44 also compared homogenisation o f kidney tissue w ith Tris buffer, 
TCA and NaOH, with heating to facilitate deproteinisation, for the analysis o f 
tobramycin. They found that recoveiy o f tobramycin from kidney fortified at 500 ppb 
was 32 % using heat deproteinisation in Tris buffer, 89 % using heat deproteinisation in
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TCA and 99 % using heat deproteinisation in NaOH. The authors suggest that TCA and 
NaOH treatment o f tissue homogenates results in hydrolysis o f anionic tissue 
components resulting in liberation o f the non-hydrolysed cationic aminoglycosides.
Solid-phase extraction is the most popular clean-up method reported, and liquid-liquid 
partitioning has also been employed. Washing o f a tissue extract w ith methylene 
chloride to remove the more non-polar interferences has been reported by Salisbury et 
a l xl', in the analysis o f muscle, kidney and liver for antibiotics, including 
aminoglycosides. The residues remained in the aqueous solution, while the non-polar 
matrix components partitioned into the organic solvent. D'Souza and Ogilvie45 found 
liquid-liquid partitioning using acetonitrile/water and methylene chloride sufficient for 
the analysis o f gentamicin in plasma but a C l8 SPE step was necessary when the 
method was applied to the analysis o f gentamicin in urine.
Cation-exchange SPE has been employed by Stead and Richards46 for the analysis o f 
gentamicin in fermentation broth and plasma. Analytes were loaded in phosphate 
buffer, pH 7.4, and a borate buffer (pH 9.0) wash step was followed by acetonitrile- 
borate (pH 10.0) elution. The authors explain that a pH o f 10.0 was necessary to 
achieve gentamicin elution and the acetonitrile is thought to assist elution due to 
improved wetting o f the dried solid-phase.
Matrix solid-phase dispersion has been reported by Me Laughlin and Henion47 for the 
extraction o f streptomycin, dihydro streptomycin, hygromycin and spectinomycin from 
kidney samples. These authors used mass spectrometric detection, so matrix 
interference was not as significant as with UV or fluorescence detection. Cyanopropyl
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sorbent was employed, a hexane wash included and the analytes eluted w ith 1 m l water 
followed by 8 m l sulphuric acid. The normal phase sorbent chosen is polar in nature 
and is suitable for the extraction o f aminoglycosides due to the hydrophilic functional 
groups on the molecules that is the presence o f hydroxyl and amino moieties. The 
hexane wash removed fats and the analytes were eluted from the sorbent/tissue blend 
using an acidic solution, which protonates the Junctional groups o f the analytes, thereby 
displacing them o ff the column.
4.2.9 Summary
To conclude this review, there is a lack o f published literature for the determination o f 
some aminoglycosides, such as kanamycin, particularly in biological matrices. The 
majority o f methods for aminoglycoside analysis use time consuming, labour intensive 
sample preparation techniques. Few methods are capable o f determining more than two 
analytes in one extraction procedure. This study presents the method development and 
validation for the analysis o f gentamicin, neomycin and kanamycin in m ilk and kidney 
samples. Ion-exchange SPE and immunoaffinity column chromatography, allow rapid, 
reliable determination o f the three analytes. A wide range o f chromatographic features 
such as column type, system fittings and sample diluent are investigated, in addition to 
optimisation o f the derivatisation technique employed.
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4.3 EXPERIMENTAL
4.3.1 Introduction
Methods for the analysis o f residues o f gentamicin, neomycin and kanamycin in m ilk 
and tissue were developed. An ion-pair chromatographic system was developed using 
heptanesulfonic acid w ith methanol modifier. Fluorescence detection was achieved by 
means o f OPA post-column derivatisation and derivatisation parameters were optimised. 
A  method was developed for the extraction o f the three analytes from m ilk and clean-up 
o f the extracted residues using ion-exchange SPE. The developed method was validated 
on the basis o f intra- and inter-assay variation in recovery, at five levels o f fortification. 
The analysis o f gentamicin residues in m ilk and tissue was also investigated using 
immunoaffinity column chromatography. The immunoaffinity chromatography method 
was validated for both matrices at three levels o f fortification, again on the basis o f 
intra- and inter-assays.
4.3.2 Chemicals and Reagents
A ll solvents were o f analytical HPLC grade, unless otherwise stated.
a) Preparation o f  standards
Gentamicin, neomycin and kanamycin were purchased from Sigma-Aldrich Chemie 
BV., Zwjindrecht, The Netherlands. Stock solutions o f 100 ng ml"1 were prepared in 
deionised water and stored in polyethylene tubes at 4°C for two months.
b) HPLC mobile phase
For ion-pair chromatography, the mobile phase consisted o f 70 % buffer/30 % 
methanol. The buffer contained heptanesulfonic acid sodium salt (0.01 M), sodium
208
sulphate (0.05 M ) and potassium dihydrogen phosphate (0.01 M). The pH was adjusted 
to 3.5 w ith ortho-phosphoric acid (98 % v/v) and all chemicals were purchased from 
Sigma-Aldrich Chemie BV., Zwjindrecht, The Netherlands.
c) Derivatisation reagent
A  0.0075 M  derivatisation reagent was prepared by dissolving ortho-phthaldialdehyde 
(1.0 g) in methanol (50 ml), 500 jj.1 mercaptoethanol was added, before diluting to 1 litre 
with borate buffer (0.5 M, pH 10). The pH o f the borate buffer solution was adjusted 
using potassium hydroxide (10 M). The derivatising reagent was degassed prior to use 
and protected from light. It was used for a maximum o f twenty-four hours.
d) Ion-exchange
For ion-exchange SPE, Bakerbond carboxylic acid, 3ml, 500 mg columns, purchased 
from J. T. Baker, Mallincrodt Baker B.V., Deventer, The Netherlands were employed.
20 % aqueous trichloroacetic acid (TCA) was prepared every 3 months.
Ion-exchange dilution buffer: citric acid buffer (0.05 M, pH 10) was prepared weekly, 
pH was adjusted using aqueous sodium hydroxide solution (50 %).
Ion-exchange washing buffer: citric acid buffer (0.05 M, pH 3.5) was prepared weekly 
and pH was adjusted using sodium hydroxide solution (50 %). Ion-exchange elution 
solution: citric acid buffer (0.05 M, pH 2.0) containing sodium sulphate (0.01 M).
e) Immunoaffinity column chromatography solutions
Immunoaffinity dilution buffer: Citric acid buffer (0.05 M, pH 7.0) was prepared 
weekly and pH was adjusted using aqueous sodium hydroxide solution (50 %). 
Immunoaffinity elution solution: citric acid buffer (0.10 M) was prepared containing 
sodium sulphate (0.02 M, pH 2.0). Phosphate buffered saline (PBS) was used for
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washing and column conditioning. PBS containing 0.5 % sodium azide was used for 
column storage.
f) Immunoaffinity column preparation
Two immunoaffinity chromatography columns were prepared, one for gentamicin and 
one for neomycin clean-up, by covalently binding the respective antibody to these 
analytes onto a solid support. Polyclonal antibodies were obtained from a rabbit. The 
support used for the preparation o f these columns was agarose, CNBr-activated 
Sepharose, (available in k it form from Pharmacia Biotech) which binds the antibodies 
through reaction w ith their primary amines. Preparation o f the columns involved a 
number o f steps, which are briefly outlined below;
1) Gel preparation
The CNBr-activated sepaharose, which is supplied in dried form, was washed w ith low 
pH buffer (pH 2-3) to remove additives and activate the reactive groups.
2) Coupling the ligand
The ligand was dissolved in coupling solution (pH 8.3 sodium carbonate buffer 
containing sodium chloride), while shaking gently overnight. Excess ligand was 
removed and un-reacted groups were blocked, by washing w ith m ildly alkaline buffer. 
The gel was then washed with acetate buffer, pH 4, containing sodium chloride, 
followed by Tris-HCL buffer, pH 8, containing sodium chloride. This washing 
procedure is repeated three times.
3) Column preparation
The gel is diluted with binding buffer (PBS), to prepare a slurry. The sluny was poured 
into a plastic syringe barrel, which was fitted w ith a frit. Once the gel bed has settled, a 
frit was inserted into the syringe barrel and pushed onto the surface o f the gel bed. The
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column was flushed with three syringe volumes o f buffer, before flushing w ith PBS, 
containing sodium azide (0.05 %) to inhibit microbial contamination. The column was 
then capped and stored at 4°C.
Prior to use the columns were equilibrated to room temperature, before flushing with 
three column volumes o f PBS. The gel was prevented from running dry during this 
conditioning step or during loading, washing or elution, by the presence o f the frit, 
installed on the surface o f the gel. After use, the columns were washed w ith two 
column volumes o f water, followed by one column volume o f PBS, followed by 
storage, at 4°C, in PBS containing 0.05 % sodium azide.
4.3.3 Instrumentation
Chromatography: A Separations High Precision pump, model 300, (Separations, The 
Netherlands) was used to deliver the mobile phase at a flow rate o f 0.3 m l m in'1. The 
column employed was a glass C8 column, 100 x 3 mm Chromsphere 5, supplied by 
Chrompack (The Netherlands). Sample volumes o f 50 jxl were injected using a Gilson 
autosampler, Model 234 (The Netherlands).
Derivatisation: Post-column derivatisation was used to form fluorescent OPA 
derivatives which were detected at 340 nm (Ex), 440 nm (Em), using a Separations 
fluorescent detector, model FP90. The mobile phase post-column was directed into a 
PEEK mixing tee, where it met w ith the post-column derivatising reagent, which was 
pumped at a flow rate o f 0.6 m l m in'1 by a Pharmacia Fine Chemicals pump, model P- 
500 (Pharmacia Biotech, The Netherlands). The mixing tee effluent was passed through 
a polypropylene coil o f 100 x 0.05 cm before reaching the detector. The system was
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allowed to equilibrate for 30 min prior to the first injection and the first injection was 
not included in validation studies.
4.3.4 Sample Fortification
Standard solutions were prepared prior to analysis, by diluting the aqueous stocks from 
100 pg ml"1 to 10 pg m l'1 (working stock) with water, followed by further dilution to 
prepare fortification solutions and standards for curve preparation. Samples were 
fortified by the addition o f 50 pi o f the standard solution into a measured volume o f 
sample. For m ilk, the sample was immediately vortexed and left to stand for 15 min. 
For fortification o f tissue samples, 50 pi fortification solution was pipetted into the 
middle o f the tissue, and the sample left to stand at room temperature for 15 min.
4.3.5 Sample Analysis
A) Milk analysis using ion-exchange clean-up
2 ml m ilk samples were measured into polypropylene tubes and samples were fortified 
as described in section 4.3.4. 400 (¿1 volumes o f aqueous TCA (20 %) were added to the 
fortified samples, and the samples were vortexed for 30 sec. The tubes were capped and 
mixed, head-over-head for 30 min. Following centrifugation at 3500 rpm for 20 min at 
4°C, the resulting supernatant was immediately decanted o ff and diluted w ith 10 ml ion- 
exchange dilution buffer (see section 4.3.2 d). This solution was then loaded in 3 ml 
aliquots, onto an SPE column conditioned w ith 5 ml methanol, followed by 5 m l water, 
followed by 5 ml dilution buffer. After gravity elution, the column was washed w ith 2 
ml ion-exchange washing buffer (see section 4.3.2 d) and centrifuged at 3500 rpm for
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10 min. The analytes were eluted under vacuum with 2 ml elution solution (see section
4.3.2 d). 50 fd o f this solution was injected into the chromatographic system.
B) Milk analysis using immunoaffinity chromatography clean-up
A 5 ml m ilk sample was measured into a polypropylene tube and the sample was 
fortified as described in section 4.3.4. A 1 ml volume o f aqueous TCA (20 %) was 
added to the fortified sample, and the sample was vortexed for 30 sec. The tube was 
capped and mixed, head-over-head for 30 min. Following centrifugation at 3500 rpm 
for 20 min at 4°C, the resulting supernatant was immediately decanted o ff and diluted 
w ith 10 ml immunoaffinity dilution buffer (see section 4.3.2 e). This solution was 
loaded in 5 m l aliquots, onto the immunoaffinity column conditioned w ith 5 m l water, 
followed by 5 ml dilution buffer. After gravity elution, the column was washed w ith 3 
ml PBS. The analytes were eluted under gravity with 2.5 ml immunoaffinity elution 
solution (see section 4.3.2 e). 50 |il o f this solution was injected into the
chromatographic system.
C) Kidney analysis using immunoaffinity chromatography clean-up
5 g kidney samples were weighed into 50 ml plastic tubes. The samples were fortified 
as described in section 4.3.4, 30 ml water was added to each tube and the tubes 
incubated for 20 min at 80 °C. The samples were centrifuged at 3500 rpm for 20 min 
and the resulting supernatant decanted off. The immunoaffinity columns were 
conditioned using 3 x 3 ml distilled water. The supernatant was allowed to flow 
through the immunoaffinity column under gravity. Following sample loading, the 
columns were washed with 15 ml PBS, followed by elution o f analytes using 3 ml 
elution solution (see section 4.3.2 e). For tissue sample analysis, during sample loading 
it was necessary to restrict the flow from the column to approximately 1 ml min"1 to
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achieve the recoveries presented. Higher flow  rates resulted in lower recoveries due to 
incomplete analyte binding.
4.3.6 Method validation
A) Analysis o f  gentamicin, neomycin and kanamycin in milk using ion-exchange clean­
up
For method validation, samples were fortified w ith each analyte individually i.e. 
samples were not fortified with a mixture containing all three analytes. The maximum 
residue lim it set by the EU for the analysis o f neomycin in m ilk is 500 ppb. Samples 
were fortified at 62.5 ppb (1/8 x MRL), 125 ppb (1/4 x MRL), 250 ppb (1/2 x MRL), 
500 ppb (1 x MRL), 1000 ppb (2 x MRL) and 2500 ppb (5 x MRL). Five different 
samples were fortified at each level and analysed in one assay to assess the intra-assay 
variation. Inter-assay variation was assessed by the analysis o f one sample, fortified at 
each level, repeated over five separate assays. A  standard drug solution o f 
concentration equivalent to that o f the fortified sample was also analysed and included 
in a standard curve from which recovery was calculated. The MRL for gentamicin in 
m ilk is 100 ppb and this was assessed sim ilarly (samples were fortified at five levels o f 
fortification; 62.5, 125, 250, 500 and 2500 ppb). Recovery was estimated for the three 
components o f gentamicin (referred to as peak 1, 2 and 3). Kanamycin MRL in m ilk is 
500 ppb and samples were fortified at 100, 200, 500, 750 and 1000 ppb. The lowest 
level o f fortification used for kanamycin studies was higher than the lowest level 
employed for gentamicin and neomycin due to the presence o f slight matrix interference 
affecting kanamycin, as this was the earliest o f the three analytes to elute. The high 
peak intensity o f the kanamycin derivative caused a deviation from linearity at high 
analyte concentrations, therefore the highest level assayed was 1000 ppb.
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B) Analysis o f  gentamicin in milk using immunoaffinity chromatography 
Intra-assay validation was carried out on five m ilk samples fortified at 50 ppb, five m ilk 
samples fortified at 100 ppb and five m ilk samples fortified a 200 ppb, using the method 
described in section 4.3.5 (B). Inter-assay validation was also carried out at 50, 100 and 
200 ppb, over five separate assays.
C) Analysis o f  gentamicin in kidney using immunoaffinity chromatography 
Intra-assay validation was carried out on three kidney samples fortified at 50 ppb, three 
kidney samples fortified at 100 ppb and three kidney samples fortified a 200 ppb using 
the method described in section 4.3.5 (C). These levels are well below the maximum 
residue lim it o f 1000 ppb for kidney, set by the EU. Inter-assay validation was also 
carried out at 50, 100 and 200 ppb, over 3 separate assays.
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4.4. RESULTS & DISCUSSION
4.4.1 Introduction
Method development and validation results are discussed in  this section. Development 
o f the chromatographic method is presented. Extraction o f the analytes from m ilk w ith 
ion-exchange clean-up is discussed. Immunoafflnity chromatography applications are 
discussed and the results for validation o f the method based on ion-exchange and 
immunoafflnity chromatography are compared.
4.4.2 Chromatography
Chromatographic analysis o f aminoglycosides is challenging due to the basic nature o f 
these analytes and the absence o f UV chromophores on the molecules. Liquid 
chromatography o f basic compounds may have tailing peaks, which are d ifficu lt to 
quantify and result in lower lim its o f detection. The primary cause o f tailing for basic 
analytes is the presence o f residual silanols on the HPLC column backbone. Despite 
advances in stationary phase packing, for example, the advent o f type B silica, polymer 
based packing, silica still dominates as the backbone material.
For the analysis o f basic compounds, most analysts work at low mobile phase pH in an 
effort to suppress silanol ionisation. However, basic analytes are positively charged 
under these conditions, therefore they are highly polar and elute o ff reversed-phase 
columns very quickly. Therefore, ion-pair chromatography is commonly employed. 
This can effectively change the charge on the column and so the polar analytes can be 
retained longer. This form o f chromatography has associated problems: a) the slow
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equilibration o f the ion-pair reagent between the stationary and mobile phase requires 
long equilibration times and, therefore use o f gradient elution is unsuitable, b) ion-pair 
systems are more sensitive to temperature changes as temperature affects the 
equilibrium o f the ion-pair between the mobile phase and the column; in this study 
temperatures above 20°C were observed to result in poor peak shape, c) ion-pair 
systems often require high concentrations o f mobile phase modifiers, increasing the risk 
o f buffer precipitation, and d) there is greater likelihood for varying retention times, due 
to the long equilibration time required by ion-pair chromatography.
The absence o f significant UV chromophores in the aminoglycosides places further 
demands on the analyst. Typically, derivatisation has been employed, either in  pre- or 
post-column mode. Therefore, the mobile phase must not only be capable o f resolving 
the basic analytes but also be compatible with the derivatisation reagent employed. A 
chromatographic method employing ion-pair chromatography has potentially poor 
reproducibility and the inclusion o f a derivatisation step serves to increase its potential 
for high variation.
4.4.2.1 Column choice
The first parameter to be investigated was the choice o f column. Despite the fact that 
one o f the aims o f the study was to employ derivatisation, UV detection was considered 
more desirable for this step as it would allow assessment o f the native analyte 
separation by the column prior to derivatisation. However, a UV scan o f the three 
analytes showed no UV absorbance above 190 nm, so UV detection o f the native 
analytes was not possible. Therefore, it was concluded that derivatisation was 
necessary for detection, and post-column derivatisation proved the most successful.
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The first column tested was a Waters C18 (xBondapak column (3.9 x 300 mm). The
48mobile phase employed was a modification o f that employed by Caturla and Cusido , 
who used ion-pair chromatography for the separation o f kanamycin and amikacin. The 
mobile phase buffer was composed o f heptane sulfonic acid, as the ion-pair, in the 
presence o f sodium sulphate and potassium phosphate. In the in itia l chromatographic 
studies a mobile phase o f 50 % buffer (containing heptane sulfonic acid as an ion-pair) 
was used. However, this resulted in co-elution o f the derivatives w ith the solvent front. 
A mobile phase with 70 % buffer proved better for eluting peaks later, but peak shape 
still remained broad and tailing. Attempts to improve peak shape by varying mobile 
phase additives (ion-pair and modifier) proved unsuccessful, so an alternative column o f 
different packing material was investigated.
A Lichrosphere 100 C l8 column (5 (ini, Merck) was used which had spherical packing 
particles offering the possibility o f increased reproducibility. However, this column 
eluted all analytes at the same retention time, failed to separate the derivatised 
components and displayed severe peak tailing. A  Lichrosphere 60 RP-Select B column 
(5 fim, Merck) was also tested. This base-deactivated column was expected to perform 
better for the analysis o f the basic aminoglycosides. Using a mobile phase containing 
70 % ion-pair buffer and 30 % methanol, partial separation o f the three gentamicin 
components was achieved. Peak shape was also noted to improve but peaks remained 
broad. One peak was obtained for kanamycin, and one peak obtained for neomycin, but 
both peaks were affected by extreme tailing. Variation in mobile phase flow  rate and 
modifier content failed to improve the peak shape and resolution o f the gentamicin 
components.
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Glass columns were then investigated. A  10 cm Lichropshpere C8 glass column was 
tested, but failed to resolve gentamicin into its various components. Kanamycin eluted 
as a broad tailing peak and neomycin eluted as one peak which had a slight “ shoulder” . 
A  10 cm Chromsphere glass C l 8 column was employed which improved neomycin and 
kanamycin tailing considerably and resolved gentamicin into three peaks. Figure 4.2 
shows the peak shape and resolution for the three analytes on the Lichrosphere RP- 
Select B column and on the Chromsphere C l8 column. To ensure the improvement in 
chromatography was due to the nature o f the packing material, a Chromsphere glass C8 
column was tested, for comparison with the Lichrosphere glass C8 column. Both C8 
columns resulted in shorter retention than the C l8, but the Chromsphere C8 column 
gave the best resolution for gentamicin, which was resolved as four peaks. The first 
peak exhibited very low peak intensity and the next two peaks were partially resolved. 
Neomycin was resolved relatively free from tailing, but it was now resolved as two 
peaks, one o f which exhibited low peak intensity. Kanamycin was resolved as one 
peak, with good peak shape. When the concentration o f analyte was dropped form 10 
pg ml"1 to 0.1 fig m l'1, the peaks o f low intensity were no longer apparent, therefore, 
they were not considered in quantitative analysis. The Chromsphere C8 glass column 
was employed in all further studies. The chromatograms in Figures 4.3-4.6 show peak 
shape and resolution, in standards and samples fortified with gentamicin, neomycin and 
kanamycin, using the C8 Chromsphere column. In conclusion, comparing the peak 
shape and resolution obtained using a Lichrosphere stainless steel column w ith a 
Lichrosphere glass column, peak shape was slightly better using the glass column. 
However, comparing the glass Lichrosphere column with a glass Chromsphere column, 
both C8 columns o f similar dimension, showed the Chromsphere packing to result in 
much better chromatography. Comparison o f the glass C l8 Chromsphere w ith the
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shorter chain length (C8), showed the C8 column resulted in shorter retention times but 
less tailing, particularly for neomycin.
4.4.2.2 Mobile phase
The effect o f mobile phase pH on retention and peak shape was investigated. Buffers 
were prepared at pH 2.5, 3.0 and 4.0. Buffer o f pH 2.5 was observed to give the best 
peak shape and resolution o f gentamicin derivatives. As the pH was increased to pH 
4.0, the peak area increased, but peaks became broader and resolution decreased. It is 
likely that the lower pH provides the best chromatographic conditions (due to reduced 
silanol activity) but the higher mobile phase pH resulted in higher intensities as it is 
closer to the optimum pH for the derivatisation reaction. A  compromise o f pH 3.5 was 
chosen to give both acceptable peak shape and intensity.
It became evident that it was necessary to maintain the column in mobile phase to 
achieve adequate chromatography. Rinsing o f the column removed some o f the ion-pair 
that built up on the column surface. The ion-pair acts by binding to the residual silanols 
and so rinsing o f the column can result in exposure o f these silanols to the analytes 
causing tailing and poor separation. The longer the column is equilibrated in an ion-pair 
environment, the greater the amount o f ion-pair likely to build up until an equilibrium is 
established, and the greater the charge on the surface o f the column. Occasionally, 
peaks were seen to be broad and poorly resolved. This could be rectified usually by 
rinsing the column in a gradient manner, starting w ith a mobile phase o f high water 
content and gradually changing to high methanol content and back to high percentage 
water.
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Many papers report good separation o f aminoglycoside antibiotics using volatile acids 
such as polyflouroacetic acid or triflouroacetic acid. These acids act as ion-pairs, 
facilitating analyte retention, and their volatile nature renders them suitable for mass 
spectrometric detection. Non-volatile salts such as the heptane sulfonic acid used in this 
study are unsuitable for mass spectrometric detection, so the use o f a perfluorinated acid 
was tested so that samples found positive by the post-column method could be 
confirmed by mass spectrometry. However, attempts to combine a mobile phase 
containing triflouroacetic acid with post-column derivatisation resulted in a highly 
coloured solution, which masked the detection o f the analytes.
The effect o f sodium sulphate in the mobile phase was investigated. Sodium sulphate is 
thought to compete with the aminoglycosides for the free silanol groups in the column 
packing material, therefore an increase in the sodium sulphate concentration may result 
in improved peak shape. A  decrease in the concentration o f sodium sulphate (from 0.05 
M) resulted in late elution o f analytes and peaks o f low intensity. The delayed retention 
is likely due to the increased polarity o f the sulphate ion relative to the sulphonate used 
as the ion-pair. Therefore, the sulphate ion is likely competing with the ion-pair for 
binding to the column and a decrease in sulphate ion concentration allows more ion-pair 
to bind, resulting in greater retention o f the analytes. An increase in the concentration 
o f sodium sulphate above 0.05 M was observed to have no effect, possibly due to the 
fact that the glass column provides few free silanol groups.
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Figure 4.2 Chromatograms showing peak shapes and resolution on the Lichrosphere
RP-Select B column, and the Chromsphere, glass C l 8 column.
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Figure 4.3 Chromatogram showing a control milk sample and a milk sample 
fortified at 100 ppb with gentamicin and analysed using ion-exchange 
SPE.
HPLC Conditions; Mobile phase: 70 % buffer [hcptanesulphonic acid sodium salt (0.01 M), sodium 
sulphate (0.05 M), potassium dihydrogen phosphate (0.01 M)], 30 % methanol, at 0.3 ml min'1. Injection 
volume: 50 ul, Post-column reagent: 7.5 mM OPA, containing mercaptoethanol (0.05 %) in borate buffer 
(0.5 M, pH 10), at a flow rate of 0.6 ml min1. Fluorescence detection 340 ran (Ex), 440 nm (Em).
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Figure 4.4 Chromatogram showing a control kidney sample and a kidney sample 
fortified at 100 ppb with gentamicin and analysed using immunoaffinity 
chromatography.
HPLC Conditions; Mobile phase: 70 % buffer [heptanesulphonic acid sodium salt (0.01 M), sodium 
sulphate (0.05 M), potassium dihydrogen phosphate (0.01 M)j, 30 % methanol, at 0.3 ml min'1. Injection 
volume: 50 ul, Post-column reagent: 7.5 mM OPA, containing mercaptoethanol (0.05 %) in borate buffer 
(0.5 M, pH 10), at a flow rate of 0.6 ml min'1. Fluorescence detection 340 nm (Ex), 440 nm (Em).
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Figure 4.5 Chromatogram showing a control milk sample and a milk sample 
fortified at 100 ppb with kanamycin and analysed using ion-exchange 
SPE.
HPLC Conditions; Mobile phase: 70 % buffer [heptanesulphonic acid sodium salt (0.01 M), sodium 
sulphate (0.05 M), potassium dihydrogen phosphate (0.01 M)j, 30 % methanol, at 0.3 ml min'1. Injection 
volume: 50 ul, Post-column reagent: 7.5 mM OPA, containing mercaptoethauol (0.05 %) in borate buffer 
(0.5 M, pH 10), at a flow rate of 0.6 ml min'1. Fluorescence detection 340 nm (Ex), 440 nm (Em).
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Many authors have reported that aminoglycoside antibiotics absorb to stainless steel. 
The system employed in itia lly  contained a stainless steel injection loop and stainless 
steel column end-fittings. These were replaced with polyetheretherketone (PEEK) 
fittings in an effort to improve neomycin tailing. The addition o f PEEK fittings was 
seen to decrease the extent o f variation; however neomycin still suffered some tailing. 
The bar chart in Figure 4.7 illustrates the decrease in variation in peak height when the 
stainless steel fittings were replaced by PEEK fittings. Variation for gentamicin is 
relatively high due to the fact that the peaks were not completely baseline resolved.
4.4.2.3 System fittings
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Figure 4 .7 Bar chart demonstrating the variation in peak height fo r  gentamicin at
1 fig  m l1, neomycin at 1 jug ml'1 and kanamycin at 0.1 /J.g ml'1 using 
PEEK and stainless steel (SS) HPLC fittings.
4.4.2.4 Standard diluent
The composition o f the standard diluent was investigated in an effort to improve peak 
shape. Mobile phase, water and 0.1 M hydrochloric acid were studied. Hydrochloric
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acid was used as the compounds all possess very basic properties and liquid 
chromatography o f basic compounds has been traditionally carried out at acidic pH, in 
an effort to reduce the activity o f the residual silanols (by preventing their ionisation). 
Therefore it was postulated that dissolving the analytes in acid would result in  better 
peak shapes.
When water was used as the standard diluent, carry-over was observed. Carryover was 
caused by the absorption o f the highly basic aminoglycosides to the stainless steel 
fittings o f the HPLC system. When the diluent was changcd to 0.1 M  hydrochloric 
acid, the carry-over problem did not occur. However, it was necessary to allow the 
column a 10 to 15 re-equilibration time between acidic injections. The acidic diluent 
was capable o f stripping the ion-pair from the column, so re-equilibration was 
necessary. The acidic diluent resulted in taller peaks but neomycin still suffered tailing. 
Deterioration in  peak shape and peak intensity after several injections in  acid diluent 
was evident for gentamicin and neomycin but not for kanamycin.
Therefore, HPLC mobile phase was used as the standard diluent for further 
investigations. The acidic nature o f this diluent, containing ion-pair reagent, prevented 
the carry-over problem observed when using water but without requiring column re­
equilibration which was necessary when using hydrochloric acid. Changing the 
standard diluent from water to HPLC mobile phase resulted in increased peak intensity, 
but base-line resolution was not achieved for the gentamicin peaks, when water was 
used as the diluent.
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Having improved chromatography by using PEEK fittings and employing a glass 
column, sample diluent was again investigated, as peak shapes were now more 
quantitative. The following diluents, 100 % water, 100 % mobile phase buffer, 70/30 
v/v buffer/methanol (which is mobile phase), and 70/30 v/v water/methanol were 
investigated, with respect to linearity and reproducibility for all three analytes.
Table 4.1 Variation in peak height of multiple injections of the same standard
in various diluents, using PEEK fittings.
Coefficient o f  variation (%>), n=5
Diluent
Neo (2 j.ig ml'1) Kan (0.1 fig ml'1) Gent (1 fig ml'1)
Water 4.4 7-8 27.8,13.7,7.0*
Buffer 0.8 2A 2.7, 8.2, 5.9
Mobile phase 4.9 3-° 11.9, 6.2, 2.6*
70/30
water/methanol 7.9 11.9 8.0
* Multiple values for CV for an analyte refer to the different peaks separated
Table 4.1 illustrates the effect o f the various diluents on reproducibility.
When water was used as the diluent, the analytes were retained longer on the 
column resulting in broad peaks, poor resolution o f the three gentamicin peaks, 
and high variation in peak response.
When 70/30 water/methanol was used as the diluent, gentamicin resolution was 
lost and eluted as one peak. Variation was also found to be relatively high for all 
three analytes.
Mobile phase showed relatively low variation for most peaks. Gentamicin was 
resolved as three peaks, however, variation was high for the first peak, possibly
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due to the fact that base-line resolution was not achieved between the first and 
second gentamicin peak. Neomycin and kanamycin eluted as one peak each, 
with low variation.
Mobile phase buffer showed the best resolution and the lowest variation for all 
three analytes and the gentamicin peaks were separated. This may be due to the 
presence o f ion-pair in this sample diluent; some authors have reported the 
inclusion o f ion-pair reagent to sample extracts prior to injection into the 
chromatographic system to achieve adequate peak shape49.
Linearity was assessed between 0 and 2 (ig m l'1 for gentamicin and neomycin and 
between 0 and 0.4 |ig m l'1 for kanamycin. Using buffer and mobile phase as diluents, 
R2 values o f 0.99 to 1.0 were obtained for each peak o f each analyte, demonstrating the 
method to be linear in the range studied.
During sample analysis, analytes were eluted o ff the SPE in citric acid buffer (0.05 M) 
containing sodium sulphate (0.01 M). This diluent was observed to result in a slight 
loss o f resolution o f gentamicin peaks 1 and 2 relative to when mobile phase buffer was 
used as the diluent. Standards were prepared in citric acid-sodium sulphate buffer 
containing each o f the three mobile phase buffer components separately (heptane 
sulfonic acid, sodium sulphate and potassium dihydrogen phosphate). The addition o f 
potassium dihydrogen phosphate resulted in a loss o f baseline resolution for all 
gentamicin peaks. The addition o f sodium sulphate also resulted in a loss o f baseline 
resolution for the gentamicin peaks, but the addition o f the ion-pair reagent (heptane 
sulfonic acid solution) was seen to restore resolution. However, peak intensity
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decreased by approximately 10 %, so unmodified citric acid buffer-sodium sulphate 
was employed as the standard and sample diluent.
4.4.3 Storage of standards
Stock solutions o f 100 |ig m l'1 o f each analyte were prepared in water and stored at 4°C 
in polypropylene containers. Due to the hydrophilic nature o f the aminoglycoside 
molecules, they are susceptible to adsorption to glass. This theory was confirmed by 
storing standards in glass and polypropylene and subjecting them to analysis after two 
weeks storage at 4°C. The peak intensity o f the standards stored in glass remained the 
same for neomycin, but decreased by an average o f approximately 10 % for gentamicin 
and kanamycin.
4.4.4 Derivatisation conditions
From the literature, derivatisation using OPA proved to be most commonly applied to 
aminoglycoside analysis and also appeared to be the most sensitive. Addition o f this 
non-polar group may also assist retention o f the analytes on the column. Pre-column 
derivatisation was in itia lly  investigated, resulting in a highly conjugated product, which 
could be detected at 350 nm, or by fluorescence detection at 340 mn (Ex) and 440 nm 
(Em).
The pre-column derivatisation reagent used (OPA in the presence o f mercaptoethanol),
AQ
was similar to that employed by Caturla and Cusido . A t an analyte concentration o f 
20 |i.g m l'1 two peaks were obtained for gentamicin, one peak o f low intensity for 
neomycin, and kanamycin displayed one peak but poor reproducibility. Peak shapes
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were notably broad and tailing. The mobile phase composition was changed from 50 % 
buffer to 70 % buffer which resulted in improved peak shape but caused the derivatives 
to elute o ff the column more quickly and so only one gentamicin peak was free from the 
solvent front. Therefore, post-column derivatisation was investigated. The post-column 
reaction was optimised in an attempt to maximise sensitivity. The first parameter 
optimised was the reagent flow rate. The reagent flow rate was varied while the mobile 
phase flow rate was kept constant, at 0.3 ml min"1. A higher mobile phase flow rate 
resulted in faster elution and a decrease in the resolution o f the gentamicin peaks. Also, 
at higher mobile phase flow rates, peak intensity was reduced due to greater dilution o f 
the derivatives with mobile phase. Figure 4.8 shows the response o f gentamicin peak 3 
to increasing the post-column reagent flow rate. Although gentamicin peak 3 was 
chosen for demonstration purposes, a similar trend was observed for all other 
gentamicin peaks. A  flow rate o f 0.9 ml m in '1 is seen to be optimum at a mobile phase 
flow rate o f 0.3 m l m in'1. Increasing the post-column reagent flow rate resulted in 
increased peak intensity but also in loss o f baseline resolution for the gentamicin peaks. 
A  reagent flow rate o f 0.6 ml min' 1 provided the best trade-off between peak intensity 
and resolution.
The effect o f varying the reaction coil length and internal diameter was also investigated 
in an effort to restore resolution. This experiment was carried out on gentamicin, as this 
was the only analyte where multiple peaks were required to be resolved. The coil 
length was first decreased (from 100 cm to 60 cm) resulting in an improvement in the 
resolution between peaks 1 and 2 o f gentamicin, however baseline resolution was still 
not achieved. While maintaining the coil length at 60 cm, the internal diameter was 
changed from 0.08 cm to 0.05 cm, which again assisted resolution o f peaks 1 and 2.
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This internal diameter was maintained and coils o f 180 cm and 30 cm length were 
tested; however, the longer coil resulted in loss o f resolution o f gentamicin peaks 1 and 
2 and the shorter coil resulted in a noisy baseline, due to non-ideal mixing. Therefore, 
the coil length was maintained at 60 cm and the internal diameter dropped to 0.05 cm. 
This coil gave the best compromise between baseline noise and gentamicin peak 
resolution. Gentamicin peaks 1 and 2 were still not completely baseline separated as is 
evident in the chromatogram in Figure 4.3.
Figure 4.8 The effect ofpost-column reagent flow  rate on the height o f  gentamicin
peak 3 at a mobile phase flow  rate o f 0.3 ml m in 1.
Attempts to increase peak separation by increasing the analyte retention time on the 
column were unsuccessful. Increasing the concentration o f ion-pair in the mobile phase 
resulted in loss o f gentamicin resolution and a decrease in peak intensity. Inclusion o f 
EDTA in the mobile phase did not assist analyte resolution and caused ion-pair 
precipitation during over-night chromatographic runs. Various ratios o f organic
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modifier to buffer were tested but no improvement was achieved. The nature o f the 
modifier was not found to improve peak resolution.
4.4.4.1 Optimisation o f  borate buffer p H
The graph in Figure 4.9 shows the results o f borate buffer pH investigations. It shows 
that the pH o f the post-column reagent is critical and that optimum pH o f borate buffer 
is 11. The actual pH at which the reaction occurs is due to a combination o f the mobile 
phase pH and the post-column reagent pH. Above and below a pH o f 11, the peak 
intensity is reduced as the reaction is not occurring at its optimum pH o f 7-8. Standards 
o f 0.25 fig m l'1 were chosen, as this was the concentration equivalent to the M RL (500 
ppb) using the method described.
Figure 4.9 Optimisation o f  borate buffer p H fo r  derivatisation o f  gentamicin, 
neomycin and kanamycin, all at 0.25 /-ig ml"y.
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Borate buffer concentration of 0.5 M was employed in the preparation of the 
derivatising reagent. From the graph in Figure 4.10, peak intensity was lower, below 
this concentration. Below 0.5 M, it is likely that the buffering capacity of the solution is 
not sufficient to maintain the optimum reaction pH in the mixing tee and reaction coil. 
A slight increase in peak intensity was observed at buffer concentrations beyond 0.5 M, 
however, higher concentrations, caused intrumental problems.
4.4.4.2 Optimisation o f  borate buffer concentration
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Figure 4.10 Optimisation o f borate buffer concentration fo r  derivatisation o f  
gentamicin, neomycin and kanamycin, all at 0.25 fig ml'1.
4.4.4.3 Optimisation o f  OPA concentration
From the graph in Figure 4.11, an OPA solution of 100 mg 100 ml' 1 results in high peak 
intensity for a 0.25 (ig ml' 1 analyte solution. There was no significant increase in peak 
intensity beyond this concentration.
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Figure 4.11 Optimisation o f OPA concentration for the derivatisation o f gentamicin,
neomycin and kanamycin, all at 0.25 /jg m l1.
4.4.4.4 Mercaptoethanol volume
This is the catalytic agent for the derivatisation reaction, therefore it is important to 
ensure that this reagent is not limiting the reaction. Using a 100 mg 100 ml"1 OPA 
solution, 25 /il mercaptoethanol was observed to be sufficient for the derivatisation of 
0.25 fig ml’1 analyte solution. Figure 4.12 below shows the volume of the 
mercaptoethanol to be one of the less critical parameters.
Figure 4.12 Optimisation o f mercaptoethanol volume fo r  derivatisation o f 
gentamicin, neomycin and kanamycin, all at 0.25 fig ml'1.
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Derivatisation of aminoglycosides using OPA suffers from instability in both pre­
column and post-column mode. The derivatives show limited stability using pre­
column derivatisation and the derivatisation reagent shows limited stability using the 
post-column method. For post-column derivatisation, the reagent is composed of OPA 
in the presence of mercaptoethanol. The solution is prepared in borate buffer buffer pH
11.0 as this basic pH is necessary to allow the reaction to occur. At this high pH, 
secondary reactions occur over-time within the reagent itself, thereby reducing its 
ability to derivatise the analytes. It is postulated that lowering of the pH would reduce 
these secondary reactions and so remove the problem of instability. However, to allow 
the derivatisation reaction to occur it would be necessary to increase the post-column 
mobile phase to a more basic pH. The post-column mobile phase may be made basic by 
the introduction of sodium hydroxide, after the column and before the introduction of 
OPA, as in Figure 4.13. In addition to overcoming the instability problem, it was 
suspected that the two solution system might increase the specificity of the method. In 
the one solution method, the post-column mobile phase combines with the basic pH and 
derivatising reagent together, at the same point in time. Using the two-solution method, 
the post-column mobile phase is made basic firstly and any susceptible substances 
present were reduced by the sodium hydroxide, before combining with the 
derivatisation reagent (OPA).
4.4.4.5 Two solution post-column derivatisation studies
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Figure 4.13 Schematic o f two solvent post-column derivatisation system.
The one solvent and two solvent systems were evaluated with respect to reproducibility, 
linearity, baseline noise, peak shape and specificity. Various concentrations of OPA 
were compared. Peak intensity was reduced using the two solvent system and the 
variation in peak height was generally greater. Peak shape and retention times were 
similar using both systems. Despite the inclusion of mixing coils before and after 
mixing tee 2 (see Figure 4.13), baseline noise was greater using the two solvent system, 
resulting in a less sensitive method. The reagent lifetime of the OPA/mercaptoethanol 
solution (used in the two solvent method) was increased relative to the 
OPA/mercaptoethanol/borate buffer solution (used in the one solvent system). With 
respect to linearity over the range 0.125 to 2.5 p.g ml"1, the increased variation of the 
two solvent system caused R2 values to be reduced from 0.99 for the one solution 
system to 0.97 for the two solution system. Fortified samples were also investigated, as 
it was suspected that the two solvent system might be more specific, with less matrix
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co-extractives evident in the chromatogram. However, chromatograms were similar 
with respect to matrix interferences and the reduced peak intensity of the two solvent 
system made quantitation more difficult. Therefore, the classical one-solvent post­
column derivatisation configuration was employed for further investigations.
4.4.5 Sample extraction
The first step commonly employed in the analysis of antibiotics in complex matrices is 
a deproteinisation step. The presence of proteins can interfere with clean-up and 
derivatisation and cause fouling of the analytical column. Sar et a l23 reported the use of 
trichloroacetic acid (TCA) to deproteinise tissue samples. In this study, TCA (20 %) 
proved successful in producing a clear supernatant following mixing and centrifugation 
of milk samples. 30 min shaking in a head-over-head mixing device was found to be 
necessary to achieve intimate mixing of the TCA with the milk sample; shorter mixing 
time resulted in a cloudy supernatant following centrifugation, which took longer to 
flow through the SPE column. Following centrifugation, a firm pellet remained 
allowing the supernatant to be decanted off. Most milk samples also had a thin fatty 
layer on the surface of the supernatant, however, this adhered to the plastic tube while 
the supernatant was decanted off.
4.4.6 Sample clean-up using ion-exchange
Due to the basic nature of the aminoglycosides, it was decided to investigate the use of 
carboxylic acid columns for their clean-up. These columns possess carboxylic acid 
(COOH) groups which are capable of trapping analytes possessing positive functional 
groups, such as the amine groups of the aminoglycosides. To ensure retention of the
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analytes on the cation-exchange column it was necessary to dilute the acidic supernatant 
with a basic buffer. In an acidic environment the acidic groups on the column are fully 
protonated and so the analytes will pass through unretained. In a basic/neutral 
environment, the carboxylic acid groups are unprotonated (COO") and capable of 
retaining positively charged species. At pH of 7.0 or above the amino groups of the 
aminoglycosides exists as positive ions and so are trapped on the activated column. The 
bar chart in Figure 4.14 shows the effect of citric acid buffer solutions (0.05 M) of 
various pH values on analyte retention; citric acid buffer pH 10 was found to give 
maximum retention. The peak height response for gentamicin peak 3 (last eluting peak) 
is shown, but retention was similar for all gentamicin components.
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Figure 4.14 Bar chart o f the optimisation o f the SPE loading buffer pH for  
gentamicin peak 3 at 2 / ig ml'1.
Dilution of the acidic supernatant in 5 ml pH 10 buffer resulted a solution of around pH 
8, in preparation for SPE. Steps taken to increase the sample extract to pH 10 did not 
result in a significant increase in recovery. Based on the SPE cation-exchange theory 
already discussed, the analytes could be removed from the column by an acidic buffer.
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HC1 (0.1 M) proved capable of eluting the analytes off the column. However, studies 
on the effect of sample diluent for chromatography (section 4.4.2.4) showed that 
continuous injection of analytes in HC1 (0.1 M) required reconditioning of the column 
at regular intervals. Citric acid buffer, pH 3.0, was found to elute the analytes off the 
column, but 4 ml of this solution was required to achieve elution from the SPE column. 
Inclusion of sodium sulphate with the citric acid buffer resulted in elution of the 
analytes in 2 ml, resulting in a final solution twice as concentrated. The sodium 
sulphate provides positive ions capable of competing with and displacing the 
aminoglycosides off the carboxylic acid column. Sodium sulphate alone was suitable 
for analyte elution, but it was necessary to adjust the pH to be similar to when citric acid 
is present. The citric acid-sodium sulphate solution was pH 2 on preparation. It was 
feared that continuous injection of such an acidic solution onto a reversed-phase column 
might affect the column so attempts were made to elute the analytes off the SPE in a 
solution of higher pH or containing an organic modifier. However, recovery was 
reduced when those solutions were used. Ultimately, continuous injection of the citric 
acid-sodium sulphate solution did not affect the column performance, so this was 
employed for SPE elution.
Following loading of the SPE column, a wash step was applied to remove matrix 
interferences. Initially, a water wash was investigated; however, matrix co-extractives 
still interfered with the resolution of neomycin and kanamycin and peak 1 of 
gentamicin. Since elution in citric acid buffer required 4 ml volume, it was considered 
that a volume of 2 ml might be used to elute matrix components without causing elution 
of the analytes. Table 4.2 shows the effect of column washing with citric acid buffer of 
various pH values.
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Table 4.2 The effect of citric acid buffer (0.05 M, 2 ml) of various pH values as 
an SPE wash solution.
Buffer pH Gentamicin eluted 
in wash
Neomycin eluted in 
wash
Kanamycin eluted 
in wash
Citric Acid Buffer, 
pH 2.0 / S y
Citric Acid Buffer, 
pH 3.0
X X s
Citric Acid Buffer, 
pH 4.0
X X X
Further investigation showed that 2 ml of citric acid buffer, (pH 3.5, 0.05 M) was the 
most effective wash solution in removing matrix interferences without analyte elution. 
Increasing the citric acid concentration to 0.10 M resulted in analyte losses in the wash 
solvent. Applying the sample to the SPE column using 0.05 M citric acid buffer, pH
10.0 as the diluent, washing the column with 0.05 M citric acid buffer pH 3.5 and 
eluting in citric acid buffer containing sodium sulphate resulted in chromatograms 
showing no interference with the 3 peaks of gentamicin, neomycin resolved from the 
matrix and kanamycin eluting close to a small matrix peak. Attempts to remove this 
interference through sample extraction with sodium hydroxide and acetonitrile, and 
through varying the nature and concentration of the SPE wash and elution, proved 
unsuccessful.
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4. 4.7 Validation results for the analysis of gentamicin, neomycin and kanamycin 
in milk, using ion-exchange SPE.
The validation plan for the analysis of gentamicin, neomycin and kanamycin in milk 
samples, using ion-exchange SPE has been described in section 4.2.6. Intra- and inter­
assay results for the determination of gentamicin (three components), neomycin and 
kanamycin in milk were determined. Recoveries in the range 62-100 % were obtained. 
The intra-assay results for the determination of gentamicin is shown in Table 4.3. 
Gentamicin recovery was assessed for the three components and the method proved to 
be equally capable of recovering all three components. In Table 4.3, variation is seen to 
be highest at the high level of fortification, 2500 ppb and at the lowest level of 
fortification, 62.5 ppb.
Table 4.3 Intra-assay variation for the determination of gentamicin residues in 
milk (2 ml) using ion-exchange SPE, n=5.
Mean Recovery (%) + SD
Fortification 
Level (ppb)
Gentamicin 
Peak 1
Gentamicin 
Peak 2
Gentamicin 
Peak 3
62.5 110 ± 8.6 72 ±9.0 96. ±4.4
125 64 ±4.3 74 ±3.6 84 ±7.7
250 72 ±2.6 62 ±3.9 77 ± 8.8
500 78 ± 4.1 80 ±5.4 82 ±5.1
1000 87 ±5.3 96 ± 12.4 97 ±4.3
2500 72 ± 13.1 99 ± 16.0 99 ± 16.6
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Intra-assay results for neomycin presented in Table 4.4, show acceptable recoveries, in 
the range 69-100 % with relatively low variation. As expected, the highest variation is 
at the lowest level of fortification, 62.5 ppb. Variation is low at all other levels of 
fortification and neomycin intra-assay recovery shows less variation than gentamicin 
intra-assay recovery.
Table 4.4 Intra-assay variation for the determination of neomycin in milk (2 
ml), using ion-exchange SPE, n=5.
Fortification 
Level (ppb)
Mean recovery 
(%) ± SD
62.5 92 ± 9.6
125 100 ± 0.2
250 94 ±3.5
500 76 ± 1.9
1000 69 ± 1.1
2500 82 ±5.8
Intra-assay results for kanamycin show the highest recovery and lowest variation for all 
three analytes. The results presented in Table 4.5 show the highest percentage 
coefficient of variation to be 6.7 %, and as with neomycin, this value is for the lowest 
level of fortification. Good peak shape and high peak intensity account for the low 
variation for kanamycin. Recovery was consistently high at all levels of fortification.
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Table 4.5 Intra-assay variation for the determination of kanamycin in milk (2 
ml), using ion-exchange SPE, n = 5
Fortification 
Level (ppb)
Mean recovery (%) ± SD
100 88 ±5.9
200 108 ±2.4
500 102 ± 1.6
750 95 ±3.2
1000 101 ± 1.2
Inter-assay results show similar percentage recoveries with higher variation. The bar 
chart in Figure 4.15 shows the percentage recovery and standard deviation (error bars) 
for samples fortified at six levels with gentamicin. Recoveries are in the range 60-99 
%, similar to the intra-assay results. The variation is seen to be high (standard deviation 
values between 16 to 19) at the lowest level of fortification, 62.5 ppb. Most other peaks 
had standard deviation values ranging between 7 and 10. Two exceptions are a standard 
deviation of 13 % on peak 1 at 2500 ppb and a standard deviation of 14 % on peak 2 at 
125 ppb. The method is seen to perform similarly for all three gentamicin peaks as the 
percentage recovery and standard deviations are similar for all three peaks.
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Figure 4.15 Bar chart demonstrating the between-assay recovery (percentage mean) 
and standard deviation (error bars) for the three gentamicin components 
in milk using ion-exchange solid-phase extraction, n=5.
The bar chart in Figure 4.16 shows the inter-assay percentage recovery and standard 
deviation (error bars) for samples fortified with neomycin. The percentage recoveries 
were in the range 64 to 99 %, similar to intra-assay results. Variation was seen to be 
somewhat lower than gentamicin inter-assay variation, with standard deviation values in 
the range 8.0 to 11.5 . Recovery was high (99 %) but variation was not elevated at the 
low level of fortification (standard deviation of 8). Kanamycin inter-assay results, 
shown in Figure 4.17, show high recoveries (86 to 109 %), similar to the intra-assay 
results. Variation in the percentage recovery was relatively similar at all levels of 
fortification (11.6 to 14 .7 standard deviation). As expected, variation was higher for 
inter-assay results relative to intra-assay results.
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Figure 4.16 Bar chart demonstrating the between-assay recovery (percentage mean) 
and standard deviation (error bars) for neomycin in milk using ion- 
exchange solid-phase extraction, n=5.
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Figure 4.17 Bar chart demonstrating the between-assay recovery (percentage mean) 
and standard deviation (error bars) for kanamycin in milk using ion- 
exchange solid-phase extraction, n=5.
4.4.8 Immunoaffinity column chromatography
Attempts to analyse the aminoglycosides in porcine muscle, liver and kidney, using the 
ion-exchange method developed for milk samples failed. The availability of antibodies
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to neomycin and gentamicin allowed immunoaffinity column chromatography to be 
assessed, as a clean-up step.
The aim of this part of the study was to investigate the analysis of neomycin and 
gentamicin using immunoaffinity column chromatography and apply the developed 
method to the clean-up of milk and tissue extracts. While the initial studies on binding 
and elution were carried out using standard drug solutions, it became obvious that the 
neomycin antibody was of inferior quality, as it possessed low coupling efficiency and 
low recoveries with high variation when it was employed for sample analysis. 
Therefore studies in milk and tissue were confined to gentamicin only. The limit of 
determination for the method was 30 ppb for gentamicin in milk and kidney. The 
method was validated at 50, 100 and 200 ppb using intra- and inter-assays. The 
validated method was also applied to the analysis of porcine muscle and liver, and veal 
muscle. More matrix interference was evident in liver extracts causing gentamicin peak 
1 to elute on the matrix front. Also, recoveries were low; in the region of 30 %. This 
may due to fact that the extraction technique applied was optimised for kidney analysis, 
and further investigations into sample extraction may enable the application of 
immunoaffinity clean-up to other tissue extracts. In developing the immunoaffinity 
method, various optimisation experiments were carried out, which will be discussed in 
the following sections.
4.4.8.1 Optimisation o f the loading solution
The presence of high salt has previously been observed to weaken antibody binding of 
streptomycin. [Haasnoot, W., Unpublished data] Therefore it was considered necessary 
to investigate the effects of salt concentration for neomycin and gentamicin binding.
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Solutions of varying salt concentration were prepared and used as sample diluents for 
standard drug solutions such as water, PBS, citric acid buffer of 0.0005 M, 0.005 M, 
0.05 M. The column was first conditioned with 6 ml water followed by 6 ml of the 
loading solution. The results are presented in Figure 4.18. The results for gentamicin 
peak 3 only arc presented, but the results for all gentamicin peaks were similar, as the 
antibody responded similarly to all gcntamicin components.
Figure 4.18 Peak heights resulting from employing solutions o f varying salt 
concentration as immunoaffinity column loading solvents (n=2).
PBS : Phosphate buffered saline, CAB : Citric acid buffer.
It was evident that the lower the concentration of citric acid buffer, the better the 
binding affinity for neomycin. This trend was not observed for gentamicin; at the lower 
gentamicin concentration, binding was reduced. For the analysis of milk samples, the 
samples were first deproteinised using acid; since the extract was acidic in nature it was 
unsuitable for application to an immunoaffinity column. It was necessary to dilute the
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acidic extract in a solution capable of adjusting the pH to near neutral. Low citric acid 
buffer concentrations (0.0005 M) were insufficient to achieve pH adjustment in milk 
samples. Water and PBS proved to be suitable loading solvents, but they were 
unsuitable for pH adjustment. Therefore, citric acid buffer was necessary and a 
concentration of 0.005 M was chosen for optimum binding efficiency of gentamicin and 
neomycin in sample extracts.
The pH of the loading solution was also investigated. Solutions of neomycin and 
gentamicin were prepared in citric acid buffer, 0.005 M, of varying pH. The solutions 
were loaded onto a pre-conditioned immunoaffinity column, the eluate collected, the 
column washed with PBS (3 ml) and eluted with citric acid buffer containing sodium 
sulphate (4 ml). Table 4.6 shows that retention on the column is increased as pH 
increases from 2 to 8. Loading analytes in diluent of pH 2 results in incomplete 
retention on the column for both analytes. Loading at pH 4 results in incomplete 
retention for neomycin but gentamicin was retained until the elution step. Loading at 
pH 6 results in some loss of neomycin in the eluate from the loading step and complete 
retention of gentamicin until the elution step. Finally, loading at pH 8 allows retention 
of both analytes until the elution step. Therefore, loading gentamicin at a pH of 4 or 
above ensures retention on the column. However, to ensure complete retention of 
neomycin on the column, the pH of the loading solution must be above 6 . A citric acid 
buffer solution of 0.005 M, pH 7.0 was finally chosen as the loading solution.
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Table 4.6 Gentamicin and neomycin responses (peak height, mm) found in the 
loading solution and eluting solution when citric acid buffer of pH 
2.0, 4.0, 6.0 and 8.0 were used as loading solutions.
Loading solutions
Antibiotic Solution pH 2.0 pH 4.0 pH 6.0 pH 8.0
Gentamicin Loading 20 0 0 0
Eluting 8 21 20 23
Neomycin Loading 29 13 6 0
Eluting 6 29 40 41
Experiments were carried out to verify that this solution was capable of adjusting the 
pH of acidic extracts to achieve analyte retention on the immunoaffinity column. 
Extracts were diluted in citric acid buffer (0.005 M) of pH 6.0, 7.0, 8.0, 9.0 and 10.0. 
Results were not significantly different, proving citric acid buffer pH 7.0, 0.005 M to 
adjust the pH of the extract sufficiently.
4.4.8.2 Optimisation o f  the washing solution
Initial studies showed that when water was employed as the column wash solution, the 
gentamicin peaks exhibited poor resolution when chromatographed. This is likely 
caused by a dilution of the salt concentration in the eluting solution, caused by some of 
the wash solution (water) still on the immunoaffinity column. Best chromatographic 
resolution was observed using PBS as the wash solution while use of citric acid buffer 
provided no significant advantage in removal of matrix or peak resolution. The volume 
of PBS employed as the wash was varied for the analysis of samples. For milk samples,
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increasing the wash solution volume beyond the volume of the column (3 ml) did not 
assist in reducing the matrix, but all analytes eluted free of matrix interferences using 
this volume. For kidney extracts, when 3 ml PBS was used as the wash solution 
gentamicin peak 1 eluted on the descending portion of the matrix peak, and increasing 
the wash up to 20 ml served to reduce the size of the matrix peak so that gentamicin 
peak 1 was resolved from matrix interferences.
4.4.83 Immunoaffinity column elution
Desorption of the analyte involves cleavage of the antigen-antibody complex. Ideally, 
the antigen-antibody complex is dissociated and the analyte eluted without damage to 
the antibody. The binding of the antigen (analyte) to the antibody is described as 
follows :
Ab + Ag «-> AbAg where Ka = [AbAg]/[Ab] [Ag]
where Ka is the affinity of the antibody for the antigen and Ka must be reduced to allow 
analyte elution. This reduction can be achieved using buffers, chaotropic ions or 
organic modifiers. Buffers of high or low pH are commonly used to elute analytes in 
immunoaffinity column chromatography. A change in pH can result in a change in the 
ionic interactions between the antigen-antibody complex. In this study, ion-pairing 
chromatography was employed together with post-column derivatisation. Section
4.4.2.4 outlines the importance of sample diluent in achieving adequate peak shape and 
intensity. Citric acid buffer, containing sodium sulphate was previously employed in the 
elution of the analytes from ion-exchange columns. This solution was of low pH and 
proved suitable for the chromatographic system employed for quantitation. It also 
proved capable of eluting the analytes from the immunoaffinity column, as the low pH
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together with the sodium sulphate salt causes sufficient changes in the ionic interaction 
of the antigen antibody complex to elute the analyte.
4.4.8.4 Determination o f  the coupling efficiency
In immunoaffmity column chromatography, as with SPE, there is a concentration of 
analyte beyond which the column is incapable of binding any further analyte molecules. 
This “breakthrough” volume is used to establish the coupling efficiency of the column, 
that is the maximum concentration of analyte the column can retain. From the previous 
study, using lon-exchangc, protein precipitation of milk samples was achieved using 
TCA, so the sample extract was acidic. Optimisation of immunoaffinity loading solvent 
studies show that the analyte will not be effectively retained by the column at low pH, 
therefore it was necessary to dilute the extract in citric acid buffer, to bring the sample 
near to pH 7. For this reason, coupling efficiency experiments were carried out using 
standard drug solutions prepared in this buffer. Fractions were loaded and the eluate 
collected and analysed. Figure 4.19 shows slight traces of neomycin breakthrough at 
2200 ng with complete breakthrough at 2300 ng. The gentamicin column exhibited 
much higher coupling efficiency with complete breakthrough at 7500 ng. The lower 
coupling efficiency for the neomycin column reflects the poor quality of the antibody, 
which became evident when samples were analysed.
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Figure 4.19 Determination o f the coupling efficiency for gentamicin and neomycin 
immunoaffinity columns. The concentration o f  analyte in the loading 
solution, shown on the x-axis, is collected on exit from the column.
4.4.8.5 Column regeneration and re-usability
The elution conditions developed, should allow the reduction of Ka (allowing release of 
the analyte) to be a reversible process, so that prolonged use of the column is permitted. 
After every experiment columns were washed with 20 ml water, followed by 10 ml PBS 
before being stored at 4°C in PBS containing sodium azide (0.5 %). Between each 
sample the column was washed with water (3 ml), elution solution (3 ml) and loading 
solvent (5 ml) in preparation for the next sample. Re-use of columns involves a risk of 
cross-contamination between samples, but control (blank) samples analysed after 
samples fortified at 200 ppb, showed no evidence of cross-contamination. For the 
analysis of milk samples, the same column was employed for up to 30 samples. For 
kidney samples, column re-usability was permissible when 1 g of kidney was employed, 
but when 5 g was employed, the column became saturated after 5 samples and the flow 
through the column became restricted.
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The specificity of the gentamicin antibody was assessed using the following analytes, 
all at 0.5 (J.g ml"1: gentamicin, neomycin, kanamycin, streptomycin,
dihydro streptomycin, spectinomyicn, lincomycin, and salinomycin. The analytes were 
applied onto the column in 1 ml volume, followed by 10 ml PBS wash and 2.5 ml citric 
acid buffer-sodium sulphate elution. The elution solution was analysed using 
hydrophilic interaction chromatography-MS (Chapter 5) and no analytes other than 
gentamicin were detected.
4.4.9 Validation results for the analysis of gentamicin in milk and kidney tissue 
using immunoaffinity column chromatography
Validation of the immunoaffinity column chromatography method is described in 
section 4.2.6. Intra-assay results are presented in Table 4.7 for milk samples fortified at 
three levels with gentamicin, and analysed using immunoaffinity column 
chromatography. Inter-assay results for milk samples analysed using immunoaffinity 
chromatography, are presented in Figure 4.20. Recoveries were in the range 63 to 82 %. 
The bar-chart shows standard deviation values (error bars) were in the range 4.9 to 12.8.
Attempts to analyse tissue samples using the ion-exchange method resulted in excessive 
matrix co-extractives. However, the application of immunoaffinity chromatography 
allowed the analysis of gentamicin residues in kidney. A typical chromatogram is 
shown in Figure 4.4. Intra-assay results are presented in Table 4.8. The intra-assay 
results show the recovery of gentamicin in kidney (63-78 %) to be reduced relative to 
milk samples, but recoveries are within the range reported by other authors and
• ?1 90 _
validation studies were carried out at limits below most published methods ’ . The
4.4.8.6 Specificity o f  gentamicin antibody
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standard deviation values were similar to the values obtained for the analysis of milk 
samples analysed by immunoaffinity column chromatography. The results show that 
the immunoaffinity column performs similarly for all three gentamicin peaks, and 
exhibits no bias towards any of the three forms of gentamicin under study.
Table 4.7 Intra-assay variation for the determination of gentamicin in milk 
using immunoaffinity column chromatography, n=5.
Mean Recovery (%) ± SD
Fortification Gentamicin Gentamicin Gentamicin
Level (ppb) Peak 1 Peak 2 Peak 3
50 77 ±8.4 85 ±8.5 84 ±7.5
100 96 ± 7.2 95 ± 13 100 ± 15
200 75 ± 2.3 72 ±4.9 69 ±5.3
100
200 100 50
Fortification Level (ppb)
Figure 4.20 Bar chart demonstrating the between-assay recovery (percentage mean) 
and standard deviation (error bars) fo r the three gentamicin components 
in milk using immunoaffinity chromatography n=5.
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Table 4.8 Intra-assay variation in recovery for the determination of gentamicin 
in kidney (5 g), using immunoaffinity column chromatography, n=3.
Mean Recovery (%) ± SD
Fortification Gentamicin Gentamicin Gentamicin
Level (ppb) Peak 1 Peak 2 Peak 3
50 78 ±4.2 63 ±5.9 74 ±8.9
100 66 ± 13 67 ±6.3 66 ± 8.1
200 73 ± 6.6 68 ± 9.2 73 ±5.7
The inter-assay results for the analysis of kidney samples fortified with gentamicin and 
analysed using immunoaffinity column chromatography, are presented in Figure 4.20. 
Recoveries were in the range 55 to 79 %, with standard deviation (error bars) in the 
range 3.8 to 20. 6 . The variation for peak 2 was consistently higher, with standard 
deviation values of 13.8 to 18.8. Since a similar trend in variation was not observed for 
the analysis of peak 2 in standards or milk samples using immunoaffinity column 
chromatography, it is unlikely that peak 2 variation is related to the performance of the 
immunoaffinity column for this form of gentamicin. The high variation may be due to 
incomplete baseline resolution, as is evident in Figure 4.4. Alternatively this form of 
gentamicin is not as easily extracted from kidney tissue as peak 1 and 3.
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Figure 4.21 Bar chart demonstrating the between-assay recovery (percentage mean) 
and standard deviation (error bars) fo r the three gentamicin components 
in kidney using immunoaffinity column chromatography, n=3.
4.4.10 Comparison of ion-exchange SPE with immunoaffinity clean-up
Application of immunaffinity column chromatography clean-up allowed the analysis of 
gentamcin residues in kidney tissue. For gentamicin residue analysis in milk, the limit 
of determination achieved using immunoaffinity column chromatography was 50 ppb 
compared with 62.5 ppb using ion-exchange. Comparison of intra-assay results for 
milk samples analysed using ion-exchange with those from milk samples analysed by 
immunoaffinity column chromatography show similar recoveries. Variation in recovery 
was observed to be slighty higher for samples analysed using immunoaffinity column 
chromatography; For samples fortified between 50 and 200 ppb, and analysed by 
immunoaffinity column chromatography, standard deviation values ranging between
2.3 and 15 were obtained. For samples fortified between 65 to 250 ppb, and analysed 
by ion-exchange, standard deviation values were in the range 2.6 to 9.0. The greater 
variation may be due to reduced baseline resolution of samples analysed using
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immunoaffmity column chromatography, due to the larger sample volume employed for 
analysis. Comparison of the inter-assay recovery for samples fortified in the range 50 to 
200 ppb and analysed using immunoaffmity column chromatography, show recovery 
was slightly reduced relative to sample fortified in the range 62.5 to 250 ppb and 
analysed using ion-exchange. For samples analysed using immunoaffmity column 
chromatography, recoveries were in the range 64 to 82 % with standard deviation values 
in the range 5 to 13. Using ion-exchange, recoveries for samples fortified between 62.5 
and 250 ppb fortification were in the range 60 to 99 % with standard deviation values in 
the range 9 to 19. Therefore, both ion-exchange SPE and immunoaffmity column 
chromatography are suitable for the analysis of gentamicin in milk samples, and both 
methods perform similarly with respect to recovery and variation in recovery. However, 
lower limits of determination can be achieved using immunoaffmity column 
chromatography, due to its increased sample capacity.
4.5 CONCLUSION
The results of the study give an insight into the behaviour of the three aminoglycosides, 
gentamicin, neomycin and kanamycin, under various chromatographic conditions. 
Chromsphere, C8 packing material was seen to give the best chromatographic 
resolution and peak shape for these analytes. For ion-pair chromatography, the addition 
of sodium sulphate in the mobile phase serves to increase retention of these polar 
analytes on the reversed-phase material and long equilibration times are required, to 
maintain consistent retention times, using this ion-pair method. To minimise variation, 
it is necessary to employ inert PEEK fittings, for aminoglycoside HPLC analysis, and to
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employ polypropylene containers for analyte storage. The derivatisation conditions for 
the OPA derivatisation of the three analytes were optimised.
The results show that ion-exchange solid-phase extraction is a suitable clean-up 
technique for the analysis of gentamicin, neomycin and kanamycin in milk. 
ImmunoafBnity column chromatography is also suitable for the analysis of gentamicin 
in milk, and for the clean-up of gentamicin residues in kidney tissue, providing a quick, 
simple method that results in chromatograms free of matrix interference. Both 
techniques are capable of analysing samples fortified at levels well below MRLs set by 
the EU.
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THE ANALYSIS OF 
AMINOGLYCOSIDE ANTIBIOTICS USING 
HYDROPHILIC INTERACTION CHROMATOGRAPHY 
WITH MASS SPECTROMETRIC DETECTION.
CHAPTER 5
2 6 4
5.1 INTRODUCTION
Lack of significant UV chromophores necessitates the use of derivatisation techniques 
for aminoglycoside detection using conventional HPLC detectors. These techniques are 
not highly specific and they can exhibit non-linearity and increase method variation. 
Therefore, mass spectrometric detection is of particular interest for the analysis of 
aminoglycoside antibiotic residues, allowing direct detection of the separated analytes. 
MS detection is a confirmatory technique, which exhibits specificity, sensitivity, wide 
applicability and it is quantitative. However, HPLC-MS analysis of aminoglycosides 
has proven problematic, due to the necessity for ion-pair chromatography. HPLC 
methods which require the use of non-volatile mobile phase reagents are unsuitable 
when detection by MS is employed. Ion-pair sulphonate salts are most commonly 
employed, which are incompatible with MS detection, due to ion suppression, where the 
mobile phase constituents ionise in preference to the analytes. The aim of this study 
was to investigate the use of hydrophilic interaction chromatography for the analysis of 
some aminoglycosides and related compounds.
5.1.1 Direct detection techniques for aminoglycoside analysis
Methods reported for the analysis of aminoglycoside residues have been discussed in 
Chapter 4, so the discussion here will be limited to direct detection techniques and other 
MS methods reported. Direct detection techniques used in combination with LC for 
aminoglycosides include refractive index detection and optical rotation. Refractive 
index detection has been employed by Inchauspe and Scmain1, following HPLC 
separation of eight aminoglycosides, but the authors worked at concentrations beyond
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that of interest to residue analysts (~ 40 |ig/injection). They employed ion-pair 
chromatography, using volatile perfluorcarboxylic acid as the ion-pair. UV detection at 
195 nm has been employed for the detection of streptomycin and dihydrostreptomycin 
in preparative mode2. This wavelength is unsuitable for the analysis of residues in 
biological samples, due to the presence of co-extracted matrix components, which 
absorb at this wavelength.
Optical activity allows the use of polarimetry to detect neomycin . Direct detection by 
pulsed amperometry has also been cited4. The presence of amino and hydroxyl groups 
on the aminoglycoside antibiotics provide electrochemical activity. Statler5 used it in 
combination with anion-exchange chromatography, for the analysis of tobramycin in 
pharmaceutical injectables. To facilitate oxidation of the analyte at the gold electrode 
surface, it was found necessary to adjust the column eluate to pH 13, by post-column 
addition of sodium hydroxide. The minimum detection limit was 2 ng (10 ul injected 
on column). Gentamicin was detected using a carbon electrode6, and the linearity was 
assessed between the limit of detection of 16 jig up to 30 fag. The authors comment that 
concentration of buffer in the mobile phase was crucial to the sensitivity of the method. 
Pulsed electrochemical detection has been employed for the analysis of neomycin7 
using a polymeric column and ion-pair chromatography, but stability problems were 
encountered and the method exhibited high variability.
5.1.2 Mass spectrometric detection for aminoglycoside analysis
No G O  MS method has been published for the analysis of aminoglycoside antibiotics 
and most LC-MS methods are limited to the analysis of pure drug solutions. Aside
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from the method reported by McLaughlin and Henion14, no methods have been
published for the analysis of aminoglycosides in tissues. Various moving belt type
• 8interfaces were investigated for the analysis of kanamycin, tobramycin and neamine . 
Chemical ionisation using ammonia was employed and the method was used for 
molecular weight determination. Time of flight plasma desorption mass spectrometry 
(TOFPDMS) has been reported for the analysis of eleven aminoglycosides9. Positive 
ion monitoring was employed, resulting in strong molecular ions. The authors also 
investigated derivatisation of the nine analytes with dinitrophenyl prior to MS detection, 
as the derivatives proved more readily extractable from an aqueous solution.
Dihydro streptomycin was determined by continuous flow fast atom bombardment (CF- 
FAB) using capillary HPLC10. Capillary LC offered superior chromatographic 
efficiency and lower mobile phase flow rates, so that the entire LC effluent could be 
introduced into the MS. The protonated molecular ion, (M+H)+ of dihydrostreptomycin 
was detected down to 4.4 ng. Gentamicin analysis has been described by Getek et al.n 
using a thermospray (TS) interface and at least three components were identified. 
Thermospray ionisation was employed with trifluroacetic acid and ammonium acetate 
in the mobile phase. For aminoglycosides, TS-MS produces low intensity molecular 
ions (M + H)+, but high intensity fragments. Sakairi and Kambara12 have detected 
kanamycin and gentamicin, amongst other analytes, using LC-MS. The gentamicin 
components were not separated by the LC system, but they have different spectra, while 
the kanamycin components were separated. Atmospheric pressure chemical ionisation 
(APCI) was applied and sensitivity was enhanced by employing selective ion 
monitoring (SIM), where only the specific aminoglycoside ions were recorded. 
Detection limits between 1 and 50 ng were reported for the various components.
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Some authors have reported the use of volatile fluorinated carboxylic acids in the 
mobile phase, for aminoglycoside separation with MS detection. These acids are 
volatile and therefore compatible with MS detection, but it has been the experience in 
our laboratory that, on the one hand, these acids may not provide adequate 
chromatography at low ion-pair concentrations while, on the other hand, sensitivity was 
poor when acid concentration was high. Inchauspe et al.13 also reported a decrease in 
the buffering capacity of perfluorinated carboxylic acids at low concentrations. 
McLaughlin and Henion14 reported the use of heptafluorobutyric acid (HFBA) and 
pentafluoropropionic acid (PFPA) for the separation of streptomycin, 
dihydrostreptomycin, spectinomycin and hygromycin B in bovine kidney, but 
confirmation was not possible at the MRL levels (20 ppb for hygromycin B, 100 ppb for 
spectinomycin and 500 ppb for streptomycin and dihydrostreptomycin) without further 
pre-concentration. In a later publication1^ , these authors employed PFPA as the ion-pair 
for the analysis of neomycin, gentamicin, streptomycin, dihydrostreptomycin, 
spectinomycin and hygromycin B in kidney. A pre-concentration step was included, to 
improve the limit of determination of the assay, thereby allowing detection of 
streptomycin and dihydrostreptomycin at MRL levels. Ion-spray MS was employed in 
both studies. It was reported that the retention times of analytes in the presence of 
matrix varied from those of standard solutions. This was likely due to matrix 
components competing with the analytes for the ion-pair. These authors also 
experienced incompatibility problems with sample diluents when using ion-pair 
chromatography, and have reported column degradation during the analysis of tissue 
extracts. Therefore, an alternative chromatographic system, without the need for ion- 
pair reagents is required.
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Conboy et al.]6 employed an anion membrane suppresser for the MS detection of 
quaternary ammonium drugs. The authors reported removal of 99.9 % of the ion-pair 
agent (methanesulfonic acid) from the chromatography eluent, but the technique was 
not suitable for neutral species or analyte ions having the same charge as the ion-pair, as 
they could be removed also by the membrane. Ion chromatography systems have been
17hyphenated to MS, for the analysis of a wide variety of analytes. Milon and Bur used 
direct liquid introduction (DLI) LC-MS for the analysis of catecholamines using 
octylsulphonate ion-pair. However, severe sensitivity problems were encountered with 
large amounts of analyte being required to achieve a reasonable signal, the acidic pH 
was incompatible with most standard MS fittings and the method required very frequent 
cleaning of the source.
In this study, the use of hydrophilic interaction chromatography (HILIC) is investigated 
for the analysis of the basic aminoglycosides. The method offers an LC separation 
method without the need to employ an ion-pair in the mobile phase. HILIC is described 
as a variant of normal phase chromatography, therefore elution is expected in the order 
least to most polar; retention increases as the polarity of the analytes increase.
5.1.3 HILIC mechanism of action
In HILIC, the stationary phase of the HILIC column is hydrophilic in nature and the 
mobile phase is hydrophobic. The stationary phase used in this study was 
PolyHydroxyethyl Aspartamide™. This material is extremely polar and is bonded on a 
silica backbone in a stainless steel column. The mobile phase consists of organic 
solvent (acetonitrile) in high proportion and, for this study, MS compatible buffer. In
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HILIC, it is postulated that there is an immobile liquid phase between the stationary and 
mobile phase, as depicted in Figure 5.1, which is a result of the affinity of the aqueous 
content of the mobile phase for the polar stationary phase. Therefore, the stationary 
phase is polar, the mobile phase mainly organic and an immobile phase sandwiched in 
between these two phases, which is mainly aqueous. In contrast to normal phase 
chromatography, which involves the direct adsorption of the analytes onto the stationary 
phase, separation in HILIC is achieved by partitioning of the analytes between the 
largely aqueous immobile phase and the mainly organic mobile phase. Analyte 
retention is proportional to the affinity of the molecule for the immobile phase. 
Therefore, more polar analytes will partition longer in the more polar immobile phase 
and so take longer to elute.
Figure 5.1 Schematic o f the internal structure within a typical HILIC column.
JO
Alpert described the “contact region concept” to explain retention of peptides in the 
immobile phase. Analyte molecules orientate themselves so that the most polar end of 
the structure is in contact with the polar stationary phase (and so in the immobile
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aqueous phase), and the least polar end is in contact with the hydrophobic mobile phase. 
The greater the number of hydrophilic (basic) domains available on the outside of the 
molecule, the greater its affinity for the immobile phase and therefore the greater the 
retention. Alpert also stated that the basicity of a peptide promoted retention using 
HILIC, but to much lesser extent than observed with ion-exchange cliromatography. 
Therefore, the HILIC method may be suitable for multiresidue analysis o f analytes of 
various polarities.
5.1.4 Alternative HILIC applications
This form of chromatography has previously been reported for the analysis of 
peptides19. Extremely hydrophobic or hydrophilic peptides that were difficult to 
separate by conventional reversed-phase HPLC were separated, with good peak shape 
and resolution, using HILIC. HILIC has also been employed for the separation of 
glucose polymers20 using amperometric detection. Gradient elution allowed the 
separation of 20 components with low variability (less than 0.4 % RSD). The authors 
reported similar findings to those obtained in this study, with respect to the effect of 
buffer and modifier on analyte retention. HILIC was applied to the analysis of a large 
number of peptides21 and retention was observed to be in proportion to the basicity of 
the molecules. For peptide analysis the PolySulfoethyl Aspartamide column is most 
commonly employed, which is less polar than the packing material used in this study, 
but possesses charged surface groups. PolyGlycoplex and Polyol-RSiL (a silica phase, 
to which OH groups have been added) were employed for the analysis of complex 
carbohydrates22. Previously, carbohydrates had been separated on various polar-bonded
* ■ 9"?phase columns, such as silica bound amine .
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The basic nature o f aminoglycosides may render them suitable analytes for separation 
by HILIC, due to the presence o f hydrophilic amino groups and basic hydroxyl groups. 
Since reversed-phase chromatography is not very suitable for the analysis o f 
aminoglycosides and ion-pair chromatography is not compatible with MS detection, 
there is a need for an alternative separation method.
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5.2 EXPERIM ENTAL
5.2.1 Introduction
The aim of the study was to assess the suitability of HILIC for the analysis of 
aminoglycosides and related antibiotics. The chromatographic behaviour of gentamicin, 
neomycin and kanamycin were of particular interest, but streptomycin, 
dihydro streptomycin, lincomycin, salinomycin and spectinomycin were also
investigated. The structures are shown in Figure 5.2 (a). Gradient elution and APCI- 
MS detection were employed. The effect of acetonitrile, buffer concentration and pH on 
analyte retention and peak shape was investigated and the effect of packing material 
pore size was tested. Finally, linearity over the range 0.05-10 |ug ml"1 was confirmed, 
and milk and kidney extracts from gentamicin fortified samples were analysed by MS.
5.2.2 Chemicals and Reagents
a) Preparation o f standards
All solvents were of analytical HPLC grade, unless otherwise stated. Gentamicin 
(Gent), Neomycin (Neo), Kanamycin (Kan), Streptomycin (Strep),
Di hydro streptomycin (Dihydro), Lincomycin (Linco), Salinomycin (Sal) and
Spectinomycin (Spec) were purchased from Sigma-Aldrich Chemie BV, Zwjindrecht, 
The Netherlands. Stock solutions of 100 mg ml"1 were prepared in milli-Q water unless 
otherwise stated and stored in polyethylene tubes; these solutions had a shelf-life of two 
weeks when stored at 4°C.
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b) HPLC mobile phases
The organic modifier, acetonitrile, was filtered through a 0.45 (,im filter and sparged 
with helium prior to use. The buffer, ammonium acetate, purchased from Merck 
(Darmstadt, Germany) was prepared in water, at various concentrations and pH values. 
The pH was adjusted while continuously stirring, using formic acid. The buffer was 
also filtered and sparged, using helium, prior to use.
c) Samples (milk and Iridney)
Milk and kidney samples, fortified with gentamicin at 100 ppb, were extracted and 
cleaned-up by a procedure involving immunoaffinity column chromatography, as 
described in Chapter 4.
5.2.3 Instrumentation
Chromatography: 3 HILIC columns were investigated. The stationary packing was 
PolyHydroxyethyl A, 5|im, in each case. Further variations are shown in Table 5.1.
Table 5.1 HILIC columns investigated in this study.
Column Dimensions Pore Size
A 200 x 4.6 mm iooo A
B 200 x 2.1 mm loo A
C 200 x 4.6 mm 500 A
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Column A was a generous gift from PolyLC Inc., (Columbia, MD, USA) and the other 
columns were purchased from Poly LC. Gradient elution was employed using a 
quaternary pump (Thermoquest, The Netherlands) to deliver the mobile phase at a flow
rate of 0.5 ml min' 1 through column B, and 1.0 ml min' 1 through columns A and C. The
following gradient was employed, unless otherwise stated:
Step 1: At time = 0, 50 % Acetonitrile, 50 % buffer (ammonium acetate),
Step 2: At time = 5 min, 5 % Acetonitrile, 95 % buffer,
Step 3: At time =15 min, 5 % Acetonitrile, 95 % buffer,
Step 4: At time =18 min, 50 % Acetonitrile, 50 % buffer.
Experiments were earned out at room temperature (20°C) and injections (50 jal) were 
made using a Thermoquest AS3000 autosampler, with cooled sample tray.
Mass spectrometric parameters: The mass spectrometer used was a Thermoquest LCQ
(San Jose, CA, USA), equipped with an atmospheric pressure ion source, used in the
positive mode. Vaporisation setting: 500°C, Capillary temperature: 180°C, EM voltage: 
1500 V, EM gain: 8. The corona discharge needle was maintained at 5 kV with nitrogen 
sheath nebulisation gas at 70 % of the maximum and auxiliary gas at 20 % of the 
maximum. The data acquired was processed using the Thermoquest x-calibur™ 
software. Mass spectrometric parameters were optimised by continuous infusion of a 5 
|i.g m lA aqueous solution of gentamicin.
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Figure 5.2 (a) Chemical structures o f the analytes under study.
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5.3 RESULTS AND DISCUSSION
5.3.1 Introduction
The aim of the study was to carry out some initial investigations into the applicability of 
HILIC as a method for chromatographic separation for aminoglycosides and related 
compounds, and its compatibility with MS detection.
5.3.2 Mass spectrometry
LC-MS offers a combination of separation of analytes and a specific confirmatory 
detection technique. When interfacing liquid chromatography with MS detection, the 
interface must be capable of transferring the analyte from the LC column to the MS ion 
source. The major challenges faced are removal of mobile phase components and 
dealing with the pressure difference between the LC outlet and the mass analyser. The 
main problems encountered are 1) limitations on the quantity of analyte which may be 
introduced into the mass spectrometer, 2) the pumping capacity of the vacuum pump 
requires reduced LC flow rates, and 3) the mobile phase composition is restricted to 
volatile reagents. Advances in the instrumentation available have assisted in over­
coming problems 1 and 2, but for aminoglycoside analysis, problem 3 remains the main 
obstacle to successful LC-MS analysis. As discussed in section 5.1, the 
chromatographic systems commonly employed for aminoglycoside analysis present 
problems when linked to mass spectrometric detection, due to the necessity for ion-pair 
reagents in the mobile phase. Ideally, the HPLC eluent should be of low ionic strength 
and should not contain a high concentration of buffers/ion-pairs, which can compete 
with ionisation of the analyte, generate high chemical background or precipitate in the 
source. This has been a limitation especially for aminoglycosides, but with HILIC the 
use of ion-pair can be avoided, resulting in a potentially more sensitive method.
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Since the aim of the study was to investigate the use of HILIC for the MS-compatible 
separation of aminoglycosides, the detection method was not fully investigated initially. 
However, some MS parameters were optimised. The most important parameters were 
temperature of the capillary and vaporiser temperature. Using APCI, the LC effluent is 
sprayed from a capillary tube and converted into a fine mist by a heated nebuliser. The 
mist is carried (assisted by a flow of nitrogen) into a region where a corona discharge 
electrode is installed. Electrons produced by the corona discharge electrode initiate 
ionisation. The ions and any ion-solvent clusters that may exist are transferred from the 
atmospheric pressure region into the high vacuum region via a heated capillary. The 
resulting desolvated ions are introduced into the mass analyser.
Full scan mass spectra were obtained for all analytes and extracted ion chromatograms 
were constructed from the full scan data. The ions monitored are listed in Table 5.2. 
Other authors have reported better sensitivity using positive ion monitoring, therefore 
positive-ion spectra were investigated.
In full scan mode, spectra from sample extracts showed some early eluting matrix co­
extractives, but none of these eluted at the same retention times as the analytes of 
interest. However, the application of MS-MS eradicated the matrix peaks. Using MS- 
MS, the sample is ionised in the usual fashion, selected ions are induced to fragment 
and the fragments analysed according to their m/z ratios. Therefore, the result is a mass 
spectrum of the selected ion. The fragment ions resulting from the three gentamicin 
components are shown in Table 5.3. Figure 5.3 shows the results of HILIC-MS analysis 
of a kidney extract, fortified with gentamicin at 100 ppb. The three molecular ions were 
detected and the fragment ions of the C la ion (Gent 1) are also shown.
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Table 5.2 Mass of the molecular ions, [M + H]+ detected for each analyte
Analyte m/z
Gentamicin (C|a) 450
Gentamicin (C2) 464
Gentamicin (Ci) 478
Neomycin 615
Kanamycin 485
Lincomycin 407
Salinomycin 773
Streptomycin 582
Dihydrostreptomycin 584
Spectinomycin 333
Table 5.3 Fragments observed for each component of gentamicin by MS-MS.
Component /M+Ilj A B C D
CI 450 322 163 160
C2 464 322 163 160 143
Cla 478 322 163 160
Fragments A and C were monitored in milk and kidney samples fortified at 100 ppb. 
This level corresponds to the MRL for gentamicin in milk and is well below the MRL 
for gentamicin in kidney (1000 ppb).
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Figure 5.2 (b) shows the postulated origin of each fragment for the three components of 
gentamicin. Each component had a distinctive molecular ion, which was evident in full 
scan mode. The m/z ratios differ due to varying number of methyl groups (R2 and R3). 
These molecular ions all gave rise to fragment ions A, m/z 322, B, m/z 163 and C, m/z 
160. Molecular ion C2 also gave rise to a fragment of m/z 143, which differs from Cl 
and Cl a due to the variation in R2 and R3. From Figure 5.2 (a), it is evident that 
fragments A, B and C contain no R groups and so these fragment ions were identical for 
all components.
5.3.3 Method development for HILIC
Initial studies on the effect of acetonitrile and buffer on chromatography were carried 
out using column A (1000 A pore size). This resulted in a chromatographic system that 
gave good retention and peak shape for the three gentamicin peaks, neomycin, 
kanamycin, spectinomycin, lincomycin and a split peak for dihydrostreptomycin. 
Salinomycin and streptomycin were not retained. The developed method was applied to 
columns B (100 A pore size) and C (500 A pore size), thereby allowing the effect of 
pore size to be investigated. The influence of the mobile phase buffer pH was also 
investigated and the method applied to milk and kidney sample extracts that contained 
gentamicin.
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5.3.3.1. The effect o f  acetonitrile on analyte retention
The effect of acetonitrile on analyte retention was investigated. The graph in Figure 5.4 
demonstrates the effect of the acetonitrile content in the initial mobile phase on analyte 
retention. The composition of the final mobile phase was 5 % acetonitrile /85 % water 
/10 % buffer (1000 mM). Similarl to that observed by Alpert for the analysis of 
peptides by HIL1C18, increasing acetonitrile composition of the mobile phase resulted in 
increased retention for most analytes. Alpert stated that increasing the organic solvent 
content of the mobile phase increased the selectivity of the sorbent to negatively 
charged peptide residues. He reported that the effect of the organic solvent content of 
the mobile phase was to have a major influence on retention of these negatively charged 
peptides, above 50 % (v/v) acetonitrile. In this study, similar effects were observed 
when the organic content of the initial mobile phase was increased from 0 to 90 % (v/v). 
Retention times increased between 20 and 70 % (v/v) acetonitrile content, after which 
the rate of increase was reduced. Above 40 % (v/v) acetonitrile, most of the analytes
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appear to be retained, resolution improved and retention increased for all analytes 
except salinomycin. Of the analytes studied, salinomycin exhibits little polarity, so it 
was poorly retained under all conditions. Neomycin, the most polar of the analytes 
studied, was retained the longest. The three gentamicin components were not 
completely resolved from each other, but the mass spectrometric detection employed 
allowed these components to be easily distinguished due to variation in the mass/charge 
ratio of the molecular ions.
Retention
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Figure 5.4 The effect o f the acetonitrile content in the initial mobile phase on analyte 
retention.
Figure 5.4 depicts the retention times resulting when the percentage acetonitrile was 
increased while the percentage of buffer was held constant (10 % of 1000 mM), and the 
remaining percentage was water. Therefore, as the percentage acetonitrile was 
increased, the water content was decreased (from 90 %, at 0 % acetonitrile to 0 %, at 90 
% acetonitrile), and so the molar concentration of buffer in the mobile phase also 
increased (from 100 to 1000 mM). To establish that the increase in retention time was a 
result of increasing acetonitrile, and not of increasing the molar concentration of buffer 
in the aqueous part, or a combination of both, the effect of increasing acetonitrile was
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investigated while keeping the buffer concentration of the mobile phase constant 
(Figure 5.5). The final mobile phase composition employed in this experiment was 5 % 
acetonitrile/65 % water/30 % buffer (1000 mM). The increase in retention times, with 
increasing acetonitrile, shown in this graph, supports the view that increasing the 
volume percent of acetonitrile resulted in increased retention, and any “levelling o ff’ of 
retention (as observed in Figure 5.4) may be due to high buffer concentration. The 
increased retention at high levels of acetonitrile may be due to proportionately more 
water being adsorbed to the polar stationary phase than is present in the flowing mobile 
phase causing the analytes to partition preferentially into this adsorbed, immobile layer 
and be retained longer. Nikolov and Reilly24 stated that the greater the polarity of the 
organic component of the mobile phase, the smaller the immobile phase, due to 
competition between both polar components of the mobile phase (organic and aqueous) 
for the polar adsorbent sites on the sorbent. Acetonitrile was used in preference to 
methanol, because it is relatively less polar, in order to promote formation of the 
immobile layer and increased retention of the polar analytes.
Figure 5.6 shows the effect of increasing the percentage volume of acetonitrile on 
neomycin retention while employing various percentages of 1000 mM buffer in the 
initial mobile phase. At each percentage buffer, the final mobile phase contained 5 % 
acetonitrile and similar percentages of buffer to that employed in the initial mobile 
phase. Neomycin is shown as this is the most polar analyte and the most responsive to 
changes in chromatographic conditions. Higher buffer content promotes earlier elution 
and under those conditions the influence of acetonitrile content on retention was not as 
important.
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Figure 5.5 The effect o f acetonitrile content in the initial mobile phase on analyte 
retention, at constant buffer concentration (100 mM) in the aqueous 
phase.
The effect of the acetonitrile content in the final mobile phase was also investigated. It 
was observed that as the percentage acetonitrile increased, analyte retention increased. 
However, the percentage acetonitrile in the final mobile phase had much less influence 
on retention time than acetonitrile content in the initial mobile phase.
Figure 5.6 The effect o f acetonitrile content in the initial mobile phase on neomycin 
retention, at various percentages o f1000 mM buffer.
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Reducing the quantity of buffer in the initial mobile phase promotes retention of the 
analytes, as shown in Figure 5.7. The results plotted were acquired at constant 
acetonitrile content (50 %) and using varying contents of ammonium acetate (1000 
mM), with water as the remainder, on column A. The final mobile phase contained 5 % 
acetonitrile and a similar buffer content to that employed in the initial mobile phase. 
The graph shows that spectinomycin, lincomycin, and salinomycin were not retained, at 
any content of buffer, under the conditions employed. At the lowest buffer content, 
longest retention and greater resolution was achieved, but peak shape for all analytes 
was poor and severe tailing was observed for neomycin. These results indicate that 
increasing the molarity of the immobile phase serves to decrease the affinity of the 
analytes for this phase, resulting in reduced retention.
53.3.2 The effect o f  buffer concentration on analyte retention
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Figure 5.7 The effect o f increasing buffer content in the initial mobile phase on 
analyte retention (ammonium acetate, 1000 mM).
Alpert18 reported a decrease in the retention of basic peptides (arginine and histidine) as 
the buffer concentration was increased. The graph in Figure 5.8 shows the effect of 
increasing the buffer content at various contents of acetonitrile, on neomycin retention.
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Again, the final mobile phase contained 5 % acetonitrile and a similar buffer content as 
that employed in the initial mobile phase. In general, retention was seen to decrease 
with increasing buffer content, but this effect was much less evident at low contents of 
acetonitrile.
The effect of buffer content in the final mobile phase on analyte retention was also 
investigated and observed to have a much smaller influence than the buffer content in 
the initial mobile phase. The lower the buffer content in the final mobile phase the 
greater the retention of the more polar analytes (neomycin, gentamicin and kanamycin), 
but no effect was observed on the retention of the less polar analytes (salinomycin, 
lincomycin and spectinomycin).
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Figure 5.8 The effect o f buffer content in the initial mobile phase on neomycin 
retention (ammonium acetate, 1000 mM).
Increasing the buffer content in the mobile phase is likely to cause a reduction in analyte 
retention as increased buffer would prevent water enrichment of the stationary phase, 
preventing or limiting the formation of the immobile phase. Reduction of the immobile
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phase may also result from competition of the buffer ions for the adsorptive sites on the 
packing material, and an increase in the polarity of the organic component of the mobile 
phase, due to the presence of dissolved buffer ions, may contribute to the reduced 
retention times. In conclusion, increasing the concentration of buffer in the initial 
mobile phase serves to decrease analyte retention.
5.3.3.3 The effect o f  buffer p H  on analyte retention
Ammonium acetate buffer was investigated at pH values between 3 and 6 . The graph in 
Figure 5.9 shows that as the pH of the mobile phase buffer was increased, retention also 
increased for most analytes. As the pH increases, the polarity of the mobile phase is 
increased, therefore the analytes partition more into the immobile, buffer phase and so 
are retained longer. This is in contrast to the observation by Alpert in the analysis of 
peptides where retention was inversely proportional to pH18. Using buffers at pH 3, 4, 
and 5, in general, retention was seen to decrease when the buffer concentration was 
increased from 10 to 100 mM. In this study, pH 5 was the lowest pH at which 
spectinomycin was retained on the column and increasing the pH to 6 did not result in 
greater retention, with lincomycin and salinomycin not being retained, even at pH 6 . 
The effect of pH was examined at a number of different buffer concentrations between 
10 and 500 mM. In conclusion, increasing the buffer pH served to increase the 
retention of the analytes.
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Figure 5.9 The effect o f buffer pH  on the retention o f  analytes, using ammonium 
acetate, prepared at 100 mM.
5.3.3.4 Peak shape
So far, discussion has been mainly centered on analyte retention. Retention is a very 
important parameter in the chromatographic analysis of aminoglycosides, as ion- 
exchange or ion-pair chromatography is almost always necessary to achieve retention. 
The peak shape of these basic analytes must also be considered. The effect of 
acetonitrile and buffer on peak asymmetry were considered. However, peak width was 
found to be a more suitable parameter to indicate peak shape as very broad peaks could 
give in good peak asymmetry values, close to 1, where peak tailing did not occur. 
Figure 5.10 shows how the measurements were made.
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Figure 5.10 Calculation o f peak asymmetry and peak width.
5.3.3.4.1 The effect o f  acetonitrile and buffer content o f  the initial mobile phase
on peak shape
When low concentrations of buffer were employed in the mobile phase, peak shape for 
some analytes was consistently poor, with peaks exhibiting end tailing. The plot in 
Figure 5.11 shows that as the buffer content of the initial mobile phase was increased, 
the peak width of neomycin decreased. This effect was evident at all mobile phase 
contents of acetonitrile. Neomycin, the most polar of the analytes was most susceptible 
to peak tailing. A similar, but less dramatic effect, was observed for the gentamicin 
peaks.
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Figure 5.11 The effect o f buffer content o f the mobile phase on neomycin peak width 
at various levels o f acetonitrile.
Figure 5.12 shows the effect of increasing the proportion of acetonitrile, on neomycin 
peak width, at various percentage contents of buffer in the initial mobile phase. Again, 
as the buffer content was increased, neomycin peak width decreased and in general, the 
of acetonitrile content of the initial mobile phase was seen to have little effect on peak 
width.
In summary, the conclusions on the effects of acetonitrile content, buffer concentration 
and buffer pH on analyte retention are that retention was promoted by low buffer 
content (section 5.3.3.2) and high acetonitrile content (section 5.3.3.1), but that high 
buffer content promotes narrower peaks. Therefore, optimum chromatographic 
conditions would incorporate high acetonitrile content in the initial mobile phase, to 
promote retention, and high buffer content to promote good peak shape, without 
reducing retention dramatically. Buffer pH should be above 3 to promote retention but, 
above pH 4, neomycin failed to elute within 40 minutes.
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Figure 5.12 The effect o f acetonitrile content on peak width fo r  neomycin at various 
buffer concentrations.
5.3.4 F ina l conditions using colum n A
To ensure good peak shape and a reasonable retention time for neomycin, a buffer of 
250 mM was used, adjusted to pH 4 with formic acid. For adequate retention 80 % 
acetonitrile was employed in the initial mobile phase. Higher acetonitrile content 
caused neomycin peak splitting and lower acetonitrile content caused lincomycin to 
elute as a broad peak and all analytes to have shorter retention times. Inclusion of 
buffer in the initial mobile phase resulted in lincomycin peak splitting and salinomycin 
peak broadening. Therefore, the initial mobile phase chosen was 80 % acetonitrile and 
20 % water but, because retention times were over long without buffer, over 5 minutes 
the mobile phase composition was changed linearly to 25 % acetonitrile and 75 % 250 
mM, pH 4.0 buffer. Figure 5.13 shows the chromatogram resulting when this mobile
phase system was employed, on column A (1000 A pore size).
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Three columns were investigated: Column A, with pore size 1000 A, Column B, with 
pore size 100 A and column C, with pore size 500 A. Satisfactory retention and peak 
shape were first achieved for most analytes on column A, using ammonium acetate 
prepared at a concentration of 250 mM (see Figure 5.13). Application of these 
optimised conditions to column B and C did not result in similar chromatography. 
Using the optimised buffer (250 mM ammonium acetate, pH 4) and column C (500 A), 
under a variety of initial and final mobile phase compositions, poor peak shape was 
observed for all analytes. Tailing was observed for gentamicin and kanamycin and split 
peaks observed for neomycin. By employing buffer prepared at 500 mM with column 
C, peak shape for most analytes improved, yet gentamicin peaks were broad and 
neomycin suffered tailing under a wide range of mobile phase conditions. On column B 
(100 A), using the optimum buffer (250 mM ammonium acetate, pH 4), peak shapes for 
lincomycin, streptomycin, dihydrostreptomycin, spectinomycin and kanamycin were 
adequate under a wide range of mobile phase conditions. However, retention of the less 
polar analytes proved more difficult to achieve on the 100 A column, when compared 
with the 500 A column, and peak shape for gentamicin and neomycin was inadequate 
using the 250 mM buffer. To achieve good peak shape for the more polar analytes with 
column B, it was necessary to employ ammonium acetate buffer at 500 mM. The best 
separation achievable with this column is shown in Figure 5.15. While the necessity to 
use 500 mM buffer (instead of 250 mM) resulted in decreased retention, it was possible 
to employ 100 % acetonitrile in the initial mobile phase, which helped increase 
retention and the final mobile phase change was to 5 % acetonitrile, 95 % buffer. Using 
either column A, B or C, as the buffer in the final mobile phase was decreased below 
125 mM, neomycin peak shape deteriorated rapidly, resulting in broad, split peaks.
5.3.5 Column pore size
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Alpert observed similar elimination of peak splitting at higher buffer concentration, in 
the analysis of peptides using HILJC18.
The effect of pH on peak shape was examined at a number of different buffer 
concentrations in the range 10-500 mM using columns B and C. It was observed that 
the higher the pH, the higher the buffer concentration necessary to achieve adequate 
peak shape. At low buffer concentrations (10, 50 and 100 mM), and pH 5 and 6, most 
analytes failed to elute within 30 minutes and tailing was observed when elution did 
occur. All three columns exhibited similar trends with respect to mobile phase 
composition; as the percentage acetonitrile was increased the retention increased and the 
acetonitrile content of the initial mobile phase was more influential that its content in 
the final mobile phase. In general, when using comparable mobile phase compositions, 
retention times were increased as the pore size decreased.
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Figure 5.13: Chromatogram 
aminoglycosides
showing the separation achieved for
WPLC C onditions ; 
M obile phase gradient ; 
@  1.0 ml m in '1.
Injection volum e ;
C olum n : Polyhydroxyelhyl Aspartanude™ , 200 x 4.6 m m , 5 um , I000A . 
80 %  acetonitrile, 20 %  250 mM  N H jA c, pH 4 at t=0,
25 %  acetonitrile, 75 %  250 m M  N H jA c, pH 4  at t=5 m in.
25 %  acetonitrile, 75 % 2 5 0  mM Nil.,Ac, pH 4 at t= I5  min.
80 %  acctonitrilc, 20 % 250 mM NH.,Ac, pH 4  a t= l 8 m in.,
50  ul o f  10 ug m l'1
295
5.3.6 Investigation of the effect of time taken to change from initial mobile phase 
conditions to final mobile phase conditions
All experiments, unless otherwise stated, were performed using a gradient which 
changed linearly between 0 and 5 min, remained until 15 min and changed back to the 
initial conditions by 18 min as outlined in section 5.2.3. Figure 5.14 shows that 
retention could be increased and resolution improved by increasing the initial gradient 
change time beyond 5 min. When the gradient was set to reach final conditions by 7.5 
min, tailing resulted for neomycin and a split peak for lincomycin. When the change­
time was set to 10 min, spectinomycin was retained well beyond the void volume but 
eluted as a broad peak, and neomycin exhibited end-tailing. When the change time was 
set to 15 min, all three gentamicin peaks were resolved from each other, but most other 
analytes exhibited poor peak shape. Therefore, when a complete multi-residue method 
is desired, for all the analytes listed, a change time of 5 min is sufficient. However, this 
time might be varied, to improve resolution, where a method is required for one or some 
of these analytes.
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Figure 5.14 The effect o f increasing the time taken to achieve the initial gradient 
change.
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Table 5.4. lists the analytes in decreasing order of retention, with neomycin being the 
most retained and salinomycin retained the least. Also shown are the number of amino 
groups (NH2) and number of hydroxyl groups (OH) on each molecule. These groups 
are shown as they are the functionalities responsible for the hydrophilicity of the 
molecules and so responsible for partitioning of the analytes within the immobile phase.
5.3.7. C hrom atography characteristics
Table 5.4 The number of hydroxyl (OH) and amino (NH2) functionalities on 
the aminoglycosides.
Number o f  OH groups Number o f  NH 2 groups
Neomycin 7 6
Gentamicin : Cl a 3 4
Gentamicin : C2 3 4
Gentamicin : Cl 3 3
Kanamycin 6/7 5/4
Streptomycin 8 2
Dihydrostreptomycin 8 2
Spectinomycin 3 0
Lincomycin 4 0
Salinomycin 4 0
The presence of the primary hydroxyl group on neomycin likely causes the increased 
retention of this analyte, as this functional group conveys high polarity to the molecule. 
In addition, the molecule contains six amino groups, resulting in a highly basic 
structure, which is likely to partition in the immobile phase to a relatively high degree.
Kanamycin also contains similar groups, in relatively high numbers, resulting in a polar 
molecule, which partitions into the immobile phase, resulting in relatively long 
retention. The gentamicin components are retained possibly due to the presence o f 
three or four amino groups. Amino groups are also likely to be responsible for the 
retention o f streptomycin and dihydrostreptomycin. Spectinomycin, lincomycin and 
salinomycin display poor retention characteristics due to the lack o f any amino groups. 
Table 5.5 shows the plate number (N) and peak asymmetry (A) values for the analytes,
obtained using column A  (1000 Á). The high retention achieved resulted in  high
column efficiency (N) for gentamicin, neomycin and kanamycin. Poor retention 
resulted in low column efficiency for spectinomycin and lincomycin and the poor 
retention together w ith band broadening is responsible for low column efficiency for 
salinomycin. Peak asymmetry was calculated as depicted in the diagram in Figure 5.10. 
An ideal gaussian peak shows a value o f one. In Table 5.5, the high asymmetry value 
for salinomycin is due to the end-tailing observed. Values o f less than one result for 
peaks affected by fronting.
Table 5.6 shows the chromatographic properties o f separations using optimised 
conditions for column B (100 A). Efficiency values (N) are low, relative to those
obtained for column A, due to the earlier elution o f the analytes and the slightly 
increased peak width. However, it is worth noting that the efficiency values for 
salinomycin increased using column B (under the optimised conditions for that column) 
compared to that obtained for column A. Peak asymmetry values were comparable for 
gentamicin and kanamycin, using both methods, but using column B, neomycin and
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spectinomycin exhibited some end-tailing resulting in elevated peak asymmetry values. 
Figure 5.15 shows the separation achieved using column B (100 A).
Table 5.5 Retention and efficiency data for aminoglycosides on column A
(1000 Â)
Retention
(mm)
Peak Width 
(mm)
Efficiency
(N)
Peak 
Asymmetry (A)
Neo 97.5 5.0 6084 1.56
Gent C la 80.0 5.0 4096 1.17
Gent C2 77.0 5.0 3795 1.0
Kan 73.5 4.0 5402 1.17
Gent C l 73.0 5.0 3411 1.40
Spec 39.0 6.0 676 1.25
Linco 23.0 4.0 529 0.80
Sal 13.5 7.0 60
, i - -1 ' -
4.50
HPLC Conditions : Column A, Mobile phase gradient at lml min'1 :
At time =0; 80/20 ACN/HA
At time = 5 min; 25/75 ACN/250 mM Ammonium Acetate, pll 4, 
At time = 15 rain; 25/75 ACN/250 mM Ammonium Acetate, pH 4„ 
At time = 18 min; 80/20 ACN/H20.
A : Calculated as depicted in Figure 5.10 
N : 16 x [(retention time/base width)’].
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Fable 5.6 Retention and efficiency data for aminoglycosides on 
column B (100 A)
Retention
(mm)
Peak Width 
(mm)
Efficiency
(N)
Peak 
Asymmetry (A)
Neo 70.0 10.0 784 2.40
Gent C l a 56.0 7.0 1024 1.50
Gent C2 55.0 8.0 756 1.04
Gent C 1 54.0 7.0 952 1.50
Kan 50.0 4.0 2500 1.17
Spec 35.5 7.0 412 2.17
Linco 29.0 7.0 275 1.17
Sal 18.5 3.0 608
- i .
1.00
Conditions ; Column B, Mobile phase gradient at 0.5 ml min’1 :
At time =0; 100 % ACN,
At time =5 min; 5/95 ACN/500 mM Ammonium Acetate, pH 4, 
At time = 15 min; 5/95 ACN/500 mM Ammonium Acetate, pH 4, 
At time = 18 min; 100 % ACN.
A : Calculated as depicted in Figure 5.10 
N : 16 x [(retention time/base width)"].
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Figure 5.15 Chromatogram o f analyte separation using HILIC Column 100 A
HPLC Conditions: 
Mobile phase gradient; 
% 0.5 ml min"1
Injection volume;
Column : Polyhydroxyethyl Aspartamide™, 200 x 2.1 mm, 5 pm, 100 , 
100 % acetonitrile, at t=0,
5 % acetonitrile, 95 % 500 mM NH4Ac, pH 4 at t=5 min 
5 % acetonitrile, 95 % 500 mM NH4Ac, pH 4 at t=15 min 
100 % acetonitrile, at t= 18 min,
50 pi
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The conditions described in Table 5.6 were used in conjunction w ith column B (100 Á),
to estimate the linearity o f the method and analyse fortified samples. Standards were
chromat ographed in a number o f different diluents, including:
A) 25 % acetonitrile, 75 % water,
B) 75 % acetonitrile, 25 % water,
C) 75 % water, 25 % 500 mM ammonium acetate, pH 4,
D) 75 % acetonitrile, 25 % 500 mM ammonium acetate, pH 4,
When diluent D (acetonitrile and buffer) was employed, the neomycin peak exhibited 
extreme tailing, streptomycin and dihydrostreptomycin resulted in split peaks and 
spectinomycin displayed very poor peak shape. Use o f diluent C resulted in much 
improved chromatography. This diluent contained no acetonitrile, which was replaced 
w ith water, resulting in a reduction in the molarity o f the buffer. Neomycin eluted as a 
broad peak with slight tailing (the peak was 1 min broad), while all other analytes 
exhibited acceptable peak shape and retention. Diluent B, comprising mainly o f 
acetonitrile, resulted in poor chromatography for all analytes except salinomycin and 
lincomycin. Using diluent A, results are comparable w ith diluent C for gentamicin, 
neomycin and kanamycin, that is, acceptable peak shape and retention, but 
spectinomycin, lincomycin and salinomycin all exhibited peak splitting. In conclusion, 
it appears that the presence o f high acetonitrile content in the diluent promotes good 
peak shape for salinomycin and lincomycin, but results in relatively poor shape for the 
other aminoglycosides.
5.3.8 L inearity  and sample analysis
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Linearity was assessed by injecting 6 standards (50 |il), prepared in diluent C, in the
1 2concentration range 0.05 to 10 jag ml" . R values of 0.999 were obtained, proving that 
the method gives adequate chromatography over a range o f analyte concentrations. 
Under these conditions, neomycin and spectinomycin peaks exhibited some tailing and 
streptomycin and dihydrostreptomycin were very poor (low intensity and peak 
splitting). Gentamicin and neomycin were detectable well above the MRL values 
shown in Table 5.7; no MRL has yet been set for kanamycin.
Table 5.7 MRLs for gentamicin and neomycin in various matrices.
M atrix
Gentamicin
(ppb)
Neomycin
(PPb)
M ilk 100 500
Muscle 100 500
Kidney 1000 5000
Liver 200 500
Fat 100 500
M ilk  samples fortified with gentamicin, neomycin and kanamycin and extracted by ion- 
exchange SPE, as described in Chapter 4, were analysed by HILIC-MS and by paired- 
ion chromatography w ith post-column derivatisation (PIC-PCD). The results are 
presented in Table 5.8. Recoveries were calculated by comparing peak areas derived 
from a standard analyte solution o f 100 (j.g m f1 chromatographed alongside the samples 
and recoveries were found to be similar using both methods.
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Table 5.8 Comparison of recovery (%) for milk samples fortified at 100 ppb 
and analysed by PIC-PCD and HILIC-MS (n=2).
PIC-PCD HILIC-MS
Mean Recovery (%>)
Gent Peak 1 68.3 73.3
Gent Peak 2 65.5 76.3
Gent Peak 3 69.0 N
Neo 79.4 84.0
Kan 54.4 55.8
N : Due to incompatibility of the ion-exchange SI‘E elution diluent with HILIC, this peak was not 
quantitated.
5.4 CONCLUSION
This preliminary study confirms the applicability o f H ILIC  for the analysis o f 
aminoglycoside drug residues. The suitability o f H ILIC  to mass spectrometric detection 
has been demonstrated and the method has been tested on m ilk and kidney sample 
extracts. The method illustrates a high degree o f specificity by providing retention time 
and structural information for the analytes. The development o f an LC-MS system for 
highly basic analytes is d ifficu lt and this is the first report o f an LC-MS method for 
aminoglycosides that does not employ ion-pair or ion-exchange chromatography. This 
is also the first report on the application o f H ILIC  to veterinary drug residue analysis. 
The method is capable o f detecting residues in tissues well below the MRL and this 
study shows that some aminoglycoside residues can be detected at levels lower than 
those reported previously. The studies carried out failed to produce a chromatographic
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method capable o f separating the basic aminoglycosides gentamicin, neomycin and 
kanamycin in  the same chromatographic run as streptomycin and dihydrostreptomycin. 
However, further investigations may result in a multi-residue method, capable o f 
achieving this. The results from this study provide a good indication o f the factors that 
affect the chromatography o f aminoglycosides, from the most polar (neomycin) to the 
relatively non-polar (spectinomycin).
This study has shown the important influence o f mobile phase composition on analyte 
retention and peak shape in HILIC separations and has illustrated the importance o f 
optimising the column pore-size for the analytes o f interest. The method shows potential 
for the analysis o f highly polar analytes and further studies into the effects o f various 
column packing materials and particle dimensions may allow multi-residue analysis o f a 
large range o f highly polar basic analytes, w ithin one chromatographic run. 
Alternatively, the method could be optimised for the analysis o f one specific analyte. A 
comparison o f the chromatograms presented in this study to those presented in Chapter 
4, where ion-pair chromatography was employed, shows H ILIC  offers superior peak 
shape and MS detection overcomes the problems o f matrix co-extractives, in addition to 
providing a confirmatory method. Also, gentamicin, neomycin and kanamycin can be 
analysed w ithin one-run, while co-elution prevented single run analysis using ion-pair 
chromatography. The application o f HILIC-MS w ill allow confirmatory analysis o f 
these analytes with a simple chromatographic method, possessing good 
chromatographic properties.
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